UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
Form 10-Q
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM                    TO          
COMMISSION FILE NUMBER 001-35964
 
 
 
COTY INC.
(Exact name of registrant as specified in its charter)
Delaware
 
13-3823358
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
350 Fifth Avenue, New York, NY
 
10118
(Address of principal executive offices)
 
(Zip Code)
(212) 389-7300
Registrant’s telephone number, including area code
 
 
 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ý       No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ý       No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer    ý
 
Accelerated filer    ¨
 
Non-accelerated filer    ¨
 
Smaller reporting company    ¨
 
 
 
Emerging growth company    ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨      No  ý
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.01 par value
COTY
New York Stock Exchange
At May 1, 2019 , 751,398,085 shares of the registrant’s Class A Common Stock, $0.01 par value, were outstanding.
 



COTY INC.
INDEX TO FORM 10-Q
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share data )
(Unaudited )
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Net revenues
$
1,990.6

 
$
2,222.7

 
$
6,533.1

 
$
7,098.6

Cost of sales
741.2

 
812.3

 
2,507.0

 
2,711.4

Gross profit
1,249.4

 
1,410.4

 
4,026.1

 
4,387.2

Selling, general and administrative expenses
1,070.5

 
1,251.6

 
3,476.8

 
3,761.9

Amortization expense
86.7

 
92.8

 
267.7

 
260.6

Restructuring costs
6.7

 
42.7

 
43.7

 
75.6

Acquisition-related costs

 
2.6

 

 
63.7

Asset impairment charges

 

 
977.7

 

Operating income (loss)
85.5

 
20.7

 
(739.8
)
 
225.4

Interest expense, net
72.0

 
72.6

 
204.4

 
199.3

Other expense, net
17.5

 
3.8

 
25.0

 
12.5

(Loss) income before income taxes
(4.0
)
 
(55.7
)
 
(969.2
)
 
13.6

Provision (benefit) for income taxes

 
4.4

 
0.9

 
(28.8
)
Net (loss) income
(4.0
)
 
(60.1
)
 
(970.1
)
 
42.4

Net income (loss) attributable to noncontrolling interests
2.3

 
1.1

 
4.1

 
(3.0
)
Net income attributable to redeemable noncontrolling interests
5.8

 
15.8

 
10.6

 
32.9

Net (loss) income attributable to Coty Inc.
$
(12.1
)
 
$
(77.0
)
 
$
(984.8
)
 
$
12.5

Net (loss) income attributable to Coty Inc. per common share:
 

 
 

 
 

 
 

Basic
$
(0.02
)
 
$
(0.10
)
 
$
(1.31
)
 
$
0.02

Diluted
(0.02
)
 
(0.10
)
 
(1.31
)
 
0.02

Weighted-average common shares outstanding:
 

 
 

 
 

 
 

Basic
751.4

 
750.1

 
751.1

 
749.4

Diluted
751.4

 
750.1

 
751.1

 
753.1


See notes to Condensed Consolidated Financial Statements.


1

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In millions)
(Unaudited)
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Net (loss) income
$
(4.0
)
 
$
(60.1
)
 
$
(970.1
)
 
$
42.4

Other comprehensive (loss) income:
 

 
 

 
 

 
 

Foreign currency translation adjustment
(18.6
)
 
247.4

 
(127.5
)
 
518.5

Net unrealized derivative (loss) gain on cash flow hedges, net of taxes of $3.4 and $1.5, and $8.9 and $(2.5) during the three and nine months ended, respectively
(11.0
)
 
6.9

 
(28.7
)
 
14.2

Pension and other post-employment benefits adjustment, net of tax of $2.0 and $(0.7), and $0.6 and $(0.7) during the three and nine months ended, respectively
(5.6
)
 
(2.3
)
 
(4.0
)
 
(0.7
)
Total other comprehensive (loss) income, net of tax
(35.2
)
 
252.0

 
(160.2
)
 
532.0

Comprehensive (loss) income
(39.2
)
 
191.9

 
(1,130.3
)
 
574.4

Comprehensive income (loss) attributable to noncontrolling interests:
 

 
 

 
 

 
 

Net income (loss)
2.3

 
1.1

 
4.1

 
(3.0
)
Foreign currency translation adjustment
(0.1
)
 
(0.2
)
 
0.1

 
0.3

Total comprehensive income (loss) attributable to noncontrolling interests
2.2

 
0.9

 
4.2

 
(2.7
)
Comprehensive income attributable to redeemable noncontrolling interests:
 
 
 
 
 
 
 
Net income
5.8

 
15.8

 
10.6

 
32.9

Comprehensive (loss) income attributable to Coty Inc.
$
(47.2
)
 
$
175.2

 
$
(1,145.1
)
 
$
544.2


See notes to Condensed Consolidated Financial Statements.

2

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except per share data )
(Unaudited)
 
March 31,
2019
 
June 30,
2018
ASSETS
 

 
 

Current assets:
 

 
 

Cash and cash equivalents
$
384.1

 
$
331.6

Restricted cash
36.1

 
30.6

Trade receivables—less allowances of $64.3 and $81.8, respectively
1,211.6

 
1,536.0

Inventories
1,183.5

 
1,148.9

Prepaid expenses and other current assets
587.2

 
603.9

Total current assets
3,402.5

 
3,651.0

Property and equipment, net
1,609.2

 
1,680.8

Goodwill
7,618.8

 
8,607.1

Other intangible assets, net
7,791.3

 
8,284.4

Deferred income taxes
183.3

 
107.4

Other noncurrent assets
151.5

 
299.5

TOTAL ASSETS
$
20,756.6

 
$
22,630.2

LIABILITIES AND EQUITY
 

 
 

Current liabilities:


 


Accounts payable
$
1,844.0

 
$
1,928.6

Accrued expenses and other current liabilities
1,488.0

 
1,844.4

Short-term debt and current portion of long-term debt
196.7

 
218.9

Income and other taxes payable
50.1

 
52.1

Total current liabilities
3,578.8

 
4,044.0

Long-term debt, net
7,490.9

 
7,305.4

Pension and other post-employment benefits
518.2

 
533.3

Deferred income taxes
836.0

 
842.5

Other noncurrent liabilities
378.0

 
388.5

Total liabilities
12,801.9

 
13,113.7

COMMITMENTS AND CONTINGENCIES (See Note 18)


 


REDEEMABLE NONCONTROLLING INTERESTS
452.2

 
661.3

EQUITY:
 

 
 

Preferred Stock, $0.01 par value; 20.0 shares authorized, 10.2 and 5.0 issued and 8.4 and 5.0 outstanding, respectively, at March 31, 2019 and June 30, 2018
0.1

 

Class A Common Stock, $0.01 par value; 1,000.0 shares authorized, 816.4 and 815.8 issued and 751.4 and 750.7 outstanding, respectively, at March 31, 2019 and June 30, 2018
8.1

 
8.1

Additional paid-in capital
10,674.6

 
10,750.8

Accumulated deficit
(1,741.8
)
 
(626.2
)
Accumulated other comprehensive income
(1.5
)
 
158.8

Treasury stock—at cost, shares: 65.0 at March 31, 2019 and June 30, 2018
(1,441.8
)
 
(1,441.8
)
Total Coty Inc. stockholders’ equity
7,497.7

 
8,849.7

Noncontrolling interests
4.8

 
5.5

Total equity
7,502.5

 
8,855.2

TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
$
20,756.6

 
$
22,630.2

See notes to Condensed Consolidated Financial Statements.

3

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY AND
REDEEMABLE NONCONTROLLING INTERESTS
For the Three and Nine Months Ended March 31, 2019
(In millions, except per share data)
(Unaudited)
 
Preferred Stock
 
Class A
Common Stock
 
Additional
Paid-in Capital
 
(Accumulated Deficit)
 
Accumulated Other Comprehensive Income (Loss)
 
Treasury Stock
 
Total Coty Inc.
Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
 
Redeemable
Noncontrolling Interests
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Shares
 
Amount
 
 
 
 
BALANCE as previousl y reported—July 1, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,750.8

 
$
(626.2
)
 
$
158.8

 
65.0

 
$
(1,441.8
)
 
$
8,849.7

 
$
5.5

 
$
8,855.2

 
$
661.3

Adjustment due to the adoption of ASU No. 2016-16 (See Note 2)


 


 


 


 


 
(112.6
)
 


 


 


 
(112.6
)
 


 
(112.6
)
 


Adjustment due to the adoption of ASC 606 (See Note 3)
 
 
 
 
 
 
 
 
 
 
(18.2
)
 
 
 
 
 
 
 
(18.2
)
 
 
 
(18.2
)
 
 
BALANCE as adjusted—July 1, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,750.8

 
$
(757.0
)
 
$
158.8

 
65.0

 
$
(1,441.8
)
 
$
8,718.9

 
$
5.5

 
$
8,724.4

 
$
661.3

Exercise of employee stock options and restricted stock units
 
 
 
 

 

 
0.7

 
 
 
 
 
 
 
 
 
0.7

 
 
 
0.7

 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
6.4

 
 
 
 
 
 
 
 
 
6.4

 
 
 
6.4

 
 
Dividends ($0.125 per common share)
 
 
 
 
 
 
 
 
(94.0
)
 
 
 
 
 
 
 
 
 
(94.0
)
 
 
 
(94.0
)
 
 
Net income (loss)
 
 
 
 
 
 
 
 
 
 
(12.1
)
 
 
 
 
 
 
 
(12.1
)
 
1.2

 
(10.9
)
 
0.8

Other comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
(48.0
)
 
 
 
 
 
(48.0
)
 
0.2

 
(47.8
)
 


Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
(1.3
)
 
(1.3
)
 
(4.3
)
Additional redeemable noncontrolling interests due to employee grants (See Note 17)


 


 


 


 
(1.6
)
 


 


 


 


 
(1.6
)
 


 
(1.6
)
 
1.6

Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
37.2

 
 
 
 
 
 
 
 
 
37.2

 
 
 
37.2

 
(37.2
)
BALANCE—September 30, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,699.5

 
$
(769.1
)
 
$
110.8

 
65.0

 
$
(1,441.8
)
 
$
8,607.5

 
$
5.6

 
$
8,613.1

 
$
622.2

Cancellation of Preferred Stock
(3.1
)
 

 


 


 


 


 


 


 


 

 


 

 


Exercise of employee stock options and restricted stock units


 


 
0.4

 

 
0.2

 


 


 


 


 
0.2

 


 
0.2

 


Shares withheld for employee taxes


 


 


 


 
(1.3
)
 


 


 


 


 
(1.3
)
 


 
(1.3
)
 


Share-based compensation expense


 


 


 


 
4.4

 


 


 


 


 
4.4

 


 
4.4

 


Dividends ($0.125 per Common Share)
 
 
 
 
 
 
 
 
(94.6
)
 
 
 
 
 
 
 
 
 
(94.6
)
 
 
 
(94.6
)
 
 
Net income (loss)
 
 
 
 
 
 
 
 
 
 
(960.6
)
 
 
 
 
 
 
 
(960.6
)
 
0.6

 
(960.0
)
 
4.0

Other comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
(77.2
)
 
 
 
 
 
(77.2
)
 
 
 
(77.2
)
 
 
Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
(11.9
)
Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
126.7

 
 
 
 
 
 
 
 
 
126.7

 
 
 
126.7

 
(126.7
)
BALANCE—December 31, 2018
1.9

 
$

 
816.2

 
$
8.1

 
$
10,734.9

 
$
(1,729.7
)
 
$
33.6

 
65.0

 
$
(1,441.8
)
 
$
7,605.1

 
$
6.2

 
$
7,611.3

 
$
487.6

Issuance of Preferred Stock
6.9

 
0.1

 


 


 
0.6

 


 


 


 


 
0.7

 


 
0.7

 


Cancellation of Preferred Stock
(0.4
)
 

 


 


 

 


 


 


 


 

 


 

 


Exercise of employee stock options and restricted stock units


 


 
0.2

 

 
0.5

 


 


 


 


 
0.5

 


 
0.5

 


Shares withheld for employee taxes


 


 


 


 
(0.1
)
 


 


 


 


 
(0.1
)
 


 
(0.1
)
 


Share-based compensation expense


 


 


 


 
(0.5
)
 


 


 


 


 
(0.5
)
 


 
(0.5
)
 


Dividends ($0.125 per Common Share)


 


 


 


 
(94.7
)
 


 


 


 


 
(94.7
)
 


 
(94.7
)
 



4

Table of Contents

Net income (loss)


 


 


 


 


 
(12.1
)
 


 


 


 
(12.1
)
 
2.3

 
(9.8
)
 
5.8

Other comprehensive loss


 


 


 


 


 


 
(35.1
)
 


 


 
(35.1
)
 
(0.1
)
 
(35.2
)
 


Distribution to noncontrolling interests, net


 


 


 


 


 


 


 


 


 

 
(3.6
)
 
(3.6
)
 
(8.3
)
Additional redeemable noncontrolling interests due to employee grants and other adjustments


 


 


 


 
0.9

 


 


 


 


 
0.9

 


 
0.9

 
0.1

Adjustment of redeemable noncontrolling interests to the higher of its redemption value or carrying value


 


 


 


 
33.0

 


 


 


 


 
33.0

 


 
33.0

 
(33.0
)
BALANCE—March 31, 2019
8.4

 
$
0.1

 
816.4

 
$
8.1

 
$
10,674.6

 
$
(1,741.8
)
 
$
(1.5
)
 
65.0

 
$
(1,441.8
)
 
$
7,497.7

 
$
4.8

 
$
7,502.5

 
$
452.2


See notes to Condensed Consolidated Financial Statements.

5

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY AND
REDEEMABLE NONCONTROLLING INTERESTS
For the Three and Nine Months Ended March 31, 2018
(In millions, except per share data)
(Unaudited)
 
Preferred Stock
 
Class A
Common Stock
 
Additional
Paid-in Capital
 
(Accumulated Deficit)
 
Accumulated Other Comprehensive Income
 
Treasury Stock
 
Total Coty Inc.
Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
 
Redeemable
Noncontrolling Interests
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Shares
 
Amount
 
 
 
 
BALANCE as previousl y reported—July 1, 2017
4.2

 
$

 
812.9

 
$
8.1

 
$
11,203.2

 
$
(459.2
)
 
$
4.4

 
65.0

 
$
(1,441.8
)
 
$
9,314.7

 
$
3.0

 
$
9,317.7

 
$
551.1

Adjustment due to the adoption of ASU No. 2016-09
 
 
 
 
 
 
 
 
 
 
8.3

 
 
 
 
 
 
 
8.3

 
 
 
8.3

 
 
BALANCE as adjusted—July 1, 2017
4.2

 
$

 
812.9

 
$
8.1

 
$
11,203.2

 
$
(450.9
)
 
$
4.4

 
65.0

 
$
(1,441.8
)
 
$
9,323.0

 
$
3.0

 
$
9,326.0

 
$
551.1

Exercise of employee stock options and restricted stock units and related tax benefits
 
 
 
 
1.5

 

 
11.2

 
 
 
 
 
 
 
 
 
11.2

 
 
 
11.2

 
 
Shares withheld for employee taxes
 
 
 
 
 
 
 
 
(3.1
)
 
 
 
 
 
 
 
 
 
(3.1
)
 
 
 
(3.1
)
 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
8.1

 
 
 
 
 
 
 
 
 
8.1

 
 
 
8.1

 
 
Dividends ($0.125 per common share)
 
 
 
 
 
 
 
 
(94.3
)
 
 
 
 
 
 
 
 
 
(94.3
)
 
 
 
(94.3
)
 
 
Net (loss) income
 
 
 
 
 
 
 
 
 
 
(19.7
)
 
 
 
 
 
 
 
(19.7
)
 
(2.2
)
 
(21.9
)
 
5.8

Other comprehensive income
 
 
 
 
 
 
 
 
 
 
 
 
239.1

 
 
 
 
 
239.1

 
0.6

 
239.7

 
 
Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
(6.4
)
Dilution of redeemable noncontrolling interest due to additional contribution
 
 
 
 
 
 
 
 
17.0

 
 
 
 
 
 
 
 
 
17.0

 
 
 
17.0

 
(17.0
)
Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
(29.0
)
 
 
 
 
 
 
 
 
 
(29.0
)
 
 
 
(29.0
)
 
29.0

BALANCE—September 30, 2017
4.2

 
$

 
814.4

 
$
8.1

 
$
11,113.1

 
$
(470.6
)
 
$
243.5

 
65.0

 
$
(1,441.8
)
 
$
9,452.3

 
$
1.4

 
$
9,453.7

 
$
562.5

Issuance of Preferred Stock
1.0

 

 
 
 
 
 

 
 
 
 
 
 
 
 
 

 
 
 

 
 
Exercise of employee stock options and restricted stock units and related tax benefits
 
 
 
 
0.4

 
 
 
2.5

 
 
 
 
 
 
 
 
 
2.5

 
 
 
2.5

 
 
Shares withheld for employee taxes
 
 
 
 
 
 
 
 
(0.3
)
 
 
 
 
 
 
 
 
 
(0.3
)
 
 
 
(0.3
)
 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
9.0

 
 
 
 
 
 
 
 
 
9.0

 
 
 
9.0

 
 
Dividends ($0.125 per common share)
 
 
 
 
 
 
 
 
(94.4
)
 
 
 
 
 
 
 
 
 
(94.4
)
 
 
 
(94.4
)
 
 
Net income (loss)
 
 
 
 
 
 
 
 
 
 
109.2

 
 
 
 
 
 
 
109.2

 
(1.9
)
 
107.3

 
11.3

Other comprehensive income
 
 
 
 
 
 
 
 
 
 
 
 
40.4

 
 
 
 
 
40.4

 
(0.1
)
 
40.3

 
 
Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
(25.3
)
Additional redeemable noncontrolling interests due to employee grants (See Note 17)
 
 
 
 
 
 
 
 
(8.3
)
 
 
 
 
 
 
 
 
 
(8.3
)
 
 
 
(8.3
)
 
8.3

Proceeds from redeemable noncontrolling interests
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
0.2

Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
(81.3
)
 
 
 
 
 
 
 
 
 
(81.3
)
 
 
 
(81.3
)
 
81.3

BALANCE—December 31, 2017
5.2

 
$

 
814.8

 
$
8.1

 
$
10,940.3

 
$
(361.4
)
 
$
283.9

 
65.0

 
$
(1,441.8
)
 
$
9,429.1

 
$
(0.6
)
 
$
9,428.5

 
$
638.3

Cancellation of Preferred Stock
(0.2
)
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
 
Exercise of employee stock options and restricted stock units and related tax benefits
 
 
 
 
0.7

 

 
6.3

 
 
 
 
 
 
 
 
 
6.3

 
 
 
6.3

 
 

6

Table of Contents

Shares withheld for employee taxes
 
 
 
 
 
 
 
 
(0.1
)
 
 
 
 
 
 
 
 
 
(0.1
)
 
 
 
(0.1
)
 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
8.7

 
 
 
 
 
 
 
 
 
8.7

 
 
 
8.7

 
 
Dividends ($0.125 per common share)
 
 
 
 
 
 
 
 
(94.6
)
 
 
 
 
 
 
 
 
 
(94.6
)
 
 
 
(94.6
)
 
 
Net (loss) income
 
 
 
 
 
 
 
 
 
 
(77.0
)
 
 
 
 
 
 
 
(77.0
)
 
1.1

 
(75.9
)
 
15.8

Other comprehensive income
 
 
 
 
 
 
 
 
 
 
 
 
252.2

 
 
 
 
 
252.2

 
(0.2
)
 
252.0

 
 
Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
(14.0
)
Additional redeemable noncontrolling interests due to employee grants (See Note 17)
 
 
 
 
 
 
 
 
0.9

 
 
 
 
 
 
 
 
 
0.9

 
 
 
0.9

 
(0.9
)
Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
(26.2
)
 
 
 
 
 
 
 
 
 
(26.2
)
 
 
 
(26.2
)
 
26.2

BALANCE—March 31, 2018
5.0

 
$

 
815.5

 
$
8.1

 
$
10,835.3

 
$
(438.4
)
 
$
536.1

 
65.0

 
$
(1,441.8
)
 
$
9,499.3

 
$
0.3

 
$
9,499.6

 
$
665.4


See notes to Condensed Consolidated Financial Statements.

7

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
 
Nine Months Ended
March 31,
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 

 
 

Net (loss) income
$
(970.1
)
 
$
42.4

Adjustments to reconcile net (loss) income to net cash provided by operating activities:
 

 
 

Depreciation and amortization
550.3

 
543.5

Deferred income taxes
(57.5
)
 
(157.7
)
Provision for bad debts
7.8

 
15.4

Provision for pension and other post-employment benefits
27.3

 
33.3

Share-based compensation
7.8

 
26.1

Asset impairment charges
977.7

 

Non-cash restructuring charges
27.8

 
0.9

Other
28.6

 
15.3

Change in operating assets and liabilities, net of effects from purchase of acquired companies:
 

 
 

Trade receivables
290.1

 
(33.5
)
Inventories
(59.4
)
 
(101.3
)
Prepaid expenses and other current assets
(7.5
)
 
(76.2
)
Accounts payable
(5.3
)
 
(80.2
)
Accrued expenses and other current liabilities
(344.1
)
 
(27.4
)
Income and other taxes payable
(3.8
)
 
64.6

Other noncurrent assets
19.4

 
(7.2
)
Other noncurrent liabilities
(37.7
)
 
(69.1
)
Net cash provided by operating activities
451.4

 
188.9

CASH FLOWS FROM INVESTING ACTIVITIES:
 

 
 

Capital expenditures
(330.9
)
 
(318.7
)
Payment for business combinations and asset acquisitions, net of cash acquired
(40.8
)
 
(265.5
)
Proceeds from sale of asset
0.7

 
3.5

Net cash used in investing activities
(371.0
)
 
(580.7
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 

 
 

Net (repayments of) proceeds from short-term debt, original maturity less than three months
(17.1
)
 
5.1

Proceeds from revolving loan facilities
1,587.4

 
2,298.1

Repayments of revolving loan facilities
(1,106.8
)
 
(1,535.8
)
Repayments of term loans and other long-term debt
(142.5
)
 
(150.6
)
Dividend payment
(282.8
)
 
(281.9
)
Net proceeds from issuance of Class A Common Stock and Series A Preferred Stock
2.0

 
20.0

Net payments of foreign currency contracts
(6.5
)
 
(2.7
)
Proceeds from noncontrolling interests

 
0.2

Distributions to noncontrolling interests, redeemable noncontrolling interests and mandatorily redeemable financial instruments
(34.3
)
 
(54.0
)
Payment of debt issuance costs
(10.7
)
 
(4.0
)
All other
(5.4
)
 
(3.5
)
Net cash (used in) provided by financing activities
(16.7
)
 
290.9

EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
(5.7
)
 
16.7

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
58.0

 
(84.2
)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period
362.2

 
570.7

CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period
$
420.2

 
$
486.5

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
 

 
 

Cash paid during the period for interest
$
195.8

 
$
194.2

Cash received during the period for settlement of interest rate swaps (See Note 13)
43.2

 

Cash paid during the period for income taxes, net of refunds received
88.4

 
83.9

SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING AND INVESTING ACTIVITIES:
 

 
 

Accrued capital expenditure additions
$
97.3

 
$
104.3

Non-cash contingent consideration for business combination (see Note 5)

 
5.0


See notes to Condensed Consolidated Financial Statements.

8

Table of Contents

COTY INC. & SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in millions, except per share data)
(Unaudited)

1 . DESCRIPTION OF BUSINESS
Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics, hair care products and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands.
The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2019 ” refer to the fiscal year ending June 30, 2019 . When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation.
The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability. The Company also generally experiences an increase in sales during its fourth fiscal quarter in its Professional Beauty segment as a result of higher demand prior to the summer holiday season.
2 . SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2018 . In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and nine months ended March 31, 2019 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2019 . All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
Restricted Cash
Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of March 31, 2019 and June 30, 2018 , the Company had restricted cash of  $36.1  and  $30.6 , respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of March 31, 2019 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of March 31, 2019 . Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the market value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, pension benefit costs, the assessment of goodwill, other intangible assets and long-lived assets for impairment, income taxes and the fair value of redeemable noncontrolling interests. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods.

9


Tax Information
The effective income tax rate for the  three months ended March 31, 2019 and 2018  was  0.0%  and  (7.9)% , respectively, and (0.1)% and (211.8)% for the nine months ended March 31, 2019 and 2018 , respectively. The negative effective tax rate in the three months ended March 31, 2018 and the nine months ended March 31, 2019 results from reporting losses before income taxes and a provision for income taxes. The negative effective tax rate in the nine months ended March 31, 2018 results from reporting income before taxes and a benefit for income taxes. The change in effective tax rate for the three months ended March 31, 2019 , as compared to the prior period, is primarily due to the impact of the Tax Act (as described below) in the prior period. The change in effective tax rate for the nine months ended March 31, 2019 , as compared to the prior year period, is primarily due to the resolution of foreign uncertain tax positions of approximately $43.0 in the prior period.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.
On December 22, 2017, “H.R.1”, formerly known as the “Tax Cuts and Jobs Act” (“Tax Act”) was enacted. The Tax Act significantly revises the U.S. corporate income tax system by, amongst other things, reducing the federal tax rate on U.S. earnings to 21% , implementing a modified territorial tax system and imposing a one-time deemed repatriation tax on historical earnings generated by foreign subsidiaries that have not been repatriated to the U.S.
On December 22, 2017, the Securities and Exchange Commission (the “SEC”) issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the enactment date of the Tax Act for companies to complete the accounting under ASC 740. The Company recorded its initial estimate of the impact of the Tax Act in fiscal 2018. This estimate was a charge of approximately $41.0 as a result of utilizing tax attributes (e.g., net operating losses and foreign tax credits) to fully offset the cash impact of the one-time deemed repatriation tax. During the second quarter of fiscal 2019, the Company finalized its calculation of the impact of the Tax Act and no additional adjustments were required.
The Tax Act requires a U.S. shareholder of a foreign corporation to include in income its global intangible low-taxed income (“GILTI”). In general, GILTI is described as the excess of a U.S. shareholder’s total net foreign income over a deemed return on tangible assets. As a result of recently released Financial Accounting Standards Board (“FASB”) guidance, an entity may choose to recognize deferred taxes for temporary differences expected to reverse as GILTI in future years or an entity can elect to treat GILTI as a period cost and include it in the tax expense of the year it is incurred. As such, the Company has elected to treat the tax on GILTI as a tax expense in the year it is incurred rather than recognizing deferred taxes. The Company has estimated the impact from GILTI for fiscal 2019 to be immaterial. Additionally, the Tax Act created the Base Erosion Anti-Abuse Tax (“BEAT”), a new minimum tax on taxable income adjusted for certain base erosion payments. The Company does not presently expect that it will be subject to the minimum tax imposed by the BEAT provisions for fiscal 2019.
As of  March 31, 2019  and  June 30, 2018 , the gross amount of UTBs was  $303.4  and  $303.6 , respectively. As of  March 31, 2019 , the total amount of UTBs that, if recognized, would impact the effective income tax rate is  $118.7 . As of March 31, 2019  and  June 30, 2018 , the liability associated with UTBs, including accrued interest and penalties, was  $134.9  and  $135.4 , respectively, which was recorded in Income and other taxes payable and Other non-current liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was  $0.6  and  $(0.2) for the  three months ended March 31, 2019 and 2018 , respectively, and $3.2  and  $1.9 for the  nine months ended March 31, 2019 and 2018 , respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of  March 31, 2019  and  June 30, 2018  was  $16.1  and  $13.1 , respectively. On the basis of the information available as of  March 31, 2019 , it is reasonably possible that a decrease of up to  $23.2  in UTBs may occur within 12 months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations.
Factoring of Receivables
On March 19, 2019, the Company entered into an Uncommitted Receivables Purchase Agreement (the “Receivables Purchase Agreement”) with a financial institution, with an aggregate facility limit of $150.0 . Eligible trade receivables are purchased by the financial institution for cash at net invoice value less a factoring fee. Pursuant to Receivables Purchase Agreement, the Company acts as collections agent for the financial institution and is responsible for the collection, and remittance to the financial institution, of all customer payments related to trade receivables factored under this arrangement. For certain customer receivables factored, the Company will retain a recourse obligation of up to 10 percent of the respective invoice’s net invoice value, payable to the financial institution if the customer’s payment is not received by the contractual due date.
The Company accounts for trade receivable transfers under the Receivables Purchase Agreement as sales and derecognizes the sold receivables from the Condensed Consolidated Balance Sheets. The fair value of sold receivables approximated their

10


book value due to their short-term nature. The Company estimated that the fair value of its servicing responsibilities was not material. Cash received from the selling of receivables under the Receivables Purchase Agreement are presented as a change in trade receivables within the operating activities section of the Condensed Consolidated Statements of Cash Flows.
During the three and nine months ended March 31, 2019 , total trade receivables factored under the Receivables Purchase Agreement, net of collections, was $109.1 , which reflects the timing of certain trade receivables factored late in the third quarter. Gross trade receivables factored under the Receivables Purchase Agreement during the three and nine months ended March 31, 2019 totaled $134.6 .
Recently Adopted Accounting Pronouncements
In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) , which implements a common revenue model that will enhance comparability across industries and require enhanced disclosures. The Company adopted this new standard on July 1, 2018. See Note  3 Revenue Recognition  for more information on the effects of the adoption of this standard.
In October 2016, the FASB issued ASU No. 2016-16,  Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, which requires entities to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company adopted the standard in the first quarter of fiscal 2019 using the modified retrospective transition method and recognized tax expense, as an adjustment to the July 1, 2018 accumulated deficit balance of $7.6 and $120.8 that were previously deferred in Prepaid expenses and other current assets and Other noncurrent assets, respectively. The recognition of this tax expense was partially offset by a previously unrecognized deferred tax asset of $15.8 , resulting in a cumulative-effect adjustment of $112.6 as an increase to the July 1, 2018 accumulated deficit balance.
In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which provides an updated model for determining if acquired assets and liabilities constitute a business. In a business combination, the acquired assets and liabilities are recognized at fair value and goodwill could be recognized. In an asset acquisition, the assets are allocated value based on relative fair value and no goodwill is recognized. The ASU narrows the definition of a business. The Company adopted the standard in the first quarter of fiscal 2019 on a prospective basis. The adoption of this guidance did not have an impact on the Company’s Condensed Consolidated Financial Statements.
In January 2017, the FASB issued ASU No. 2017-04,  Intangibles Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment , which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test. The Company early adopted the ASU during the first quarter of fiscal 2019. As of July 1, 2018, the adoption of this guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
In March 2017, the FASB issued ASU No. 2017-07, Compensation Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”), which requires employers to report the service cost component of net periodic benefit cost in the same line item or items as other compensation costs arising from services rendered by the underlying employees during the period. The other components of net periodic benefit cost are required to be reported separately and outside of operating income. In addition, only the service cost component would be eligible for capitalization in assets. The new guidance also allows a practical expedient that permits employers to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. The Company adopted this standard during the first quarter of fiscal 2019 and retrospectively applied it to each prior period presented. In doing so, as a practical expedient, the Company used the prior comparative period Employee Benefit Plans footnote (see Note 12 ).
The following table presents our results under our historical method of accounting and as adjusted to reflect our adoption of ASU No. 2017-07:
 
Three Months Ended
March 31, 2018
 
Nine Months Ended
March 31, 2018
 
As Previously Reported
 
Effect of Adoption of ASU No. 2017-07
 
As Adjusted
 
As Previously Reported
 
Effect of Adoption of ASU No. 2017-07
 
As Adjusted
Cost of sales
$
812.4

 
$
(0.1
)
 
$
812.3

 
$
2,711.7

 
$
(0.3
)
 
$
2,711.4

Selling, general and administrative expenses
1,252.3

 
(0.7
)
 
1,251.6

 
3,764.0

 
(2.1
)
 
3,761.9

Operating income
19.9

 
0.8

 
20.7

 
223.0

 
2.4

 
225.4

Other expense, net
3.0

 
0.8

 
3.8

 
10.1

 
2.4

 
12.5

Net income
(60.1
)
 

 
(60.1
)
 
42.4

 

 
42.4


11


In May 2017, the FASB issued ASU No. 2017-09, Compensation Stock Compensation (Topic 718): Scope of Modification Accounting, which narrows the scope of changes in grant terms that would require modification accounting. The Company adopted this standard during the first quarter of fiscal 2019 on a prospective basis. The adoption did not have an effect on the Company’s Condensed Consolidated Financial Statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles Goodwill and Other Internal-Use Software (Subtopic 350-40) , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted the standard in the first quarter of fiscal 2019 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
Recently Issued Accounting Pronouncements
In August 2018, the FASB issued ASU No. 2018-14, Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans , which modified the disclosure requirements by removing, modifying and clarifying disclosures related to defined benefit plans. The amendment will be effective for the Company in fiscal 2021 with early adoption permitted. The Company is evaluating the impact this guidance will have on the Company’s Condensed Consolidated Financial Statements and related disclosures.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement , which modified the disclosure requirements by removing, modifying and adding disclosures related to fair value measurements. The amendment will be effective for the Company in fiscal 2021 with early adoption permitted. The Company is evaluating the impact this guidance will have on the Company’s Condensed Consolidated Financial Statements and related disclosures.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU No. 2016-13”), which requires that a financial asset (or a group of financial assets) measured at an amortized cost basis be presented at the net amount expected to be collected. This approach to estimating credit losses applies to most financial assets measured at amortized cost and certain other instruments, including but not limited to, trade and other receivables. In November 2018, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments-Credit Losses , which clarifies the scope of the guidance in ASU No. 2016-13. The amendment will be effective for the Company in fiscal 2021 with early adoption permitted. The Company is evaluating the impact this guidance will have on the Company’s Condensed Consolidated Financial Statements and related disclosures.
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in its balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. Lessees and lessors have the option to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach or to initially apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.
Additionally, in December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors , which provides lessors the election to consider certain sales and similar taxes as lessee costs and exclude them from consideration in the contract, requires lessors to exclude certain lessor costs paid directly to third parties from expenses and related revenues, and requires the allocation of certain variable payments to the lease and nonlease components when changes in facts and circumstances related to the payments occur.
The new leasing guidance will be effective for the Company in fiscal 2020 with early adoption permitted. The Company has an implementation team in place that is performing a comprehensive evaluation of the impact the standard will have on the Company’s Condensed Consolidated Financial Statements and related disclosures. The evaluation includes assessing the Company’s lease portfolio, the implementation of new software to meet reporting requirements and the impact to business processes. Based on the current status of the evaluation, management believes the adoption of the new standard will have a significant impact on the Condensed Consolidated Balance Sheets. The Company expects to finalize its evaluation and assessment as required by the new leases standard and quantify the balance sheet impact upon adoption at July 1, 2019 during the fourth quarter of fiscal 2019. Upon adoption, the Company’s lease liability will be based on the present value of such payments and the related right-of-use asset will be based on the lease liability, adjusted for initial direct costs, prepaid lease payments and lease incentives received. The Company plans to adopt the new standard when it becomes effective in the fiscal 2020 first quarter using the modified retrospective transition approach for leases that exist at adoption and will not restate the prior comparative periods.

12


3 . REVENUE RECOGNITION
Adoption of ASC 606, Revenue from Contracts with Customers
On July 1, 2018, the Company adopted ASC 606, Revenue from Contracts with Customers and all related amendments (the “New Revenue Standard”) using the modified retrospective method applied to those contracts which were not completed as of July 1, 2018. Results for reporting periods beginning after July 1, 2018 are presented under the New Revenue Standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition .
The Company recorded a net increase to its accumulated deficit as of July 1, 2018 (as presented below) due to the cumulative impact of adopting the New Revenue Standard, with the impact primarily related to the timing of accrual for certain customer incentives and markdowns at the time of sell-in and reclassification of certain marketing fixtures expense as a reduction of gross revenue.
The cumulative effects of the revenue accounting changes on the Company's Condensed Consolidated Balance Sheet as of July 1, 2018 were as follows:
 
June 30, 2018
 
Adjustments
 
July 1, 2018
ASSETS
 
 
 
 
 
Property and equipment, net
$
1,680.8

 
$
(6.2
)
 
$
1,674.6

Deferred income taxes
107.4

 
0.6

 
108.0

Other noncurrent assets
299.5

 
6.9

 
306.4

 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accrued expenses and other current liabilities
$
1,844.4

 
$
20.7

 
$
1,865.1

Deferred income taxes
842.5

 
(1.2
)
 
841.3

Accumulated deficit
(626.2
)
 
(18.2
)
 
(644.4
)
The following table summarizes the impacts of adopting the New Revenue Standard on the Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2019 :
 
As reported (New Revenue Standard)
 
Current period adjustments
 
As adjusted (previous revenue standard)
Net revenues
$
1,990.6

 
$
25.6

 
$
2,016.2

Selling, general and administrative expenses
1,070.5

 
1.0

 
1,071.5

Net (loss) income
(4.0
)
 
18.4

 
14.4

Net (loss) income attributable to Coty Inc.
(12.1
)
 
18.6

 
6.5

 
 
 
 
 
 
Net (loss) income attributable to Coty Inc. per common share:
 
 
 
 
 
Basic
$
(0.02
)
 
$
0.03

 
$
0.01

Diluted
(0.02
)
 
0.03

 
0.01


13


The following table summarizes the impacts of adopting the New Revenue Standard on the Condensed Consolidated Statements of Operations for the Nine Months Ended March 31, 2019 :
 
As reported (New Revenue Standard)
 
Current period adjustments
 
As adjusted (previous revenue standard)
Net revenues
$
6,533.1

 
$
8.9

 
$
6,542.0

Selling, general and administrative expenses
3,476.8

 
2.3

 
3,479.1

Net (loss) income
(970.1
)
 
5.0

 
(965.1
)
Net (loss) income attributable to Coty Inc.
(984.8
)
 
5.0

 
(979.8
)
 
 
 
 
 
 
Net (loss) income attributable to Coty Inc. per common share:
 
 
 
 
 
Basic
$
(1.31
)
 
$
0.01

 
$
(1.30
)
Diluted
(1.31
)
 
0.01

 
(1.30
)
Revenue Recognition Accounting Policy
For periods after July 1, 2018, revenue is recognized at a point in time and/or over time when control of the promised goods or services is transferred to the Company’s customers, which usually occurs upon delivery. Revenue is recognized in an amount that reflects the consideration we expect to be entitled to in exchange for transferring those goods or services. At contract inception, the Company assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. The Company’s revenue contracts principally represent a performance obligation to sell its beauty products to trade customers and are satisfied when control of promised goods and services is transferred to the customers.
Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns (estimated based on an analysis of historical experience and position in product life cycle) and various trade spending activities. Trade spending activities represent variable consideration promised to the customer and primarily relate to advertising, product promotions and demonstrations, some of which involve cooperative relationships with customers. The costs of trade spend activities are estimated using the expected value method considering all reasonably available information, including contract terms with the customer, the Company’s historical experience and its current expectations of the scope of the activities, and is reflected in the transaction price when sales are recorded.
The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant.
The Company’s sales return accrual reflects seasonal fluctuations, including those related to the holiday season in its second quarter. This accrual is a subjective critical estimate that has a direct impact on reported net revenues, and is calculated based on history of actual returns, estimated future returns and information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that the Company has considered, and will continue to consider, include the financial condition of our customers, store closings by retailers, changes in the retail environment, and our decision to continue to support new and existing brands.
The Company accounts for certain customer store fixtures as other assets. Such fixtures are amortized using the straight-line method over the period of 3 to 5 years as a reduction of revenue.
For the presentation of the Company’s revenues disaggregated by segment and product category see Note 4 Segment Reporting .
4 . SEGMENT REPORTING
The Company’s organizational structure is category focused, putting the consumers first, by specifically targeting how and where they shop and what and why they purchase. Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer as the CODM.
The Company has the following three divisions which represent its operating segments and reportable segments:

14


Luxury — primarily focused on prestige fragrances, premium skin care and premium color cosmetics;
Consumer Beauty — primarily focused on color cosmetics, retail hair coloring and styling products, mass fragrance, mass skin care and body care;
Professional Beauty — primarily focused on hair and nail care products for professionals.
Certain revenues and shared costs and the results of corporate initiatives are managed outside of the three segments by Corporate. The items within Corporate relate to corporate-based responsibilities and decisions and are not used by the CODM to measure the underlying performance of the segments. Corporate primarily includes restructuring and realignment costs, costs related to acquisition activities and certain other expense items not attributable to ongoing operating activities of the segments.
With the adoption of ASU No. 2017-07 (see Note 2 Summary of Significant Accounting Policies ), the non-service cost components of net periodic benefit cost have been removed from consolidated operating expenses and included in consolidated other expense, net. For segment reporting, however, all components of net periodic benefit cost are included in segment operating results as these components continue to comprise the basis on which the CODM analyzes segment results. In order to reconcile the total of segment operating income (loss) to consolidated operating income (loss), reclassification adjustments related to the non-service costs components have been included in Corporate in the table below.
With the exception of goodwill and acquired intangible assets, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill and acquired intangible assets by segment is presented in Note 9 Goodwill and Other Intangible Assets, net .
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
SEGMENT DATA
2019
 
2018
 
2019
 
2018
Net revenues:
 
 
 
 
 
 
 
Luxury
$
729.2

 
$
752.5

 
$
2,539.6

 
$
2,468.1

Consumer Beauty
840.3

 
1,021.7

 
2,636.9

 
3,203.7

Professional Beauty
421.1

 
448.5

 
1,356.6

 
1,426.8

Total
$
1,990.6

 
$
2,222.7

 
$
6,533.1

 
$
7,098.6

Operating income (loss):
 
 
 
 
 
 
 
Luxury
$
87.7

 
$
59.4

 
$
250.0

 
$
201.2

Consumer Beauty
24.1

 
64.2

 
(901.4
)
 
225.4

Professional Beauty
30.7

 
11.4

 
109.5

 
83.2

Corporate
(57.0
)
 
(114.3
)
 
(197.9
)
 
(284.4
)
Total
$
85.5

 
$
20.7

 
$
(739.8
)
 
$
225.4

Reconciliation:
 
 
 
 
 
 
 
Operating income (loss)
$
85.5

 
$
20.7

 
$
(739.8
)
 
$
225.4

Interest expense, net
72.0

 
72.6

 
204.4

 
199.3

Other expense, net
17.5

 
3.8

 
25.0

 
12.5

(Loss) income before income taxes
$
(4.0
)
 
$
(55.7
)
 
$
(969.2
)
 
$
13.6

Presented below are the percentage of revenues associated with the Company’s product categories:
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
PRODUCT CATEGORY
2019
 
2018
 
2019
 
2018
Fragrance
36.6
%
 
36.2
%
 
40.6
%
 
38.3
%
Color Cosmetics
27.7

 
26.1

 
25.6

 
26.2

Hair Care
25.7

 
25.4

 
24.7

 
24.6

Skin & Body Care
10.0

 
12.3

 
9.1

 
10.9

Total Coty Inc.
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%

15


5 . BUSINESS COMBINATIONS
Burberry Beauty Business Acquisition
On October 2, 2017, the Company acquired the exclusive global license rights and other related assets for the Burberry Limited (“Burberry”) luxury fragrances, cosmetics and skincare business (the “Burberry Beauty Business”). The Burberry Beauty Business acquisition further strengthens the Company’s position in the global beauty industry. Total purchase consideration, after post-closing adjustments, was £191.7 million , the equivalent of $256.3 , at the time of closing. Included in the purchase price was cash consideration of £183.3 million , the equivalent of $245.1 , at the time of closing, in addition to £8.4 million , the equivalent of $11.2 , of estimated contingent consideration, at the time of closing.
The aggregate future contingent consideration payments will range from  zero  to  £16.7 million and will be payable on a quarterly basis to Burberry as certain items of inventory transferred to the Company at the acquisition date are subsequently used or sold. The amount of the contingent consideration recorded was estimated as of the acquisition date and is subject to change based on the related inventory usage. The fair value of the contingent consideration was determined by estimating the future inventory usage and corresponding payments over a four-year period, with the contingent payments being made in each of the respective years. The estimate of the portion of contingent consideration payable within twelve months from the March 31, 2019 balance sheet date is recorded in Accrued expenses and other current liabilities and the remainder is recorded in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet. From the date of acquisition through the end of the third quarter of fiscal 2019, the Company made  £3.5 million  in contingent payments.
The Company has finalized the valuation of assets acquired and liabilities assumed for the Burberry Beauty Business acquisition. The Company recognized certain measurement period adjustments as disclosed below during the three months ended September 30, 2018. The measurement period for the Burberry Beauty Business acquisition closed on October 1, 2018.
The following table summarizes the allocation of the purchase price to the net assets of the Burberry Beauty Business as of the October 2, 2017 acquisition date:
 
Estimated
fair value as previously reported
 (a)
 
Measurement period adjustments  (b)
 
Final fair value as adjusted
 
Estimated
useful life
(in years)
Inventories
$
47.9

 
$

 
$
47.9

 
 
Property, plant and equipment
5.8

 

 
5.8

 
1 - 3
License and distribution rights
177.8

 
6.7

 
184.5

 
3 - 15
Goodwill
34.9

 
(9.4
)
 
25.5

 
 Indefinite
Net other liabilities
(10.1
)
 
2.7

 
(7.4
)
 
 
Total purchase price
$
256.3

 
$

 
$
256.3

 
 
 
 
(a)  
As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018.
(b)  
The Company recorded measurement period adjustments in the first quarter of fiscal 2019. The measurement period adjustments related to an increase in the value of the License and distribution rights due to changes in assumptions that were used at the date of acquisition for valuation purposes. The measurement period adjustment related to the decrease in net other liabilities acquired was a result of obtaining new facts and circumstances about acquired accrued expenses that existed as of the acquisition date. All measurement period adjustments were offset against Goodwill.
Goodwill is expected to be deductible for tax purposes. The goodwill is attributable to expected synergies resulting from integrating the Burberry Beauty Business products into the Company’s existing sales channels. Goodwill of  $12.9 , $6.8  and $5.8  is allocated to the Luxury, Consumer Beauty and Professional Beauty segments, respectively. The allocation of goodwill to the segments were due to the reduction in corporate and regional overhead allocated to these segments due to the addition of the Burberry Beauty Business.
6 . ACQUISITION-RELATED COSTS
Acquisition-related costs, which are expensed as incurred, represent non-restructuring costs directly related to acquiring and integrating an entity, for both completed and contemplated acquisitions. These costs can include finder’s fees, legal, accounting, valuation, other professional or consulting fees, including fees related to transitional services, and other internal costs which can include compensation related expenses for dedicated internal resources. The Company recognized acquisition-related costs of $0.0 and $2.6 for the three months ended March 31, 2019 and 2018 , respectively and $0.0 and $63.7 for the nine months ended March 31, 2019 and 2018 , respectively, which have been recorded in Acquisition-related costs in the Condensed Consolidated Statements of Operations. Acquisition-related costs incurred during the three and nine months ended

16


March 31, 2018 were primarily related to the acquisition of The Procter & Gamble Company’s (“P&G”) beauty business (the “P&G Beauty Business”).
7 . RESTRUCTURING COSTS
Restructuring costs for the three and nine months ended March 31, 2019 and 2018 are presented below:
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Global Integration Activities
$
2.6

 
$
33.3

 
$
31.3

 
$
58.2

2018 Restructuring Actions
4.5

 
8.6

 
13.3

 
20.5

Other Restructuring
(0.4
)
 
0.8

 
(0.9
)
 
(3.1
)
Total
$
6.7

 
$
42.7

 
$
43.7

 
$
75.6

Global Integration Activities
In connection with the acquisition of the P&G Beauty Business, the Company has and expects to continue to incur restructuring and related costs aimed at integrating and optimizing the combined organization (“Global Integration Activities”).
Of the expected costs, the Company has incurred cumulative restructuring charges of $502.0 related to approved initiatives through March 31, 2019 , which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:
 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Fiscal 2017
$
333.9

 
$
22.4

 
$
4.6

 
$
3.3

 
$
364.2

Fiscal 2018
67.5

 
19.3

 
14.3

 
5.4

 
106.5

Fiscal 2019
0.3

 
1.5

 
27.8

 
1.7

 
31.3

Cumulative through March 31, 2019
$
401.7

 
$
43.2

 
$
46.7

 
$
10.4

 
$
502.0

Over the next two fiscal years, the Company expects to incur approximately $25.0 of additional restructuring charges pertaining to the approved actions, primarily related to contract terminations, employee termination benefits and other related exit costs.
The related liability balance and activity for the Global Integration Activities restructuring costs are presented below:
 
Severance and
Employee
Benefits
 
Third-Party
Contract
Terminations
 
Fixed Asset Write-offs
 
Other
Exit
Costs
 
Total
Program
Costs
Balance—July 1, 2018
$
203.0

 
$
17.0

 
$

 
$
3.1

 
$
223.1

Restructuring charges
7.8

 
1.6

 
27.8

 
1.9

 
39.1

Payments
(130.3
)
 
(7.1
)
 

 
(3.2
)
 
(140.6
)
Changes in estimates
(7.5
)
 
(0.1
)
 

 
(0.2
)
 
(7.8
)
Non-cash utilization

 

 
(27.8
)
 

 
(27.8
)
Effect of exchange rates
(3.6
)
 

 

 

 
(3.6
)
Balance—March 31, 2019
$
69.4

 
$
11.4

 
$

 
$
1.6

 
$
82.4

The Company currently estimates that the total remaining accrual of $82.4 will result in cash expenditures of approximately $25.7 , $47.3 and $9.4 in fiscal 2019, 2020 and thereafter, respectively.
2018 Restructuring Actions
During fiscal 2018, the Company began evaluating initiatives to reduce fixed costs and enable further investment in the business (the “2018 Restructuring Actions”).
Of the expected costs, the Company incurred cumulative restructuring charges of $81.7 related to approved initiatives through March 31, 2019 , primarily related to role eliminations in Europe and North America, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:

17


 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Fiscal 2018
$
63.5

 
$
0.2

 
$
1.3

 
$
3.4

 
$
68.4

Fiscal 2019
12.1

 
(0.1
)
 

 
1.3

 
13.3

Cumulative through March 31, 2019
$
75.6

 
$
0.1

 
$
1.3

 
$
4.7

 
$
81.7

Over the next three fiscal years, the Company expects to incur approximately $9.0 of additional restructuring charges pertaining to the approved actions, primarily related to employee termination benefits.
The related liability balance and activity of restructuring costs for the 2018 Restructuring Actions are presented below:
 
Severance and
Employee
Benefits
 
Third-Party
Contract
Terminations
 
Other Exit Costs
 
Total
Program
Costs
Balance—July 1, 2018
$
48.0

 
$
0.2

 
$
3.3

 
$
51.5

Restructuring charges
13.6

 

 
1.3

 
14.9

Payments
(43.2
)
 

 
(2.8
)
 
(46.0
)
Changes in estimates
(1.5
)
 
(0.1
)
 

 
(1.6
)
Effect of exchange rates
(0.5
)
 

 
(0.2
)
 
(0.7
)
Balance—March 31, 2019
$
16.4

 
$
0.1

 
$
1.6

 
$
18.1

The Company currently estimates that the total remaining accrual of $18.1 will result in cash expenditures of approximately $7.5 , $10.5 and $0.1 in fiscal 2019, 2020 and thereafter, respectively.
Other Restructuring
In connection with the acquisition of the Burberry Beauty Business, the Company recorded the reversal of $(0.1) of restructuring costs relating to third-party contract terminations during the nine months ended March 31, 2019 . The related liability balances were $1.0 and $3.9 at March 31, 2019 and June 30, 2018 , respectively. The Company currently estimates that the total remaining accrual of $1.0 will result in cash expenditure in fiscal 2020.
The Company executed a number of other legacy restructuring activities in prior years, which are substantially completed. The Company recognized (income) expenses, net, of $(0.6) and $(4.7) during the nine months ended March 31, 2019 and 2018 , respectively. The related liability balances were $5.6 and $9.4 at March 31, 2019 and June 30, 2018 , respectively. The Company currently estimates that the total remaining accrual of $5.6 will result in cash expenditures of $1.2 , $2.4 and $2.0 in fiscal 2019, 2020 and 2021, respectively.
In connection with the acquisition of the P&G Beauty Business, the Company assumed restructuring liabilities of approximately $21.7 at October 1, 2016. The Company recognized (income) expenses, net, of $(0.2) and $1.6 during the nine months ended March 31, 2019 and 2018 , respectively. The related liability balances were $3.6 and $7.0 at March 31, 2019 and June 30, 2018 , respectively. The Company estimates that the remaining accrual of $3.6 at March 31, 2019 will result in cash expenditures of $0.4 , $2.7 and $0.5 in fiscal 2019 , 2020 and thereafter, respectively.
8 . INVENTORIES
Inventories as of March 31, 2019 and June 30, 2018 are presented below:
 
March 31,
2019
 
June 30,
2018
Raw materials
$
265.6

 
$
278.6

Work-in-process
15.1

 
21.8

Finished goods
902.8

 
848.5

Total inventories
$
1,183.5

 
$
1,148.9


18


9 . GOODWILL AND OTHER INTANGIBLE ASSETS, NET
Assessment for Impairments
The Company tests goodwill and indefinite-lived intangible assets for impairment at least annually as of May 1, or more frequently, if certain events or circumstances warrant. There were no impairments of goodwill at the Company’s reporting units in fiscal 2018.
In the course of evaluating the results for the second quarter of fiscal 2019, the Company noted the cash flows associated with its Consumer Beauty reporting unit were adversely impacted by negative category trends and market share losses in the color cosmetics, hair color and mass fragrance categories mainly impacting the CoverGirl, Rimmel, Max Factor, Bourjois and Clairol trademarks; additional shelf-spaces losses for CoverGirl, Clairol, and Max Factor; expected increased costs in the short-term to offset the lower service levels caused by supply chain disruptions; and lower than expected net revenues and profitability for Younique. Additionally, the Company considered the impact of a 75 basis point increase in the discount rate, which adversely affected the fair value of the reporting unit. Management concluded that these adverse factors represented indicators of impairment that warranted an interim impairment test for goodwill and certain other intangible assets in the Consumer Beauty reporting unit. As a result, in the second quarter of fiscal 2019, the Company recognized asset impairment charges of  $930.3 , of which  $832.5  related to goodwill,  $90.8  related to indefinite-lived other intangible assets (mainly related to the CoverGirl and Clairol trademarks) and $7.0 related to finite-lived other intangible assets, as described below and recorded in Asset impairment charges in the Condensed Consolidated Statements of Operations.
Additionally, the Company identified indicators of impairment related to the philosophy trademark that is part of the Luxury reporting unit and recorded an asset impairment charge of $22.8 for the second quarter of fiscal 2019. In addition to the impact of a 75 basis point increase in the discount rate for the trademark, the Company considered the impact of the business indicators of lower than expected net revenue growth in the U.S. and a decrease in the level of expected profitability of the trademark.
Goodwill
Goodwill as of March 31, 2019 and June 30, 2018 is presented below:
 
Luxury
 
Consumer Beauty
 
Professional Beauty
 
Total
Gross balance at June 30, 2018
$
3,366.6

 
$
4,927.5

 
$
953.8

 
$
9,247.9

Accumulated impairments
(403.7
)
 
(237.1
)
 

 
(640.8
)
Net balance at June 30, 2018
$
2,962.9

 
$
4,690.4

 
$
953.8

 
$
8,607.1

 
 
 
 
 
 
 
 
Changes during the period ended March 31, 2019:
 
 
 
 
 
 
 
Measurement period adjustments  (a)
$
(10.5
)
 
$
0.6

 
$
0.5

 
$
(9.4
)
Foreign currency translation
(50.5
)
 
(86.3
)
 
(9.6
)
 
(146.4
)
Impairment charges

 
(832.5
)
 

 
(832.5
)
 
 
 
 
 
 
 
 
Gross balance at March 31, 2019
$
3,305.6

 
$
4,841.8

 
$
944.7

 
$
9,092.1

Accumulated impairments
(403.7
)
 
(1,069.6
)
 

 
(1,473.3
)
Net balance at March 31, 2019
$
2,901.9

 
$
3,772.2

 
$
944.7

 
$
7,618.8

 
 
(a) Includes measurement period adjustments in connection with the Burberry Beauty Business acquisition (Refer to Note 5 Business Combinations ).
Other Intangible Assets, net
Other intangible assets, net as of March 31, 2019 and June 30, 2018 are presented below:
 
March 31, 2019
 
June 30,
2018
Indefinite-lived other intangible assets
$
3,043.7

 
$
3,186.2

Finite-lived other intangible assets, net
4,747.6

 
5,098.2

Total Other intangible assets, net
$
7,791.3

 
$
8,284.4


19


The changes in the carrying amount of indefinite-lived other intangible assets are presented below:
 
Luxury
 
Consumer Beauty
 
Professional Beauty
 
Total
Gross balance at June 30, 2018
$
414.6

 
$
1,703.1

 
$
1,266.3

 
$
3,384.0

Accumulated impairments
(118.8
)
 
(75.9
)
 
(3.1
)
 
(197.8
)
Net balance at June 30, 2018
$
295.8

 
$
1,627.2

 
$
1,263.2

 
$
3,186.2

 
 
 
 
 
 
 
 
Changes during the period ended March 31, 2019:
 
 
 
 
 
 
 
Foreign currency translation
$
(10.5
)
 
$
(13.2
)
 
$
(5.2
)
 
$
(28.9
)
Impairment charges
(22.8
)
 
(90.8
)
 

 
(113.6
)
 
 
 
 
 
 
 
 
Gross balance at March 31, 2019
$
404.1

 
$
1,689.9

 
$
1,261.1

 
$
3,355.1

Accumulated impairments
(141.6
)
 
(166.7
)
 
(3.1
)
 
(311.4
)
Net balance at March 31, 2019
$
262.5

 
$
1,523.2

 
$
1,258.0

 
$
3,043.7

Intangible assets subject to amortization are presented below:
 
Cost
 
Accumulated Amortization
 
Accumulated Impairment
 
Net
June 30, 2018
 
 
 
 
 
 
 
License agreements
$
3,362.7

 
$
(792.9
)
 
$

 
$
2,569.8

Customer relationships
1,960.5

 
(508.7
)
 
(5.5
)
 
1,446.3

Trademarks
1,002.1

 
(185.5
)
 
(0.4
)
 
816.2

Product formulations and technology
361.2

 
(95.3
)
 

 
265.9

Total
$
6,686.5

 
$
(1,582.4
)
 
$
(5.9
)
 
$
5,098.2

March 31, 2019
 
 
 
 
 
 
 
License agreements  (a)
$
3,215.1

 
$
(839.0
)
 
$
(19.6
)
 
$
2,356.5

Customer relationships  (a)
1,943.1

 
(603.3
)
 
(5.5
)
 
1,334.3

Trademarks  (b)
1,037.8

 
(218.0
)
 
(0.4
)
 
819.4

Product formulations and technology
356.8

 
(119.4
)
 

 
237.4

Total
$
6,552.8

 
$
(1,779.7
)
 
$
(25.5
)
 
$
4,747.6

 
 
(a) Includes measurement period adjustments during the nine months ended March 31, 2019 in connection with the Burberry Beauty Business acquisition (Refer to Note 5 Business Combinations ).
(b) Includes an acquired trademark of $40.8 .

In July 2018, the Company acquired a trademark associated with a preexisting license. As a result of the acquisition, the preexisting license was effectively terminated, and accordingly the Company recorded $12.6 of Asset impairment charges in the Condensed Consolidated Statement of Operations related to the license agreement.
Amortization expense was $86.7 and $92.8 for the three months ended March 31, 2019 and 2018 , respectively and $267.7 and $260.6 for the nine months ended March 31, 2019 and 2018 , respectively.

20


10 . DEBT
The Company’s debt balances consisted of the following as of March 31, 2019 and June 30, 2018 , respectively:
 
March 31, 2019
 
June 30,
2018
Short-term debt
$
8.5

 
$
9.2

2018 Coty Credit Agreement
 
 
 
2018 Coty Revolving Credit Facility due April 2023
814.2

 
368.1

2018 Coty Term A Facility due April 2023
3,162.6

 
3,371.5

2018 Coty Term B Facility due April 2025
2,337.1

 
2,390.5

Senior Unsecured Notes
 
 
 
2026 Dollar Notes due April 2026
550.0

 
550.0

2023 Euro Notes due April 2023
617.8

 
640.9

2026 Euro Notes due April 2026
280.8

 
291.4

Other long-term debt and capital lease obligations
1.3

 
1.6

Total debt
7,772.3

 
7,623.2

Less: Short-term debt and current portion of long-term debt
(196.7
)
 
(218.9
)
Total Long-term debt
7,575.6

 
7,404.3

Less: Unamortized debt issuance costs (a)
(73.5
)
 
(86.2
)
Less: Discount on Long-term debt
(11.2
)
 
(12.7
)
Total Long-term debt, net
$
7,490.9

 
$
7,305.4

 
 
(a) Consists of unamortized debt issuance costs of $26.4 and $31.4 for the 2018 Coty Revolving Credit Facility, $24.6 and $29.2 for the 2018 Coty Term A Facility and $9.7 and $10.9 for the 2018 Coty Term B Facility, $7.4 and $8.3 for the 2026 Dollar and Euro Notes and $5.4 and $6.4 for the 2023 Euro Notes as of March 31, 2019 and June 30, 2018 , respectively.
On April 5, 2018, the Company issued senior unsecured notes in a private offering and entered into a new credit agreement (the “2018 Coty Credit Agreement”). The net proceeds of the offering of the notes, together with borrowings under the 2018 Coty Credit Agreement, were used to repay in full and refinance the indebtedness outstanding under the Company’s previously existing long-term debt agreements and to pay accrued interest, related premiums, fees and expenses in connection therewith. Future borrowings under the 2018 Coty Credit Agreement could be used for corporate purposes.
Offering of Senior Unsecured Notes
On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million  of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act.
The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the 2018 Credit Facilities described below). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors (as later defined). The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.
The 2026 Dollar Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. Interest on the 2026 Dollar Notes is payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018.
The 2023 Euro Notes will mature on April 15, 2023 and the 2026 Euro Notes will mature on April 15, 2026. The 2023 Euro Notes will bear interest at a rate of  4.00% per annum, and the 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018.

21


Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.
The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default.
2018 Coty Credit Agreement
On April 5, 2018, the Company entered into the 2018 Coty Credit Agreement which amended and restated the prior Coty Credit Agreement. The 2018 Coty Credit Agreement provides for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of a senior secured revolving facility in an aggregate principal amount of $3,250.0 denominated in U.S. dollars, specified alternative currencies or other currencies freely convertible into U.S. dollars and readily available in the London interbank market (the “2018 Coty Revolving Credit Facility”) (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the “2018 Coty Credit Facilities”). Initial borrowings under the 2018 Coty Term Loan B Facility were issued at a 0.250% discount.
The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.
The obligations of the Company under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.
Scheduled Amortization
The Company makes quarterly payments of  1.25% and 0.25% , which began on September 30, 2018, of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, respectively. The remaining balance of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility will be payable on the maturity date for each facility, respectively.
Interest
The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either:
LIBOR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or
Alternate base rate (“ABR”) plus the applicable margin.
In the case of the 2018 Coty Revolving Credit Facility and the 2018 Coty Term A Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:

22


Pricing Tier
 
Total Net Leverage Ratio:
 
LIBOR plus:
 
Alternative Base Rate Margin:
1.0
 
Greater than or equal to 4.75:1
 
2.000%
 
1.000%
2.0
 
Less than 4.75:1 but greater than or equal to 4.00:1
 
1.750%
 
0.750%
3.0
 
Less than 4.00:1 but greater than or equal to 2.75:1
 
1.500%
 
0.500%
4.0
 
Less than 2.75:1 but greater than or equal to 2.00:1
 
1.250%
 
0.250%
5.0
 
Less than 2.00:1 but greater than or equal to 1.50:1
 
1.125%
 
0.125%
6.0
 
Less than 1.50:1
 
1.000%
 
—%
Pricing Tier
 
Debt Ratings S&P/Moody’s:
 
LIBOR plus:
 
Alternative Base Rate Margin:
5.0
 
Less than BB+/Ba1
 
2.000%
 
1.000%
4.0
 
BB+/Ba1
 
1.750%
 
0.750%
3.0
 
BBB-/Baa3
 
1.500%
 
0.500%
2.0
 
BBB/Baa2
 
1.250%
 
0.250%
1.0
 
BBB+/Baa1 or higher
 
1.125%
 
0.125%
In the case of the USD portion of the 2018 Coty Term B Facility, the applicable margin means  2.25%  per annum, in the case of LIBOR loans, and  1.25%  per annum, in the case of ABR loans. In the case of the Euro portion of the 2018 Coty Term B Facility, the applicable margin means  2.50%  per annum, in the case of EURIBOR loans.
In no event will LIBOR be deemed to be less than 0.00% per annum.
Fair Value of Debt
 
March 31, 2019
 
June 30, 2018
 
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
2018 Coty Credit Agreement
$
6,313.9

 
$
6,090.2

 
$
6,130.1

 
$
6,070.8

Senior Unsecured Notes
1,448.6

 
1,437.0

 
1,482.3

 
1,449.9

The Company uses the market approach to value the 2018 Coty Credit Agreement and the Senior Unsecured Notes. The Company obtains fair values from independent pricing services to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized a Level 2 in the fair value hierarchy.
Debt Maturities Schedule
Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding capital lease obligations as of March 31, 2019 , are presented below:
Fiscal Year Ending June 30,
 
2019, remaining
$
47.0

2020
187.8

2021
187.8

2022
187.8

2023
4,084.2

Thereafter
3,067.9

Total
$
7,762.5


23


Covenants
The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.
Quarterly Test Period Ending
Total Net Leverage Ratio  (a)  
March 31, 2019 through June 30, 2019
5.25 to 1.00
September 30, 2019 through December 31, 2019
5.00 to 1.00
March 31, 2020 through June 30, 2020
4.75 to 1.00
September 30, 2020 through December 31, 2020
4.50 to 1.00
March 31, 2021 through June 30, 2021
4.25 to 1.00
September 30, 2021 through June 30, 2023
4.00 to 1.00
 
 
(a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted cash and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement). Adjusted EBITDA as defined in the 2018 Coty Credit Agreement includes certain add backs related to cost savings, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement.
In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which our Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.
As of March 31, 2019 , the Company was in compliance with all covenants contained within the Debt Agreements.
11 . INTEREST EXPENSE, NET
Interest expense, net for the three and nine months ended March 31, 2019 and 2018 is presented below:
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Interest expense
$
76.8

 
$
75.5

 
$
223.3

 
$
212.5

Foreign exchange gains, net of derivative contracts
(0.3
)
 
0.6

 
(4.1
)
 
(5.3
)
Interest income
(4.5
)
 
(3.5
)
 
(14.8
)
 
(7.9
)
Total interest expense, net
$
72.0

 
$
72.6

 
$
204.4

 
$
199.3


24


12 . EMPLOYEE BENEFIT PLANS
The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below:
 
Three Months Ended March 31,
 
Pension Plans
 
Other Post-
Employment Benefits
 
 
 
U.S.
 
International
 
 
Total
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$

 
$

 
$
8.5

 
$
9.8

 
$
0.3

 
$
0.5

 
$
8.8

 
$
10.3

Interest cost
0.2

 
0.2

 
3.3

 
3.1

 
0.5

 
0.6

 
4.0

 
3.9

Expected return on plan assets

 

 
(2.1
)
 
(1.8
)
 

 

 
(2.1
)
 
(1.8
)
Amortization of prior service cost (credit)

 

 
0.1

 

 
(1.5
)
 
(1.4
)
 
(1.4
)
 
(1.4
)
Amortization of net (gain) loss
(0.2
)
 
(0.2
)
 

 
0.3

 

 

 
(0.2
)
 
0.1

Net periodic benefit cost (credit)
$

 
$

 
$
9.8

 
$
11.4

 
$
(0.7
)
 
$
(0.3
)
 
$
9.1

 
$
11.1

 
Nine Months Ended March 31,
 
Pension Plans
 
Other Post-
Employment Benefits
 
 
 
U.S.
 
International
 
 
Total
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$

 
$

 
$
25.3

 
$
29.4

 
$
0.9

 
$
1.5

 
$
26.2

 
$
30.9

Interest cost
0.6

 
0.5

 
9.9

 
9.3

 
1.5

 
1.8

 
12.0

 
11.6

Expected return on plan assets

 

 
(6.3
)
 
(5.6
)
 

 

 
(6.3
)
 
(5.6
)
Amortization of prior service cost (credit)

 

 
0.3

 
0.2

 
(4.5
)
 
(4.2
)
 
(4.2
)
 
(4.0
)
Amortization of net (gain) loss
(0.6
)
 
(0.5
)
 
0.2

 
1.0

 

 
(0.1
)
 
(0.4
)
 
0.4

Net periodic benefit cost (credit)
$

 
$

 
$
29.4

 
$
34.3

 
$
(2.1
)
 
$
(1.0
)
 
$
27.3

 
$
33.3

13 . DERIVATIVE INSTRUMENTS
Foreign Exchange Risk
The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. The Company entered into derivatives for which hedge accounting treatment has been applied which the Company anticipates realizing in the Consolidated Statements of Operations through fiscal 2020.
Interest Rate Risk
The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative and positive impacts of changes in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value.
During August 2018, the Company extended the maturity of the interest rate swap portfolio through 2021 by replacing its original swap contracts with swap contracts having longer maturities to manage the medium term exposure to interest rate increases. The Company received $43.2 for settlement of the original swap contracts. As the forecasted interest expense under the original swap agreements is still probable, the related accumulated other comprehensive income (loss) (“AOCI/(L)”) will be amortized in line with the timing of the forecasted transactions. As of March 31, 2019 and June 30, 2018 , the Company had interest rate swap contracts designated as effective hedges in the notional amount of $2,000.0 .

25


Derivative and non-derivative financial instruments which are designated as hedging instruments:
The accumulated gain on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $264.1 and $115.0 as of March 31, 2019 and June 30, 2018 , respectively.
The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below:
Gain (Loss) Recognized in OCI
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Foreign exchange forward contracts
$
(0.2
)
 
$
(0.2
)
 
$
0.2

 
$
(0.4
)
Interest rate swap contracts
(11.4
)
 
11.2

 
(27.3
)
 
22.7

Net investment hedge
70.5

 
(23.7
)
 
149.1

 
(56.7
)
The accumulated gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $3.0 and $31.7 as of March 31, 2019 and June 30, 2018 , respectively. The estimated net gain related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $5.5 . As of March 31, 2019 , all of the Company’s remaining foreign currency forward contracts designated as hedges were highly effective.
The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below:
Condensed Consolidated Statements of Operations
Classification of Gain (Loss) Reclassified from AOCI/(L)
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Foreign exchange forward contracts:
 
 
 
 
 
 
 
Net revenues
$

 
$
0.3

 
$

 
$
0.7

Cost of sales
0.1

 
0.2

 
0.1

 
0.7

Interest rate swap contracts:
 
 
 
 
 
 
 
Interest expense
$
2.7

 
$
(2.2
)
 
$
10.4

 
$
(3.1
)
Derivatives not designated as hedging:
The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below:
Condensed Consolidated Statements of Operations
Classification of Gain (Loss) Recognized in Operations
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Selling, general and administrative expenses
$

 
$
(0.2
)
 
$
0.1

 
$
(1.1
)
Interest expense, net
(4.1
)
 
(7.0
)
 
(5.7
)
 
6.1

Other expense, net

 
(0.3
)
 
1.4

 
(0.3
)
14 . EQUITY
Common Stock
As of March 31, 2019 , the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of March 31, 2019 , total authorized shares of Class A Common Stock was 1,000.0 million and total outstanding shares of Class A Common Stock was 751.4 million .
As of March 31, 2019 , the Company’s largest stockholder was JAB Cosmetics B.V. (“JABC”), which owned approximately 40% of Coty’s Class A shares. Both JABC and the shares of the Company held by Cottage Holdco B.V., a wholly-owned subsidiary of JABC, are indirectly controlled by Lucresca SE, Agnaten SE and JAB Holdings B.V. (“JAB”). During the three and nine months ended March 31, 2019 , JABC acquired  nil and 10.8 million shares of Class A Common Stock, respectively, in open market purchases on the New York Stock Exchange. On April 30, 2019, Cottage Holdco B.V. completed a tender offer transaction (the “Offer”), acquiring 150 million of outstanding Class A shares of the Company at a price of  $11.65 per share and as a result, is the Company’s largest stockholder. Immediately after completion of this tender offer

26


transaction, JABC indirectly controls approximately 60% of Coty’s Class A shares. The Company did not receive any proceeds from these stock purchases conducted by JABC.
Preferred Stock
As of March 31, 2019 , total authorized shares of preferred stock are 20.0 million . There are two classes of Preferred Stock outstanding as of March 31, 2019 , Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01 per share.
On January 15, 2019, the Company cancelled 3,067,554 shares of its Series A Preferred Stock that were forfeited during the six months ended December 31, 2018, reducing the total authorized number of shares of Series A Preferred Stock from 6,319,641 to 3,252,087 .
On February 4, 2019, the Company authorized, designated and issued 6,925,341 shares of Series A-1 Preferred Stock.
As of March 31, 2019 , total authorized shares of Series A Preferred Stock and Series A-1 Preferred Stock are 3.3 million and 6.9 million , respectively, total issued shares of Series A Preferred Stock and Series A-1 Preferred Stock are 1.9 million and 6.9 million , respectively, and total outstanding shares of Series A Preferred Stock and Series A-1 Preferred Stock are 1.5 million and 6.9 million , respectively. The Series A Preferred Stock and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law.
Of the 1.5 million outstanding shares of Series A Preferred Stock, 1.0 million shares vested on March 27, 2017, 0.3 million shares vest on February 16, 2022 and 0.2 million shares vest on November 16, 2022. Of the 6.9 million outstanding shares of Series A-1 Preferred Stock, 4.1 million shares vest on November 12, 2021, 1.4 million shares vest on November 12, 2022 and 1.4 million shares vest on November 12, 2023. As of March 31, 2019 , the Company classified $0.7 of Preferred Stock as equity, and $1.7 as a liability recorded in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.
Treasury Stock - Share Repurchase Program
On February 3, 2016, the Board authorized the Company to repurchase up to  $500.0 of its Class A Common Stock (the “Incremental Repurchase Program”). Until October 1, 2018, repurchases were subject to certain restrictions imposed by the tax matters agreement, dated October 1, 2016, as amended, between the Company and P&G entered into in connection with the P&G Beauty Business acquisition. Following October 1, 2018, repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, available cash, the Company’s deleveraging strategy and general market conditions. For the three and nine months ended March 31, 2019 , the Company did not repurchase any shares of its Class A Common Stock. As of March 31, 2019 , the Company had authority for $396.8 remaining under the Incremental Repurchase Program.
Dividend s
The following dividends were declared during the nine months ended March 31, 2019 :
Declaration Date
 
Dividend Type
 
Dividend Per Share
 
Holders of Record Date
 
Dividend Value
 
Dividend Payment Date
 
Dividends Paid
 
Dividends Payable (a)
Fiscal 2019
  August 21, 2018
 
Quarterly
 
$
0.125

 
August 31, 2018
 
$
94.6

 
September 14, 2018
 
$
93.8

 
$
0.8

  November 7, 2018
 
Quarterly
 
$
0.125

 
November 30, 2018
 
$
95.1

 
December 14, 2018
 
$
93.9

 
$
1.2

  February 8, 2019
 
Quarterly
 
$
0.125

 
February 28, 2019
 
$
95.1

 
March 15, 2019
 
$
93.9

 
$
1.2

Fiscal 2019
 
 
 
$
0.375

 
 
 
$
284.8

 
 
 
$
281.6

 
$
3.2

 
 
(a)  
The dividend payable is the value of the remaining dividends payable upon settlement of the RSUs and phantom units outstanding as of the Holders of Record Date.
In addition to the activity noted in the table above, the Company made a payment of $1.2  for the previously accrued dividends on RSUs that vested during the  nine months ended March 31, 2019 . Total dividends paid during the nine months ended March 31, 2019 was $282.8 , which was recorded as a decrease to additional paid-in capital (“APIC”) in the Condensed Consolidated Balance Sheet as of March 31, 2019 .
The Company recorded an additional decrease to APIC in the Condensed Consolidated Balance Sheet as of  March 31, 2019 of $0.5 , consisting of $3.2 dividends payable on dividends declared during the nine months ended March 31, 2019 offset by $1.2 dividends paid for previously accrued dividends on vested RSUs and $1.5 of dividends no longer expected to vest as a result of forfeitures of outstanding RSUs. Total dividends recorded to APIC in the Condensed Consolidated Balance Sheet as of March 31, 2019 is $(283.3) . Total accrued dividends on unvested RSUs and phantom units of $2.0 and $4.5 are included in

27


Accrued expenses and other current liabilities and Other noncurrent liabilities , respectively, in the Condensed Consolidated Balance Sheet as of March 31, 2019 .
Accumulated Other Comprehensive Income (Loss)
 
 
 
Foreign Currency Translation Adjustments
 
 
 
 
 
Gain (loss) on Cash Flow Hedges
 
Gain on Net Investment Hedge
 
Other Foreign Currency Translation Adjustments
 
Pension and Other Post-Employment Benefit Plans  (a)
 
Total
Balance—July 1, 2018
$
31.7

 
$
115.0

 
$
(44.3
)
 
$
56.4

 
$
158.8

Other comprehensive (loss) income before reclassifications
(20.8
)
 
149.1

 
(276.7
)
 

 
(148.4
)
Net amounts reclassified from AOCI/(L)
(7.9
)
 

 

 
(4.0
)
 
(11.9
)
Net current-period other comprehensive (loss) income
(28.7
)
 
149.1

 
(276.7
)
 
(4.0
)
 
(160.3
)
Balance—March 31, 2019
$
3.0

 
$
264.1

 
$
(321.0
)
 
$
52.4

 
$
(1.5
)
 
 
(a) For the nine months ended March 31, 2019 , net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial gains of $4.6 , net of tax of $0.6 .
 
 
 
Foreign Currency Translation Adjustments
 
 
 
 
 
Gain on Cash Flow Hedges
 
Loss on Net Investment Hedges
 
Other Foreign Currency Translation Adjustments
 
Pension and Other Post-Employment Benefit Plans
 
Total
Balance—July 1, 2017
$
12.6

 
$
(23.7
)
 
$
(20.8
)
 
$
36.3

 
$
4.4

Other comprehensive income (loss) before reclassifications
15.5

 
(56.7
)
 
574.9

 
(0.7
)
 
533.0

Net amounts reclassified from AOCI/(L)
(1.3
)
 

 

 

 
(1.3
)
Net current-period other comprehensive income (loss)
14.2

 
(56.7
)
 
574.9

 
(0.7
)
 
531.7

Balance—March 31, 2018
$
26.8

 
$
(80.4
)
 
$
554.1

 
$
35.6

 
$
536.1

15 . SHARE-BASED COMPENSATION PLANS
Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below:
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
Equity plan expense
$
(0.5
)
 
$
8.7

 
$
10.3

 
$
25.8

Liability plan (income) expense

 
1.2

 
(2.6
)
 
0.3

Fringe expense

 
1.1

 
0.5

 
2.9

Total share-based compensation expense
$
(0.5
)
 
$
11.0

 
$
8.2

 
$
29.0

The share-based compensation expense (income) for the three and nine months ended March 31, 2019 of  $(0.5) and $8.2 , respectively, includes  $8.5 and $26.0  expense for the respective periods offset by  $(9.0) and $(17.8)  income for the respective periods primarily due to significant executive forfeitures of share-based compensation instruments and the impact of actual forfeitures on the change in estimated forfeiture rates during the period.
As of March 31, 2019 , the total unrecognized share-based compensation expense related to unvested stock options, Series A and A-1 Preferred Stock and restricted and other share awards is $55.0 , $8.3 and $87.6 , respectively. The unrecognized

28


share-based compensation expense related to unvested stock options, Series A and A-1 Preferred stock and restricted and other share awards is expected to be recognized over a weighted-average period of 4.49 , 4.56 and 3.74 years, respectively.
Restricted Share Units and Other Share Awards
On October 1, 2018, the Company’s Board of Directors approved a modification of the vesting schedules for certain RSUs granted during fiscal 2017, 2018 and 2019 to improve the Company’s ability to retain the affected employees, from five year cliff vesting to graded vesting where 60% of each award granted vests after three years, 20% of each award granted vests after four years and 20% of each award granted vests after five years. Five hundred sixty employees held outstanding awards subject to the October 1, 2018 modification. During the three and nine months ended March 31, 2019 , the incremental stock based compensation expense resulting from the modification was offset by income from actual and expected forfeitures in the modified awards.
The Company granted approximately 0.7 million and 6.8 million RSUs and other share awards during the three and nine months ended March 31, 2019 , respectively, with a weighted-average grant date fair value per share of $11.31 , which vest, as granted, on the third through fifth anniversary of the grant date. The Fiscal 2019 Annual Equity Long Term Incentive Plan (“ELTIP”) RSUs, of which 5.0 million RSUs were awarded on September 4, 2018, was modified as noted above. The RSUs granted are accompanied by dividend equivalent rights and, as such, were valued at the closing market price of the Company’s Class A Common Stock on the date of grant. The Company recognized share-based compensation expense of $2.2 and $6.2 for the three months ended March 31, 2019 and 2018 , respectively, and $9.9 and $18.7 for the nine months ended March 31, 2019 and 2018 , respectively.
Series A Preferred Stock and Series A-1 Preferred Stock
The Company granted no shares of Series A Preferred Stock and 6.9 million shares of Series A-1 Preferred Stock during the three and nine months ended March 31, 2019 . The Company recognized share-based compensation (income) expense of $(0.4) and $1.4 for the three months ended March 31, 2019 and 2018 , respectively, and $(4.6) and $1.0 for the nine months ended March 31, 2019 and 2018 , respectively.
Non-Qualified Stock Options
The Company granted 16.3 million and 18.6 million non-qualified stock options during the three and nine months ended March 31, 2019 , respectively. Of the 16.3 million stock options, 2.6 million vest on the fifth anniversary of the grant date and 13.7 million vest on a graded vesting schedule where 60% of each award granted vests after three years, 20% of each award granted vests after four years and 20% of each award granted vests after five years. The Company recognized share-based compensation expense of $(2.3) and $3.4 for the three months ended March 31, 2019 and 2018 , respectively, and $2.9 and $9.3 for the nine months ended March 31, 2019 and 2018 , respectively.

29


16 . NET (LOSS) INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE
Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below:
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2019
 
2018
 
2019
 
2018
 
(in millions, except per share data)
Net (loss) income attributable to Coty Inc.
$
(12.1
)
 
$
(77.0
)
 
$
(984.8
)
 
$
12.5

Weighted-average common shares outstanding—Basic
751.4

 
750.1

 
751.1

 
749.4

Effect of dilutive stock options and Series A Preferred Stock  (a)

 

 

 
1.3

Effect of restricted stock and RSUs (b)

 

 

 
2.4

Weighted-average common shares outstanding—Diluted
751.4

 
750.1

 
751.1

 
753.1

Net (loss) income attributable to Coty Inc. per common share:
 
 
 
 
 
 
 
Basic
$
(0.02
)
 
$
(0.10
)
 
$
(1.31
)
 
$
0.02

Diluted
(0.02
)
 
(0.10
)
 
(1.31
)
 
0.02

 
 
(a)  
For the three and nine months ended March 31, 2019 and the three months ended March 31, 2018 , outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase shares of common stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2018 , outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 14.6 million shares of common stock were excluded in the computation of diluted EPS as their inclusion would be anti-dilutive.
(b)  
For the three and nine months ended March 31, 2019 and the three months ended March 31, 2018 , RSUs were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2018 , 2.7 million of outstanding RSUs were excluded in the computation of diluted EPS as their inclusion would be anti-dilutive.
17 . MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS
Mandatorily Redeemable Financial Interest
United Arab Emirates subsidiary
The Company is required under a shareholders agreement (the “U.A.E. Shareholders Agreement”) to purchase all of the shares held by the noncontrolling interest holder equal to 25% of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. The Company has determined such shares to be a mandatorily redeemable financial instrument (“MRFI”) that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the U.A.E. Shareholders Agreement. As of March 31, 2019 and June 30, 2018 , the liability amounted to $7.7 and $8.2 , of which $6.3 and $6.7 , respectively, was recorded in Other noncurrent liabilities and $1.4 and $1.5 , respectively, was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.
Southeast Asian subsidiary
On May 23, 2017, the Company entered into the Sale of Shares and Termination Deed (the “Termination Agreement”) to purchase the remaining 49% noncontrolling interest from the noncontrolling interest holder of a certain Southeast Asian subsidiary for a purchase price of $45.0 . Additionally, all remaining retained earnings will be paid out as dividends prior to the purchase. As a result of the Termination Agreement, the noncontrolling interest balance is recorded as an MRFI. The MRFI balance will be accreted to the redemption value until the effective date of the purchase with changes in the balance being reflected in Other expense, net in the Condensed Consolidated Statements of Operations.
As of March 31, 2019 and June 30, 2018 , the MRFI liability amounted to $52.6 and $45.1 , respectively, which was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.

30


Redeemable Noncontrolling Interests
Younique
As of June 30, 2018, the Younique membership holders had a 40.6% membership interest in Foundation, which holds 100% of the units of Younique. During the nine months ended March 31, 2019 , additional shares of Foundation were issued to employees of Younique under a stock ownership program, incentive stock grants were granted and shares were forfeited under the program, resulting in a net impact of a 0.1% increase to the noncontrolling interest ownership percentage. The cumulative impact of the additional shares for the nine months ended March 31, 2019 was recorded as an increase to redeemable noncontrolling interests (“RNCI”) of $1.7 and a decrease in APIC of $1.7 .
The Company accounts for the 40.7% noncontrolling interest portion of Foundation as RNCI due to the noncontrolling interest holder’s right to put their shares to the Company in certain circumstances. While Foundation is a majority-owned consolidated subsidiary, the Company records income tax expense based on the Company’s 59.3% membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the  40.7%  noncontrolling interest of Foundation’s net income excluding a provision for income taxes. The Company recognized $369.7 and $597.7 as the RNCI balances as of March 31, 2019 and June 30, 2018 , respectively.
Subsidiary in the Middle East
As of March 31, 2019 , the noncontrolling interest holder in the Company’s subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. The Company adjusts the RNCI to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $80.4 and $63.6 as the RNCI balances as of March 31, 2019 and June 30, 2018 , respectively.
18 . COMMITMENTS AND CONTINGENCIES
Legal Matters
The Company is involved, from time to time, in various litigation, regulatory, administrative and other legal proceedings, including consumer class or collective actions, personal injury (including asbestos related claims), intellectual property, competition and advertising claims litigation, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities.
Certain Litigation . Two purported stockholder class action lawsuits concerning the Offer and the Schedule 14D-9 have been filed by putative stockholders against the Company and the directors of the Company in the U.S. District Court for the District of Delaware. The first case, which was filed on April 3, 2019, is captioned Lawrence Phillips, on behalf of himself and all others similarly situated, vs. the Company, Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer and Paul S. Michaels, Case No. 1:19-cv-00628. The second case, which was filed on April 9, 2019, is captioned Robert Rumsey, individually and on behalf of all others similarly situated, v. the Company, Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer and Paul S. Michaels, Case No. 1:19-cv-00650. The plaintiffs allege that the Company’s Schedule 14D-9 omits certain information, including, among other things, certain financial data and certain analyses underlying the opinion of Centerview Partners LLC. Plaintiffs assert claims under the federal securities laws and seek, among other things, injunctive and/or monetary relief. The Company believes that plaintiffs’ allegations lack merit and intends to contest them vigorously. 
A third purported stockholder class action lawsuit concerning the Offer and the Schedule 14D-9 was filed against the directors of the Company, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company is not named as a defendant. The case, which was filed on May 6, 2019, is captioned Massachusetts Laborers’ Pension Fund, on behalf of itself and all similarly situated holders of Coty Inc., v. Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer, Paul S. Michaels, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V., Case No. 2019-0336-

31


CB. The plaintiff alleges that the directors and the JAB Defendants breached their fiduciary duties to the Company’s stockholders and seeks, among other things, monetary relief.
Other Matters . In connection with the Offer, several putative stockholders served on the Company demands to inspect certain books and records of the Company pursuant to Section 220 of the Delaware General Corporation Law. Each demand seeks to inspect documents as part of a purported investigation of possible breaches of fiduciary duty by the Board in connection with the Offer.
Brazilian Tax Assessments
In connection with a local tax audit of one of the Company’s subsidiaries in Brazil, the Company was notified of tax assessments issued in March 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for the 2016-2017 tax periods. The Company is currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties, through March 31, 2019 amount to a total of R$249.0 million (approximately $63.8 ). The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable.
19 . SUBSEQUENT EVENTS
Quarterly Dividend
On May 8, 2019 , the Company announced a quarterly cash dividend of $0.125 per share on its Common Stock, RSUs and phantom units. The dividend will be payable on June 28, 2019 to holders of record of Common Stock as of June 6, 2019 .
Stock Dividend Reinvestment Program
On May 8, 2019, the Board approved a stock dividend reinvestment program giving shareholders the option to receive their full dividend in cash or to receive their dividend in 50% cash / 50% common stock. Shareholders will be able to make this election on a quarterly basis, beginning with the third quarter 2019 dividend payment.

32


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2018 (“Fiscal 2018 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. Also, when used in this discussion, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The following report includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.
All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.
Forward Looking Statements
Certain statements in this Form 10-Q are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, the Company’s strategic planning, the Company’s targets and outlook for future reporting periods (including the extent and timing of revenue and profit trends and the Consumer Beauty division’s stabilization), the Company’s future operations and strategy, synergies, savings, performance, cost, timing and integration relating to our recent acquisitions (including The Procter & Gamble Company’s beauty business (the “P&G Beauty Business”)), allocation and amount of advertising and consumer promotion costs, ongoing and future cost efficiency and restructuring initiatives and programs (including timing and impact), strategic transactions (including mergers and acquisitions, joint ventures, investments, divestitures, licenses and portfolio rationalizations), future cash flows and liquidity and borrowing capacity, future effective tax rates, timing and size of cash outflows and debt deleveraging, impact and timing of supply chain disruptions and the resolution thereof, finalization of a strategic plan and the anticipated priorities of our new senior management, the future impact of the U.S. tax laws including the base erosion anti-abuse tax and the global intangible low-taxed income rules, and the timing and implementation of a stock dividend reinvestment program. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including:
our ability to develop and achieve our global business strategies, our ability to compete effectively in the beauty industry and achieve the benefits contemplated by our strategic initiatives within the expected time frame or at all;
our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including any launches or relaunches and their associated costs and discounting, and consumer receptiveness to our marketing and consumer engagement activities (including digital marketing and media);
use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, income taxes, the assessment of goodwill, other intangible assets and long-lived assets for impairment, the market value of inventory, pension expense and the fair value of acquired assets and liabilities associated with acquisitions and the fair value of redeemable noncontrolling interests;
the impact of any future impairments;
managerial, integration, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with multiple ongoing and future strategic initiatives and internal reorganizations;
the continued integration of the P&G Beauty Business and other recent acquisitions with our business, operations, systems, financial data and culture and the ability to realize synergies, avoid future supply chain and other business disruptions, reduce costs (including through our cash efficiency initiatives) and realize other potential efficiencies and

33

Table of Contents

benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;
increased competition, consolidation among retailers, shifts in consumers’ preferred distribution and marketing channels (including to digital and luxury channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes;
our and our business partners’ and licensors’ abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers), public goodwill, and defend claims by third parties for infringement of intellectual property rights;
any change to our capital allocation and/or cash management priorities;
any unanticipated problems, liabilities or other challenges associated with an acquired business which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters;
our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;
our dependence on certain licenses (especially in our Luxury division) and our ability to renew expiring licenses on favorable terms or at all;
our dependence on entities performing outsourced functions, including outsourcing of distribution functions, third-party manufacturers, logistics and supply chain suppliers, and other suppliers, including third-party software providers;
administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches and marketing efforts;
global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of Brexit, the current U.S. administration, the results of elections in European countries and in Brazil, changes in the U.S. tax code and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S. and in other regions where we operate including the European Union and China;
currency exchange rate volatility and currency devaluation and our ability to hedge exposure to currency exchange fluctuations;
the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including litigation relating to the tender offer by Cottage Holdco B.V. (the “Offer”);
our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;
disruptions in operations and sales, including due to disruptions in supply chain, logistics, restructurings and other business alignment activities, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, and the impact of such disruptions on our ability to generate profits, stabilize or grow revenues or cash flows, comply with our contractual obligations and accurately forecast demand and supply needs and/or future results, and on our relationships with licensors and retailers, our in-store execution and product launches and promotions;
restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs, including access to capital under current market conditions;
increasing dependency on information technology and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, including our digital transformation initiatives, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union

34

Table of Contents

General Data Protection Regulation (the “GDPR”)) or to protect against theft of customer, employee and corporate sensitive information;
our ability to attract and retain key personnel and the impact of the recent senior management transitions;
the distribution and sale by third parties of counterfeit and/or gray market versions of our products;
the results of our ongoing strategic review and the creation, revision and implementation of our strategic plan;
the impact of the Offer on our relationships with key customers and suppliers and certain material contracts;
our relationship with Cottage Holdco B.V., as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;
future sales of a significant number of shares in the public market by our majority stockholder or contractually by certain commercial banks on behalf of our majority stockholder, as may be required to satisfy any potential future credit difficulties in connection with our majority stockholder’s credit agreement, or the perception that such sales could occur; and
other factors described elsewhere in this document and from time to time in documents that we file with the SEC.
All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.
Industry, Ranking and Market Data
Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations about our industry, market position, market opportunity and market sizes, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we generally believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.
Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2019 ” refer to the fiscal year ending June 30, 2019 . Any reference to a year not preceded by “fiscal” refers to a calendar year.

OVERVIEW
We are one of the world’s largest beauty companies, with a purpose to celebrate and liberate the diversity of consumers’ beauty. The transformational acquisition of the P&G Beauty Business and our other strategic transactions have strengthened and diversified our presence across the countries, categories and channels in which we compete.
Certain market segments and geographies in which we compete generally continue to grow moderately. While the body care category is experiencing growth in Latin America, single digit declines in the luxury fragrances, luxury skincare, mass color cosmetics and mass fragrances categories in the U.S. and certain key geographies in Western Europe continue to impact our business and financial results. In certain categories, our revenues are declining faster than the category.
The economics of developing, producing, launching, supporting and discontinuing products impact the timing of our sales and operating performance each period. In addition, as product life cycles shorten, results are driven primarily by successfully developing, introducing and marketing new, innovative products.
Despite strong consumer demand and innovation in the Luxury and Professional Beauty divisions, results in fiscal 2019 reflected the impact of the supply chain disruptions on all divisions, as discussed below. The deterioration in Consumer

35

Table of Contents

Beauty’s results were further impacted by the continued weakness in U.S. and Europe mass beauty categories, and the continued impact from distribution losses, primarily in the U.S.
Leadership changes and strategic review of business
Our top priority is taking the necessary steps to stabilize our consumer business and build a sustainable foundation to position the Company for long-term success. The composition of our board of directors has evolved, and we implemented several executive leadership changes to drive our ongoing transformation and growth. Under the direction of our new leadership team, we are undertaking a broad review of the Company and our business with the objective of designing a strategic roadmap for consistent and profitable growth, with an emphasis on gross margin improvement. As part of this initiative, we may make changes to any of the current strategies for our business, brands, operations, capital allocation and organization, including restructuring programs. We expect to provide more details as management defines and implements this initiative.

Transformation of our business
Following our acquisition of the P&G Beauty Business, we have been focused on integrating, restructuring and optimizing the combined organization. Through March 31, 2019 , we incurred life-to-date Global Integration Activities expenditures of approximately $1,290 million and $420 million of operating and capital expenditures, respectively, and we expect additional expenses to be incurred in future periods through fiscal 2021. We currently expect to incur to a total of approximately $1.4 billion of operating expenditures in connection with the Global Integration Activities. As of March 31, 2019, we have substantially completed the one order, one invoice, one shipment integration program, which enables us to sell, ship and invoice our brands in a more efficient way for our customers, allowing significant simplification for our customers and employees and increasing our scalability potential.
We have been engaged in a transformation of our supply chain aimed at integrating and optimizing the combined organization, and we continue to focus on streamlining our supply chain footprint and processes in order to increase efficiency and improve utilization. In fiscal 2019, we experienced disruptions in our supply chain in connection with these integration activities which have negatively impacted our results and our realization of our net synergies (the “Supply Chain Disruptions”). We have resolved the most critical supply chain issues, and we expect a small impact on our results during the fourth quarter of fiscal 2019.
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures including Adjusted operating income, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share (collectively, the “Adjusted Performance Measures”). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Three Months Ended March 31, 2019 As Compared To Three Months Ended March 31, 2018 and Nine Months Ended March 31, 2019 As Compared To Nine Months Ended March 31, 2018.” These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.
Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance, preparation of our annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:
strategic plans and annual budgets are prepared using the Adjusted Performance Measures;
senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and
senior management’s annual compensation is calculated, in part, by using some of the Adjusted Performance Measures.
In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.
Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our

36

Table of Contents

management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.
Adjusted operating income excludes restructuring costs and business structure realignment programs, amortization, acquisition-related costs and acquisition accounting impacts, asset impairment charges and other adjustments as described below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense as described below and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.
Adjusted Performance Measures reflect adjustments based on the following items:
Costs related to acquisition activities: We have excluded acquisition-related costs and acquisition accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and the maturities of the businesses being acquired. Also, the size, complexity and/or volume of past acquisitions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions.
Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance
Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.
Other (income) expense: We have excluded the impact of costs incurred for legal and advisory services rendered in connection with the evaluation of the tender offer initiated on February 13, 2019 by certain of our shareholders. Our management believes these costs do not reflect our underlying ongoing business, and the adjustment of such costs helps investors and others compare and analyze performance from period to period.
Noncontrolling interests: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage.
Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments are based on the tax rates related to the jurisdiction in which the adjusted items are received or incurred.
While acquiring brands and licenses comprises a part of our overall growth strategy, along with targeting organic growth opportunities, we have excluded acquisition-related costs and acquisition accounting impacts in connection with business

37

Table of Contents

combinations because these costs are unique to each transaction and the amount and frequency are not consistent and are significantly impacted by the timing and size of our acquisitions. Our management assesses the success of an acquisition as a component of performance using a variety of indicators depending on the size and nature of the acquisition, including:
the scale of the combined company by evaluating consolidated and segment financial metrics;
the expansion of product offerings by evaluating segment, brand, and geographic performance and the respective strength of the brands;
the evaluation of market share expansion in categories and geographies;
the earnings per share accretion and substantial incremental free cash flow generation providing financial flexibility for us; and
the comparison of actual and projected results, including achievement of projected synergies, post integration; provided that timing for any such comparison will depend on the size and complexity of the acquisition.
Constant Currency
We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in “constant currency”, excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.
Basis of Presentation of Acquisitions, Divestitures and Terminations
During the period when we complete an acquisition, divestiture or early license termination, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results and (ii) the divested brands or businesses or early terminated brands in the prior year period, to maintain comparable financial results with the current fiscal year period. Acquisitions, divestitures and early license terminations that would impact the comparability of financial results between periods presented in the Management’s Discussion and Analysis of Financial Condition and Results of Operations are shown in the table below.
Period of acquisition, divestiture, or termination
 
Acquisition, divestiture, or termination
 
Impact on basis of presentation
First quarter fiscal 2018
 
n/a
 
n/a
Second quarter fiscal 2018

 
Acquisition : Burberry Beauty Business (Luxury segment)

 
First quarter fiscal 2019 financial contribution excluded
Third quarter fiscal 2018

 
Termination : Guess (Consumer Beauty segment)
 
First, second and third quarter fiscal 2018 financial contribution excluded

Fourth quarter fiscal 2018

 
Divestitures of licenses : Playboy (Consumer Beauty segment) and Cerruti (Luxury segment)
 
First, second and third quarter fiscal 2018 financial contribution excluded

When used herein, the term “Acquisitions” and “Divestitures” or “Divestiture”, as applicable, refer to the financial contributions of the related acquisitions or divestitures and early license terminations shown above, during the period that is not comparable as a result of such acquisitions or divestitures and early license terminations.

38

Table of Contents

THREE MONTHS ENDED MARCH 31, 2019 AS COMPARED TO THREE MONTHS ENDED MARCH 31, 2018
NET REVENUES
In the three months ended March 31, 2019 , net revenues decreased 10% , or $232.1 , to $1,990.6 from $2,222.7 in the three months ended March 31, 2018 . The impact of the termination of the Guess license and the divestitures of the licenses of Playboy and Cerruti , had a negative impact of 2% on the total percentage change in net revenues in the three months ended March 31, 2019 as compared to the three months ended March 31, 2018 . Excluding the impact of the Divestitures, total net revenues decreased 8% , or $189.9 , to $1,990.6 in the three months ended March 31, 2019 from $2,180.5 in the three months ended March 31, 2018 , reflecting a negative price and mix impact of 7% , a negative foreign currency exchange translation impact of 4% , partially offset by an increase in unit volume of 3% . The decrease in net revenues primarily reflects: (i) shelf-space losses, which have contributed to the negative market share trends in the color cosmetics and hair color categories in North America; (ii) performance challenges in our brands across Europe which have contributed to the region’s negative market share trends in the color cosmetics category; and (iii) the negative impact of foreign currency exchange translation.

Net Revenues by Segment
 
Three Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
NET REVENUES
 
 
 
 
 
Luxury
$
729.2

 
$
752.5

 
(3
%)
Consumer Beauty
840.3

 
1,021.7

 
(18
%)
Professional Beauty
421.1

 
448.5

 
(6
%)
Total
$
1,990.6

 
$
2,222.7

 
(10
%)
Luxury
In the three months ended March 31, 2019 , net revenues from the Luxury segment decreased 3% , or $23.3 , to $729.2 from $752.5 in the three months ended March 31, 2018 . The impact of the divestiture of the license of Cerruti , had a negative contribution of 1% on the total change in net revenues for the segment in the three months ended March 31, 2019 as compared to the three months ended March 31, 2018 . Excluding the impact of the Divestiture, net revenues from the Luxury segment decreased 2% , or $14.8 , to $729.2 in the three months ended March 31, 2019 , from $744.0 in the three months ended March 31, 2018 reflecting a negative foreign currency exchange translation impact of 5% partially offset by a positive increase in unit volume of 3% . The decrease in net revenues primarily reflects: (i) the negative impact of foreign currency exchange translation; (ii) lower net revenues from Tiffany & Co due to lower launch activity and declines in existing product lines; and (iii) lower net revenues from Chloé due to lower launch activity in the current year compared to the prior year launch of Chloé Nomade in the third quarter of fiscal 2018. These decreases were offset by: (i) increased net revenues from Burberry due to the integration and growth of the brand since the acquisition of the Burberry Beauty Business in the second quarter of fiscal 2018; and (ii) increased net revenues from Calvin Klein due to the continued success from the launch of Calvin Klein Women as well as the launch of the new Euphoria advertising campaign. A positive performance from Hugo Boss due to increased net revenues from the launch of Boss Bottled Infinite in the quarter, which was more than offset by the negative impact from foreign currency exchange translation.
Consumer Beauty
In the three months ended March 31, 2019 , net revenues from the Consumer Beauty segment decreased 18% , or $181.4 , to $840.3 from $1,021.7 in the three months ended March 31, 2018 . The impact of the termination of Guess and the divestiture of the license of Playboy had a negative contribution of 3% on the total change in net revenues for the segment in the three months ended March 31, 2019 as compared to the three months ended March 31, 2018 . Excluding the impact of the Divestitures, net revenues from the Consumer Beauty segment decreased 15% , or $147.7 to $840.3 in the three months ended March 31, 2019 , from $988.0 in the three months ended March 31, 2018 reflecting a negative price and mix impact of 14% , a negative foreign currency exchange translation impact of 5% , partially offset by an increase in unit volume of 4% . The decrease in net revenues primarily reflects:
(i)
Shelf-space losses primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative share trends in the color cosmetics and hair color categories in North America;
(ii)
Performance challenges in our brands across Europe which have contributed to the region’s negative market share trends in the color cosmetics category;

39

Table of Contents

(iii)
Reduced net revenues from Younique due to a decline in product sales and presenter sponsorship as we continue to refine our product offerings to drive improvements in presenter sales activity, recruitment and retention;
(iv)
Reduced net revenues in North America due to the adoption of the New Revenue Standard primarily impacting CoverGirl and Sally Hansen; and
(v)
the negative impact of foreign currency exchange translation.
These net revenue declines were partially offset by increased net revenue from the overall body care category in the current period primarily driven by lower net revenues in the third quarter of fiscal 2018 as a result of our positive pricing adjustments in Brazil, which significantly impacted shipments of local body care brands in Brazil. The negative price and mix impact for the segment primarily reflects this higher volume from the body care category, which has relatively lower-priced products.
Professional Beauty
In the three months ended March 31, 2019 , net revenues from the Professional Beauty segment decreased 6% , or $27.4 , to $421.1 from $448.5 in the three months ended March 31, 2018 , reflecting a negative foreign currency exchange translation impact of 5% , a decrease in unit volume of 5% , partially offset by a positive price and mix impact of 4% . The decrease in net revenues primarily reflects lower net revenues for hair care brands due to lower shipments to optimize trade inventory levels for certain key U.S. customers and the negative impact of foreign currency exchange translation. This decrease was partially offset by increases in net revenues from  ghd  due to the product launch of the ghd Glide in the quarter and continued success from the launch of  Platinum +.

Net Revenues by Geographic Regions
In addition to our reporting segments, net revenues by geographic regions are as follows. We define our geographic regions as North America (comprising Canada and the United States), Europe and ALMEA (comprising Asia, Latin America, the Middle East, Africa and Australia):
 
Three Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
NET REVENUES
 
 
 
 
 
North America
$
611.7

 
$
713.5

 
(14
%)
Europe
837.9

 
976.0

 
(14
%)
ALMEA
541.0

 
533.2

 
1
%
Total
$
1,990.6

 
$
2,222.7

 
(10
%)
North America
In the three months ended March 31, 2019 , net revenues in North America decreased 14% , or $101.8 , to $611.7 compared to $713.5 in the three months ended March 31, 2018 . Excluding the impact of the Divestitures, net revenues in North America decreased 13% , or $94.4 , to $611.7 in the three months ended March 31, 2019 from $706.1 in the three months ended March 31, 2018 , primarily due to: (i) shelf-space losses in the United States primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative share trends in the color cosmetics and hair color categories in North America; (ii) the adoption of the New Revenue Standard primarily impacting CoverGirl and Sally Hansen, (iii) reduced net revenues from Younique due to a decline in product sales and presenter sponsorship as we continue to refine our product offerings to drive improvements in presenter sales activity, recruitment and retention; and (iv) lower net revenues for hair care brands due to lower shipments to optimize trade inventory levels for certain key U.S. customers. These decreases were partially offset by increased net revenues in the United States from Burberry due to the integration and growth of the brand since the acquisition of the Burberry Beauty Business in the second quarter of fiscal 2018.
Europe
In the three months ended March 31, 2019 , net revenues in Europe decreased 14% , or $138.1 , to $837.9 from $976.0 in the three months ended March 31, 2018 . Excluding the impact of the Divestitures, net revenues in Europe decreased 12% , or $117.4 , to $837.9 in the three months ended March 31, 2019 from $955.3 in the three months ended March 31, 2018 , primarily due to: (i) performance challenges in our brands across Europe which have contributed to the region’s negative share trends in the color cosmetics category; and (ii) the negative impact of foreign currency exchange translation. Excluding the impact of the Divestitures and the negative foreign currency exchange translation impact of 7%, net revenues in Europe decreased 5% .
ALMEA

40

Table of Contents

In the three months ended March 31, 2019 , net revenues in ALMEA increased 1% , or $7.8 , to $541.0 from $533.2 in the three months ended March 31, 2018 . Excluding the impact of the Divestitures, net revenues in ALMEA increased 4% , or $21.9 , to $541.0 in the three months ended March 31, 2019 from $519.1 in the three months ended March 31, 2018 , primarily reflecting: (i) increased net revenue in Brazil primarily due to lower net revenues in the third quarter of fiscal 2018 as a result of our pricing adjustments in Brazil, which significantly impacted shipments of local body care brands in Brazil; and (ii) incremental net revenue from Burberry primarily in China and the Middle East due to the integration and growth of the brand since the acquisition of the Burberry Beauty Business in the second quarter of fiscal 2018. These increases were partially offset by: (i) decreased net revenues in China and the Middle East primarily from Max Factor due to changes to retailer trade inventory levels, which has also resulted in increased sales discounts; and (ii) the negative impact of foreign currency exchange translation. Excluding the impacts of the Divestitures and the negative foreign currency exchange translation impact of 7%, net revenues in ALMEA increased 11% .
COST OF SALES
In the three months ended March 31, 2019 , cost of sales decreased $71.1 , to $741.2 from $812.3 in the three months ended March 31, 2018 . Cost of sales as a percentage of revenues increased to 37.2% in the three months ended March 31, 2019 from 36.5% in the three months ended March 31, 2018 , resulting in a gross margin decline of approximately 70 basis points primarily reflecting: (i) the negative mix impact within the Consumer Beauty segment associated with a higher proportionate net revenue contribution from lower-margin body care products driven by lower sales volume in the third quarter of fiscal 2018 as a result of our positive pricing adjustments in Brazil, which significantly impacted shipments of Brazil local body care brands; (ii) increased sales discounts in the Consumer Beauty segment partially reflecting a change in the timing of accrual recognition for certain customer incentives and markdowns from the New Revenue Standard; (iii) increased freight expenses primarily due to an increase in import duties and freight rates; and (iv) increased excess and obsolescence expense in the Consumer Beauty segment. These declines were partially offset by: (i) a favorable mix impact associated with the increased proportionate net revenue contribution from higher-margin Luxury and Professional Beauty products in the third quarter of fiscal 2019 compared to the third quarter of fiscal 2018; and (ii) decreased excess and obsolescence expense for artwork transition activities on acquired inventory in connection with the acquisition of the P&G Beauty Business.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
In the three months ended March 31, 2019 , selling, general and administrative expenses decreased 14% , or $181.1 , to $1,070.5 from $1,251.6 in the three months ended March 31, 2018 . Selling, general and administrative expenses as a percentage of net revenues decreased to 53.8% in the three months ended March 31, 2019 from 56.3% in the three months ended March 31, 2018 , or approximately 250 basis points. This decrease primarily reflects:
(i)
170 basis points related to lower advertising and consumer promotion costs due to a rationalization of non-strategic spending in non-working media and other consumer promotion activities across all divisions and a decrease primarily in media spending within the Consumer Beauty segment due to a higher investment spend in the prior year on the brand relaunches of CoverGirl and Clairol ;
(ii)
60 basis points related to lower negative transactional impact from our exposure to foreign currency exchange fluctuations;
(iii)
50 basis points related to lower share-based compensation expense due to significant executive forfeitures of share-based compensation instruments and the impact of actual forfeitures on the change in the estimated forfeiture rates during the period; and
(iv)
30 basis points related to lower bad debt expense.
These decreases were partially offset by an increase of 70 basis points in distribution and warehousing expenses due to an increase in storage and handling costs.

OPERATING INCOME (LOSS)
In the three months ended March 31, 2019 , operating income increased greater than 100%, or $64.8 , to $85.5 from $20.7 in the three months ended March 31, 2018 . Operating margin, or operating income as a percentage of net revenues, increased to 4.3% in the three months ended March 31, 2019 as compared to 0.9% in the three months ended March 31, 2018 .
The basis point increase in operating income as a percentage of net revenues for the three months ended March 31, 2019 as compared to the respective prior year period, are comprised of the following:

41

Table of Contents

 
Three Months Ended
March 31,
(bps rounded to nearest tenth)
2019/2018
Selling, general and administrative expenses
250

Restructuring
160

Acquisition-related costs
10

Amortization
(10
)
Cost of sales
(70
)
Total basis point increase
340

Operating Income by Segment
 
Three Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Operating income (loss)
 
 
 
 
 
Luxury
$
87.7

 
$
59.4

 
48
%
Consumer Beauty
24.1

 
64.2

 
(62
%)
Professional Beauty
30.7

 
11.4

 
>100%

Corporate
(57.0
)
 
(114.3
)
 
50
%
Total
85.5

 
20.7

 
>100%

Luxury
In the three months ended March 31, 2019 , operating income for Luxury increased 48% , or $28.3 , to $87.7 from $59.4 in the three months ended March 31, 2018 . Operating margin increased to 12.0% of net revenues in the three months ended March 31, 2019 as compared to 7.9% in the three months ended March 31, 2018 , primarily reflecting lower selling, general and administrative expenses as a percentage of net revenues.
Consumer Beauty
In the three months ended March 31, 2019 , operating income for Consumer Beauty decreased 62% , or $40.1 , to $24.1 from $64.2 in the three months ended March 31, 2018 . Operating margin decreased to 2.9% of net revenues in the three months ended March 31, 2019 as compared to 6.3% in the three months ended March 31, 2018 , primarily reflecting higher cost of goods sold as a percentage of net revenues and higher amortization expense as a percentage of net revenues, partially offset by lower selling, general and administrative expenses as a percentage of net revenues.
Professional Beauty
In the three months ended March 31, 2019 , operating income for Professional Beauty increased greater than 100%, or $19.3 , to $30.7 as compared to $11.4 in the three months ended March 31, 2018 . Operating margin increased to 7.3% of net revenues in the three months ended March 31, 2019 as compared to 2.5% in the three months ended March 31, 2018 , reflecting lower selling, general and administrative expenses as a percentage of net revenues and lower cost of goods sold as a percentage of net revenues.
Corporate
Corporate primarily includes corporate expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.
In the three months ended March 31, 2019 , the operating loss for Corporate was $57.0 compared to $114.3 in the three months ended March 31, 2018 , as described under “Adjusted Operating Income for Coty Inc.” below.

42

Table of Contents

Adjusted Operating Income by Segment
We believe that adjusted operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below, by segment:
 
Three Months Ended March 31, 2019
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating income (loss)
 
 
 
 
 
Luxury
$
87.7

 
$
(38.4
)
 
$
126.1

Consumer Beauty
24.1

 
(31.7
)
 
55.8

Professional Beauty
30.7

 
(16.6
)
 
47.3

Corporate
(57.0
)
 
(57.3
)
 
0.3

Total
85.5

 
(144.0
)
 
229.5

 
Three Months Ended March 31, 2018
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating income (loss)
 
 
 
 
 
Luxury
$
59.4

 
$
(41.0
)
 
$
100.4

Consumer Beauty
64.2

 
(33.1
)
 
97.3

Professional Beauty
11.4

 
(18.7
)
 
30.1

Corporate
(114.3
)
 
(115.1
)
 
0.8

Total
20.7

 
(207.9
)
 
228.6

 
 
(a)  
See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “Adjusted Operating Income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization expense, which is reflected in the Luxury, Consumer Beauty and Professional Beauty divisions.
Adjusted Operating Income for Coty Inc.
We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to adjusted operating income is presented below:
 
Three Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Reported operating income
$
85.5

 
$
20.7

 
>100%

% of net revenues
4.3
%
 
0.9
%
 
 
Amortization expense
86.7

 
92.8

 
(7
%)
Restructuring and other business realignment costs
57.3

 
111.0

 
(48
%)
Costs related to acquisition activities

 
4.1

 
(100
%)
Total adjustments to reported operating income
144.0

 
207.9

 
(31
%)
Adjusted operating income
$
229.5

 
$
228.6

 
%
% of net revenues
11.5
%
 
10.3
%
 
 
In the three months ended March 31, 2019 , adjusted operating income remained relatively consistent at $229.5 compared to $228.6 in the three months ended March 31, 2018 . Adjusted operating margin increased to 11.5% of net revenues in the three months ended March 31, 2019 from 10.3% in the three months ended March 31, 2018 , primarily driven by approximately 260 basis points related to lower selling, general and administrative costs as a percentage of net revenues offset by approximately 140 basis points related to higher cost of sales as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, adjusted operating income increased 5% .

43

Table of Contents

Amortization Expense
In the three months ended March 31, 2019 , amortization expense decreased to $86.7 from $92.8 in the three months ended March 31, 2018 . In the three months ended March 31, 2019 , amortization expense of $38.4 , $31.7 , and $16.6 was reported in the Luxury, Consumer Beauty and Professional Beauty segments, respectively. In three months ended March 31, 2018 , amortization expense of $41.0, $33.1, and $18.7 was reported in the Luxury, Consumer Beauty, and Professional Beauty segments, respectively.
Restructuring and Other Business Realignment Costs
We continue to analyze our cost structure, including opportunities to simplify and streamline operations. In particular, in connection with the acquisition of the P&G Beauty Business, we have and will continue to incur restructuring and related costs aimed at integrating and optimizing the combined organization, which we refer to as the Global Integration Activities. In addition, in 2018, we began evaluating initiatives to reduce fixed costs and enable further investment in the business, which we refer to as the 2018 Restructuring Actions. Of the total expected costs associated with the 2018 Restructuring Actions of $250.0 , we have incurred cumulative restructuring charges of $81.7 related to approved initiatives through March 31, 2019.
In the three months ended March 31, 2019 , we incurred restructuring and other business structure realignment costs of $57.3 , as follows:
We incurred restructuring costs of $6.7 primarily related to the 2018 Restructuring Actions and the Global Integration Activities, included in the Condensed Consolidated Statements of Operations; and
We incurred business structure realignment costs of $50.6 primarily related to our Global Integration Activities and certain other programs. This amount includes $48.4 reported in selling, general and administrative expenses and $2.2 reported in cost of sales in the Condensed Consolidated Statements of Operations, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.
In the three months ended March 31, 2018 , we incurred restructuring and other business structure realignment costs of $111.0 as follows:
We incurred restructuring costs of $42.7 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Condensed Consolidated Statements of Operations.
We incurred business structure realignment costs of $68.3 primarily related to our Global Integration Activities and certain other programs. This amount includes $51.8 reported in selling, general and administrative expenses and $16.5 reported in cost of sales in the Condensed Consolidated Statements of Operations, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.
In all reported periods, all restructuring and other business realignment costs were reported in Corporate.
Costs Related to Acquisition Activities
In the three months ended March 31, 2019 , there were no acquisition related charges incurred.
In the three months ended March 31, 2018 , we incurred $4.1 of costs related to acquisition activities. We recognized acquisition-related costs of $2.6 included in the Condensed Consolidated Statements of Operations. These costs may include finder’s fees, legal, accounting, valuation, and other professional or consulting fees, and other internal costs which may include compensation related expenses for dedicated internal resources. We also incurred approximately $1.5 in cost of sales primarily reflecting revaluation of acquired inventory in connection with the acquisition of the Burberry Beauty Business in the Condensed Consolidated Statements of Operations.
In all reported periods, all costs related to acquisition activities were reported in Corporate.
INTEREST EXPENSE, NET
In the three months ended March 31, 2019 , Interest expense, net was $72.0 as compared with $72.6 in the three months ended March 31, 2018 . This decrease is primarily due to lower average borrowing rates.
OTHER EXPENSE, NET
We incurred $17.5 and $3.8 of other expense in the three months ended March 31, 2019 and 2018, respectively. In the three months ended March 31, 2019 , other expense is primarily associated with $12.7 of legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders and $3.3 due to the change in the Mandatorily Redeemable Financial Instrument (“MRFI”) balance associated with a certain Southeast Asian subsidiary.

44

Table of Contents

INCOME TAXES
The effective income tax rate for the three months ended March 31, 2019 and 2018 was 0.0%  and  (7.9)% , respectively. The change in the effective tax rate for the three months ended March 31, 2019 , as compared to the prior period is primarily due to the impact of the Tax Act in the prior period.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to our unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.
Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:
 
Three Months Ended
March 31, 2019
 
Three Months Ended
March 31, 2018
(in millions)
(Loss) Income Before Income Taxes
 
Provision for Income Taxes
 
Effective Tax Rate
 
(Loss) Income Before Income Taxes
 
Provision for Income Taxes
 
Effective Tax Rate
Reported (loss) income before income taxes
$
(4.0
)
 
$

 
%
 
$
(55.7
)
 
$
4.4

 
(7.9
%)
Adjustments to reported operating income (a) (b)
144.0

 
38.6

 
 
 
207.9

 
31.8

 
 
Other adjustments  (b)(c)
12.7

 
0.8

 
 
 

 

 
 
Adjusted income before income taxes
$
152.7

 
$
39.4

 
25.8
%
 
$
152.2

 
$
36.2

 
23.8
%
 
 
(a)  
See a description of adjustments under “adjusted operating (loss) income for Coty Inc.”
(b)  
The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.
(c)  
In the three months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.
The adjusted effective tax rate was 25.8% for the three months ended March 31, 2019 compared to 23.8% for the three months ended March 31, 2018 . The differences were primarily due to the jurisdictional mix of income.

NET (LOSS) INCOME ATTRIBUTABLE TO COTY INC.
Net loss attributable to Coty Inc. increased to $12.1 in the three months ended March 31, 2019 from $77.0 in the three months ended March 31, 2018 . This increase primarily reflects higher operating income.
We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”


45

Table of Contents

 
Three Months Ended
March 31,
 

(in millions)
2019
 
2018
 
Change %
Reported net (loss) attributable to Coty Inc.
$
(12.1
)
 
$
(77.0
)
 
84
%
% of net revenues
(0.6
%)
 
(3.5
%)
 
 
Adjustments to reported operating income (a)
144.0

 
207.9

 
(31
%)
Adjustment to other expense (b)
12.7

 

 
N/A

Adjustments to noncontrolling interests  (c)
(3.6
)
 
(2.9
)
 
(24
%)
Change in tax provision due to adjustments to reported net income attributable to Coty Inc.
(39.4
)
 
(31.8
)
 
(24
%)
Adjusted net income attributable to Coty Inc.
$
101.6

 
$
96.2

 
6
%
% of net revenues
5.1
 %
 
4.3
 %
 
 

Per Share Data
 
 
 
 
 
Adjusted weighted-average common shares
 
 
 
 
 
Basic
751.4

 
750.1

 
 
Diluted
753.9

 
754.0

 
 
Adjusted net income attributable to Coty Inc. per common share
 
 
 
 
 
Basic
$
0.14

 
$
0.13

 
 
Diluted
0.13

 
0.13

 
 
 
 
(a)  
See a description of adjustments under “Adjusted Operating Income for Coty Inc.”
(b)  
In the three months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.
(c)  
The amounts represent the impact of non-GAAP adjustments to net income attributable to noncontrolling interest related to the Company’s majority-owned consolidated subsidiaries. The amounts are based on the relevant noncontrolling interest’s percentage ownership in the related subsidiary, for which the non-GAAP adjustments were made.

NINE MONTHS ENDED MARCH 31, 2019 AS COMPARED TO NINE MONTHS ENDED MARCH 31, 2018
NET REVENUES
In the nine months ended March 31, 2019 , net revenues decreased 8% , or $565.5 , to $6,533.1 from $7,098.6 in the nine months ended March 31, 2018 . The impact of the acquisition of the Burberry Beauty Business had a positive contribution of 1% to the total change in net revenues in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018 . This was more than offset by the impact of the termination of the Guess license and the divestitures of the licenses of Playboy and Cerruti , which had a negative impact of 2% on the total change in net revenues in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018 . Excluding the impacts of the Acquisition and Divestitures, total net revenues decreased 7% , or $481.1 , to $6,470.8 in the nine months ended March 31, 2019 from $6,951.9 in the nine months ended March 31, 2018 , reflecting a negative foreign currency exchange translation impact of 4% , a decrease in unit volume of 2% , and a negative price and mix impact of 1% . The decrease in net revenues primarily reflects:
(i)
Shelf-space losses primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative market share trends in the color cosmetics and hair color categories in North America;
(ii)
Performance challenges in our brands across Europe which have contributed to the region’s negative market share trends in the color cosmetics category;
(iii)
the Supply Chain Disruptions, which have been significantly mitigated in the third quarter of fiscal 2019;


46

Table of Contents

Net Revenues by Segment
 
Nine Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Net revenues
 
 
 
 
 
 
Luxury
$
2,539.6

 
 
$
2,468.1

 
3
%
Consumer Beauty
2,636.9

 
 
3,203.7

 
(18
%)
Professional Beauty
1,356.6

 
 
1,426.8

 
(5
%)
Total
$
6,533.1

 
 
$
7,098.6

 
(8
%)
Luxury
In the nine months ended March 31, 2019 , net revenues from the Luxury segment increased 3% , or $71.5 , to $2,539.6 from $2,468.1 in the nine months ended March 31, 2018 . The impact of the acquisition of the Burberry Beauty Business had a positive contribution of 3% on the total change in net revenues for the segment in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018 . This was partially offset by the impact of the divestiture of the license of Cerruti , had a negative contribution of 1% on the total change in net revenues for the segment in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018 . Excluding the impacts of the Acquisition and Divestiture, net revenues from the Luxury segment increased 1% , or $35.5 , to $2,477.3 in the nine months ended March 31, 2019 from $2,441.8 in the nine months ended March 31, 2018 , reflecting an increase in unit volume of 6% , offset by a negative foreign currency exchange translation impact of 3% and a negative price and mix impact of 2% . The increase in net revenues primarily reflects: (i) increased net revenues from Burberry due to the integration and growth of the brand since the acquisition of the Burberry beauty Business in the second quarter of fiscal 2018; (ii) increased net revenues from Calvin Klein due to the continued success from the launch of Calvin Klein Women in the first quarter of fiscal 2019; and (iii) increased net revenues from Gucci due to the launch of Gucci Bloom Nettare di Fiori in the first quarter of fiscal 2019. These increases were offset by a net revenue decline in Hugo Boss due to the Supply Chain Disruptions, which have been significantly mitigated during the third quarter of fiscal 2019.
Consumer Beauty
In the nine months ended March 31, 2019 , net revenues from the Consumer Beauty segment decreased 18% , or $566.8 , to $2,636.9 from $3,203.7 in the nine months ended March 31, 2018 . The impact of the termination of Guess and the divestiture of the license of Playboy had a negative contribution of 4% on the total change in net revenues for the segment in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018 . Excluding the impact of the Divestitures, net revenues from the Consumer Beauty segment decreased 14% , or $446.4 , to $2,636.9 in the nine months ended March 31, 2019 from $3,083.3 in the nine months ended March 31, 2018 , reflecting a negative price and mix impact of 7% , a negative foreign currency exchange translation impact of 4% and a decrease in unit volume of 3% . The decrease in net revenues primarily reflects:
(i)
Shelf-space losses primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative share trends in the color cosmetics and hair color categories in North America;
(ii)
Performance challenges in our brands across Europe which have contributed to the region’s negative market share trends in the color cosmetics category;
(iii)
The Supply Chain Disruptions which resulted in lower net revenues in the first half of the year mainly in the color cosmetics category, namely the Rimmel, Max Factor and Bourjois brands ;
(iv)
Reduced net revenues from Younique due to a decline in product sales and presenter sponsorship as we continue to refine our product offerings to drive improvements in presenter sales activity, recruitment and retention; and
(v)
the negative impact of foreign currency exchange translation.
These net revenue declines were partially offset by increased net revenue from the overall body care category due to growth in Brazil. The negative price and mix impact for the segment primarily reflects this higher volume from the body care category which has relatively lower-priced products.

47

Table of Contents

Professional Beauty
In the nine months ended March 31, 2019 , net revenues from the Professional Beauty segment decreased 5% , or $70.2 , to $1,356.6 from $1,426.8 in the nine months ended March 31, 2018 primarily reflecting a decrease in unit volume of 5% and a negative foreign currency exchange translation impact of 4% , partially offset by a positive price and mix impact of 4% . The decrease in this segment primarily reflects: (i) lower net revenues due to the Supply Chain Disruptions mainly impacting OPI and brands across the hair care category; (ii) decreased volume for hair care brands due to lower shipments to optimize retailer trade inventory levels for certain key U.S. customers; and (iii) the negative impact of foreign currency exchange translation. These decreases were partially offset by: (i) a net revenue increase in ghd due to the product launch of the ghd Glide in the quarter and continued success from the launch of Platinum+; and (ii) favorable price and mix impacts from the  Wella Koleston Perfect ME+  product restage in the first quarter of fiscal 2019.
Net Revenues by Geographic Regions
In addition to our reporting segments, net revenues by geographic regions are as follows.
 
Nine Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Net revenues
 
 
 
 
 
North America
$
1,998.8

 
$
2,207.8

 
(9
%)
Europe
2,911.7

 
3,240.1

 
(10
%)
ALMEA
1,622.6

 
1,650.7

 
(2
%)
Total
$
6,533.1

 
$
7,098.6

 
(8
%)
North America
In the nine months ended March 31, 2019 , net revenues in North America decreased 9% , or $209.0 , to $1,998.8 from $2,207.8 in the nine months ended March 31, 2018 . Excluding the impacts of the Acquisition and Divestitures, net revenues in North America decreased 9% , or $198.0 , to $1,984.2 in the nine months ended March 31, 2019 from $2,182.2 in the nine months ended March 31, 2018 , primarily due to: (i) shelf-space losses in the United States primarily impacting CoverGirl, Rimmel and Clairol , which have contributed to the negative share trends in the color cosmetics and hair color categories in North America; (ii) reduced net revenues in the United States from the Supply Chain Disruptions; and (iii) reduced net revenues from Younique due to a decline in product sales and presenter sponsorship as we continue to refine our product offerings to drive improvements in presenter sales activity, recruitment and retention. These decreases were partially offset by increased net revenues from Burberry in the United States due to the integration of the Burberry Beauty Business.
Europe
In the nine months ended March 31, 2019 , net revenues in Europe decreased 10% , or $328.4 , to $2,911.7 from $3,240.1 in the nine months ended March 31, 2018 . Excluding the impacts of the Acquisition and Divestitures, net revenues in Europe decreased 9% , or $277.3 , to $2,882.7 in the nine months ended March 31, 2019 from $3,160.0 in the nine months ended March 31, 2018 , primarily due to: (i) performance challenges in our brands across Europe which have contributed to the region’s negative share trends in the color cosmetics category; (ii) declines in Rimmel, Bourjois, and Max Factor across the region due to the Supply Chain Disruptions; (iii) declines in mass fragrances categories in Western Europe in part due to negative market share and category trends in the mass fragrances category; and (iv) negative foreign currency exchange translation impacts. These declines were partially offset by incremental net revenues from Burberry and Calvin Klein across the region. Excluding the impact of the Acquisition, Divestitures and the negative foreign currency exchange translation impact of 4%, net revenues in Europe decreased 5% .
ALMEA
In the nine months ended March 31, 2019 , net revenues in ALMEA decreased 2% , or $28.1 , to $1,622.6 from $1,650.7 in the nine months ended March 31, 2018 . Excluding the impacts of the Acquisition and Divestitures, net revenues in ALMEA remained relatively consistent at $1,603.9 in the nine months ended March 31, 2019 from $1,609.7 in the nine months ended March 31, 2018 , primarily reflecting: (i) unfavorable foreign currency exchange translation impacts of certain currencies in Latin America; and (ii) lower net revenues in China and the Middle East from Max Factor and the retail hair line of Wella hair products due to changes to retailer trade inventory levels. These decreases were partially offset by: (i) higher net revenues in Japan and Brazil from the professional product line of Wella hair products and from the overall body care category growth in Brazil; and (ii) incremental net revenues from Burberry and Gucci across the region. Excluding the impacts of the Acquisition, Divestitures and the negative foreign currency exchange translation impact of 7%, net revenues in ALMEA increased 7% .

48

Table of Contents


COST OF SALES
In the nine months ended March 31, 2019 , cost of sales decreased 8% , or $204.4 , to $2,507.0 from $2,711.4 in the nine months ended March 31, 2018 . Cost of sales as a percentage of net revenues increased to 38.4% in the nine months ended March 31, 2019 from 38.2% in the nine months ended March 31, 2018 resulting in a gross margin decline of approximately 20 basis points primarily reflecting: (i) the negative mix impact within the Consumer Beauty segment associated with a higher proportionate net revenue contribution from lower-margin body care products, which has its primary commercial market located in Brazil; (ii) increased sales discounts in the Consumer Beauty segment; (iii) increased freight expenses primarily due to an increase in import duties and freight rates; (iv) increased excess and obsolescence expense in the Consumer Beauty segment; and (v) increased designer license fees due to an unfavorable mix of Luxury brands with higher royalty rates. These declines were partially offset by: (i) a favorable mix impact associated with the increased proportionate net revenue contribution from higher-margin Luxury and Professional Beauty products in the nine months ended March 31, 2019 as compared to the nine months ended March 31, 2018; (ii) net pricing improvements with the launch of  Wella Koleston Perfect ME+  in the first quarter of fiscal 2019; (iii) lower costs from distributor terminations and accelerated depreciation of buildings and equipment associated with plant closures related to the Global Integration Activities in fiscal 2018; and (iv) decreased excess and obsolescence expense for artwork transition activities on acquired inventory in connection with the acquisition of the P&G Beauty Business.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
In the nine months ended March 31, 2019 , selling, general and administrative expenses decreased 8% , or $285.1 , to $3,476.8 from $3,761.9 in the nine months ended March 31, 2018 . Selling, general and administrative expenses as a percentage of net revenues increased to 53.2% in the nine months ended March 31, 2019 from 53.0% in the nine months ended March 31, 2018 , or approximately 20 basis points. This increase primarily reflects:
(i)
60 basis points related to higher distribution and warehousing expenses due to a strategic shift in certain markets to distribute through subsidiaries as opposed to third-party distributors;
(ii)
50 basis points related to higher administrative costs due to the decline in net revenues in the Consumer Beauty segment out-pacing the overall decrease in administrative costs from compensation expense savings as a result of the Global Integration Activities, 2018 Restructuring Actions and certain other programs;
These increases were partially offset by:
(i)
30 basis points related to lower advertising and consumer promotion spending primarily due to a rationalization of non-strategic spending in non-working media and other consumer promotion activities across all divisions;
(ii)
30 basis points related to lower share-based compensation expense due to significant executive forfeitures of share-based compensation instruments;
(iii)
10 basis points related to lower transactional impact from our exposure to foreign currency exchange fluctuations; and
(iv)
10 basis points related to lower bad debt expense.
OPERATING (LOSS) INCOME
In the nine months ended March 31, 2019 , operating income decreased greater than 100%, or $965.2 to a loss of $739.8 from income of $225.4 in the nine months ended March 31, 2018 . Operating margin, or operating income as a percentage of net revenues, decreased to (11.3)% in the nine months ended March 31, 2019 as compared to 3.2% in the nine months ended March 31, 2018 .

49

Table of Contents

The basis point decrease in operating income as a percentage of net revenues for the nine months ended March 31, 2019 as compared to the respective prior year period, are comprised of the following:
 
Nine Months Ended
March 31,
(bps rounded to nearest tenth)
2019/2018
Asset impairment charges
(1,500
)
Amortization
(40
)
Cost of sales
(20
)
Selling, general and administrative expenses
(20
)
Acquisition-related costs
90

Restructuring
40

Total basis point decrease
(1,450
)


Operating Income (Loss) by Segment
 
Nine Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Operating income (loss)
 
 
 
 
 
Luxury
$
250.0

 
$
201.2

 
24
%
Consumer Beauty
(901.4
)
 
225.4

 
<(100%)

Professional Beauty
109.5

 
83.2

 
32
%
Corporate
(197.9
)
 
(284.4
)
 
30
%
Total
(739.8
)
 
225.4

 
<(100%)

Luxury
In the nine months ended March 31, 2019 , operating income for Luxury increased 24% , or $48.8 , to $250.0 from $201.2 in the nine months ended March 31, 2018 . Operating margin increased to 9.8% of net revenues in the nine months ended March 31, 2019 as compared to 8.2% in the nine months ended March 31, 2018 , primarily reflecting lower selling, general and administrative expenses as a percentage of net revenues.
Consumer Beauty
In the nine months ended March 31, 2019 , operating income for Consumer Beauty decreased greater than 100%, or $1,126.8 , to a loss of $901.4 from income of $225.4 in the nine months ended March 31, 2018 . Operating margin decreased to (34.2)% of net revenues in the nine months ended March 31, 2019 as compared to 7.0% in the nine months ended March 31, 2018 , primarily reflecting the asset impairment charges recognized in the second quarter of fiscal 2019.
Professional Beauty
In the nine months ended March 31, 2019 , operating income for Professional Beauty increased by 32% , or $26.3 , to $109.5 from $83.2 in the nine months ended March 31, 2018 . Operating margin increased to 8.1% of net revenues in the nine months ended March 31, 2019 as compared to 5.8% in the nine months ended March 31, 2018 , primarily reflecting lower cost of goods sold as a percentage of net revenues and lower selling, general and administrative expenses as a percentage of net revenues.
Corporate
Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.
In the nine months ended March 31, 2019 , the operating loss for Corporate was $197.9 compared to $284.4 in the nine months ended March 31, 2018 , as described under “Adjusted Operating Income for Coty Inc.” below.


50

Table of Contents

Adjusted Operating Income (Loss) by Segment
We believe that Adjusted Operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported Operating income (loss) to Adjusted Operating income is presented below, by segment:
 
Nine Months Ended March 31, 2019
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating income (loss)
 
 
 
 
 
Luxury
$
250.0

 
$
(154.6
)
 
$
404.6

Consumer Beauty
(901.4
)
 
(1,026.1
)
 
124.7

Professional Beauty
109.5

 
(52.7
)
 
162.2

Corporate
(197.9
)
 
(199.0
)
 
1.1

Total
(739.8
)
 
(1,432.4
)
 
692.6

 
Nine Months Ended March 31, 2018
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating income (loss)
 
 
 
 
 
Luxury
$
201.2

 
$
(114.5
)
 
$
315.7

Consumer Beauty
225.4

 
(92.1
)
 
317.5

Professional Beauty
83.2

 
(54.0
)
 
137.2

Corporate
(284.4
)
 
(286.8
)
 
2.4

Total
225.4

 
(547.4
)
 
772.8

 
 
(a)  
See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “Adjusted operating income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization expense, which is reflected in the Luxury, Consumer Beauty and Professional Beauty divisions, and asset impairment charges, which are reflected in the Luxury and Consumer Beauty divisions.

Adjusted Operating Income for Coty Inc.
We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below:
 
Nine Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Reported operating (loss) income
$
(739.8
)
 
$
225.4

 
<(100%)

% of net revenues
(11.3
)%
 
3.2
%
 
 
Asset impairment charges
977.7

 

 
N/A

Amortization expense
267.7

 
260.6

 
3
%
Restructuring and other business realignment costs
187.0

 
217.2

 
(14
%)
Costs related to acquisition activities

 
69.6

 
(100
%)
Total adjustments to reported operating income
1,432.4

 
547.4

 
>100%

Adjusted operating income
$
692.6

 
$
772.8

 
(10
%)
% of net revenues
10.6
 %
 
10.9
%
 
 

Adjusted operating income in the nine months ended March 31, 2019 decreased 10% , or $80.2 , to $692.6 from $772.8 in the nine months ended March 31, 2018 . Adjusted operating margin decreased to 10.6% of net revenues in the nine months ended March 31, 2019 as compared to 10.9% in the nine months ended March 31, 2018 , primarily driven by approximately 60

51

Table of Contents

basis points related to higher cost of sales as a percentage of net revenues partially offset by approximately 30 basis points related to lower selling, general and administrative costs as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, adjusted operating income decreased 6%.
Asset Impairment Charges
In the nine months ended March 31, 2019 , we incurred $977.7 of asset impairment charges primarily due to:
(i)
$930.3 related to goodwill and other intangible assets in the Consumer Beauty division recorded during the second quarter;
(ii)
$22.8 related to the philosophy trademark that is part of the Luxury reporting unit recorded during the second quarter;
(iii)
$12.6 charge in the Luxury Division during the first quarter due to an acquired trademark associated with a terminated pre-existing license as a result of the acquisition; and
(iv)
$12.0 related to a Corporate equity security investment recorded during the second quarter.
In the nine months ended March 31, 2018 , we did not incur any asset impairment charges.

Amortization Expense
In the nine months ended March 31, 2019 , amortization expense increased to $267.7 from $260.6 in the nine months ended March 31, 2018 . In the nine months ended March 31, 2019 , amortization expense of $119.2 , $95.8 , and $52.7 was reported in the Luxury, Consumer Beauty and Professional Beauty segments, respectively. In the nine months ended March 31, 2018 , amortization expense of $114.5, $92.1, and $54.0 was reported in the Luxury, Consumer Beauty, and Professional Beauty segments, respectively.
Restructuring and Other Business Realignment Costs
We continue to analyze our cost structure, including opportunities to simplify and streamline operations. In particular, in connection with the acquisition of the P&G Beauty Business, we have and will continue to incur restructuring and related costs aimed at integrating and optimizing the combined organization, which we refer to as the Global Integration Activities. In addition, in 2018, we began evaluating initiatives to reduce fixed costs and enable further investment in the business, which we refer to as the 2018 Restructuring Actions. Of the total expected costs associated with the 2018 Restructuring Actions of $250.0 , we have incurred cumulative restructuring charges of $81.7 related to approved initiatives through March 31, 2019.
In the nine months ended March 31, 2019 , we incurred restructuring and other business structure realignment costs of $187.0 , as follows:
We incurred restructuring costs of $43.7 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Condensed Consolidated Statements of Operations.
We incurred business structure realignment costs of $143.3 primarily related to our Global Integration Activities and certain other programs. Of this amount $131.3 is included in selling, general and administrative expenses and $12.0 is included in cost of sales, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.
In the nine months ended March 31, 2018 , we incurred restructuring and other business structure realignment costs of $217.2 as follows:
We incurred Restructuring costs of $75.6 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Condensed Consolidated Statements of Operations.
We incurred business structure realignment costs of $141.6 primarily related to our Global Integration Activities and certain other programs. Of this amount $104.4 is included in selling, general and administrative expenses and $37.2 is included in cost of sales, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.
In all reported periods, all restructuring and other business realignment costs were reported in Corporate.
Costs Related to Acquisition Activities
In the nine months ended March 31, 2019 , there were no acquisition related charges incurred.
In the nine months ended March 31, 2018 , we incurred $69.6 of costs related to acquisition activities. We recognized acquisition-related costs of $63.7 included in the Condensed Consolidated Statements of Operations. These costs were primarily incurred in connection with the acquisition of P&G Beauty Business. These costs include amounts paid for external

52

Table of Contents

consulting fees and internal costs for converting the data received from P&G during the transition period to satisfy the Company’s internal and external financial reporting, regulatory and other requirements, as well as legal, accounting, and valuation services, and fees paid directly to P&G. We also incurred $3.5 and $2.4 in costs of sales primarily reflecting revaluation of acquired inventory in connection with the acquisitions of Younique and the Burberry Beauty Business, respectively, in the Condensed Consolidated Statements of Operations.
In all reported periods, all costs related to acquisition activities were reported in Corporate.
INTEREST EXPENSE, NET
In the nine months ended March 31, 2019 , interest expense, net was $204.4 as compared with $199.3 in the nine months ended March 31, 2018 . This increase is primarily due to higher average debt levels.
OTHER EXPENSE, NET
We incurred $25.0 and $12.5 of other expense in the nine months ended March 31, 2019 and 2018 , respectively. In the nine months ended March 31, 2019 , other expense is primarily associated with $12.7 of legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders and $10.7 due to the change in the MRFI balance associated with a certain Southeast Asian subsidiary.
INCOME TAXES
The effective income tax rate for the nine months ended March 31, 2019 and 2018 was (0.1%) and (211.8)% , respectively. The change in the effective tax rate for the nine months ended March 31, 2019 , as compared to the prior period results from the resolution of foreign uncertain tax positions of approximately $43.0 in the prior period.
The effective income tax rates vary from the blended rate of approximately 21% due to the effect of: (i) jurisdictions with different statutory rates, (ii) adjustments to our unrecognized tax benefits and accrued interest; (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.
Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:
 
Nine Months Ended
March 31, 2019
 
Nine Months Ended
March 31, 2018
(in millions)
(Loss) Income Before Income Taxes
 
Provision for Income Taxes
 
Effective Tax Rate
 
Income Before Income Taxes
 
(Benefit) Provision for Income Taxes
 
Effective Tax Rate
Reported (loss) income before income taxes
$
(969.2
)
 
$
0.9

 
(0.1
%)
 
$
13.6

 
$
(28.8
)
 
(211.8
%)
Adjustments to reported operating income (a)(b)
1,432.4

 
84.5

 
 
 
547.4

 
128.6

 
 
Other adjustments (b)(c)
12.7

 
0.8

 
 
 

 

 
 
Adjusted income before income taxes
$
475.9

 
$
86.2

 
18.1
%
 
$
561.0

 
$
99.8

 
17.8
%
 
 
(a)  
See a description of adjustments under “adjusted operating income for Coty Inc.”.
(b)  
The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.
(c)  
In the three months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.

The adjusted effective tax rate was 18.1% for the nine months ended March 31, 2019 compared to 17.8% for the nine months ended March 31, 2018 . The differences were primarily due to the resolution of foreign uncertain tax positions.

53

Table of Contents

NET (LOSS) INCOME ATTRIBUTABLE TO COTY INC.
Net (loss) income attributable to Coty Inc. decreased to a loss of $(984.8) in the nine months ended March 31, 2019 , from income of $12.5 in the nine months ended March 31, 2018 . This decrease primarily reflects a higher operating loss.
We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”
 
Nine Months Ended
March 31,
 
 
(in millions)
2019
 
2018
 
Change %
Reported net (loss) income attributable to Coty Inc.
$
(984.8
)
 
$
12.5

 
<(100%)

% of net revenues
(15.1
%)
 
0.2
%
 
 
Adjustments to reported operating income (a)
1,432.4

 
547.4

 
>100%

 Adjustments to other expense (b)
12.7

 

 
N/A

Adjustments to noncontrolling interests (c)
(11.0
)
 
(21.6
)
 
49
%
Change in tax provision due to adjustments to reported net income attributable to Coty Inc.
(85.3
)
 
(128.6
)
 
34
%
Adjusted net income attributable to Coty Inc.
364.0

 
409.7

 
(11
%)
% of net revenues
5.6
 %
 
5.8
%
 
 

Per Share Data
 
 
 
 
 
Adjusted weighted-average common shares
 
 
 
 
 
Basic
751.1

 
749.4

 
 
Diluted
753.0

 
753.1

 
 
Adjusted net income attributable to Coty Inc. per common share
 
 
 
 
 
Basic
$
0.48

 
$
0.55

 
 
Diluted
0.48

 
0.54

 
 
 
 
(a)  
See a description of adjustments under “Adjusted Operating Income for Coty Inc.”
(b)  
In the nine months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.
(c)  
The amounts represent the impact of non-GAAP adjustments to net income attributable to noncontrolling interest related to the Company’s majority-owned consolidated subsidiaries. The amounts are based on the relevant noncontrolling interest’s percentage ownership in the related subsidiary, for which the non-GAAP adjustments were made.

FINANCIAL CONDITION
LIQUIDITY AND CAPITAL RESOURCES
Overview
Our primary sources of funds include cash expected to be generated from operations, borrowings from issuance of debt and committed and uncommitted lines of credit provided by banks and lenders in the U.S. and abroad. As of March 31, 2019 , we had cash and cash equivalents of $384.1 compared with $331.6 as of June 30, 2018 .
Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during the three and six months buildup before the holiday season in anticipation of higher global sales during the second fiscal quarter, as well as cash demands immediately following the holiday season primarily related to post-holiday sales returns. In the second fiscal quarter, we typically experience strong cash generation as a result of increased demand by retailers associated with the holiday season. Our principal uses of cash are to fund operating expenditures, capital expenditures, integration costs, interest payments, acquisitions, dividends, any share repurchases and principal payments on debt. Working capital movements are influenced by the sourcing of materials related to the production of products within each of our segments. Cash and working capital management initiatives, including the phasing of vendor payments and factoring of trade receivables from time-to-time, may also impact the timing of our operating cash flows, as we seek to efficiently manage our cash and working capital requirements.
As a result of the cash on hand, our expected ability to generate cash from operations and through access to our revolving credit facility and other lending sources, we believe we have sufficient liquidity to meet our ongoing needs on both a near term

54

Table of Contents

and long-term basis. On a quarterly basis, however we may consider factoring trade receivables under our receivables purchase facility and phasing of vendor payments in order to supplement the timing of our cash flows.

Debt
Debt balances consisted of the following as of March 31, 2019 and June 30, 2018 , respectively:
 
March 31, 2019
 
June 30,
2018
Short-term debt
$
8.5

 
$
9.2

2018 Coty Credit Agreement
 
 
 
2018 Coty Revolving Credit Facility due April 2023
814.2

 
368.1

2018 Coty Term A Facility due April 2023
3,162.6

 
3,371.5

2018 Coty Term B Facility due April 2025
2,337.1

 
2,390.5

Senior Unsecured Notes
 
 
 
2026 Dollar Notes due April 2026
550.0

 
550.0

2023 Euro Notes due April 2023
617.8

 
640.9

2026 Euro Notes due April 2026
280.8

 
291.4

Other long-term debt and capital lease obligations
1.3

 
1.6

Total debt
7,772.3

 
7,623.2

Less: Short-term debt and current portion of long-term debt
(196.7
)
 
(218.9
)
Total Long-term debt
7,575.6

 
7,404.3

Less: Unamortized debt issuance costs
(73.5
)
 
(86.2
)
Less: Discount on Long-term debt
(11.2
)
 
(12.7
)
Total Long-term debt, net
$
7,490.9

 
$
7,305.4

Short-Term Debt
We maintain short-term lines of credit and other short-term debt with financial institutions around the world. As of March 31, 2019 , total short-term debt decreased to $8.5 from $9.2 as of June 30, 2018 .
Long-Term Debt
On April 5, 2018, we issued senior unsecured notes in a private offering and entered into a new credit agreement (the “2018 Coty Credit Agreement”). The net proceeds of the offering of the notes, together with borrowings under the 2018 Coty Credit Agreement, were used to repay in full and refinance the indebtedness outstanding under our previously existing long-term debt agreements and to pay accrued interest, related premiums, fees and expenses in connection therewith. Future borrowings under the 2018 Coty Credit Agreement could be used for corporate purposes.
Offering of Senior Unsecured Notes
On April 5, 2018 we issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million  of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act.
The Senior Unsecured Notes are senior unsecured debt obligations of Coty Inc. and will be pari passu in right of payment with all of our existing and future senior indebtedness (including the 2018 Credit Facilities described below). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors (as later defined). The Senior Unsecured Notes are senior unsecured obligations of Coty Inc. and are effectively junior to all existing and future secured indebtedness of Coty Inc. to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.
The 2026 Dollar Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. Interest on the 2026 Dollar Notes is payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018.

55

Table of Contents

The 2023 Euro Notes will mature on April 15, 2023 and the 2026 Euro Notes will mature on April 15, 2026. The 2023 Euro Notes will bear interest at a rate of  4.00% per annum, and the 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018.
Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, we will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.
The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default.
2018 Coty Credit Agreement
On April 5, 2018, we entered into the 2018 Coty Credit Agreement which amended and restated the prior Coty Credit Agreement. The 2018 Coty Credit Agreement provides for (a) our incurrence of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by Coty Inc. and Coty B.V., a Dutch subsidiary of Coty Inc. (the “Dutch Borrower” and, together with Coty Inc., the “Borrowers”), of a senior secured revolving facility in an aggregate principal amount of $3,250.0 denominated in U.S. dollars, specified alternative currencies or other currencies freely convertible into U.S. dollars and readily available in the London interbank market (the “2018 Coty Revolving Credit Facility”) (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the “2018 Coty Credit Facilities”). As of March 31, 2019 , the remaining capacity available on the 2018 Coty Revolving Credit Facility was $2,435.8 . Initial borrowings under the 2018 Coty Term Loan B Facility were issued at a 0.250% discount.
The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.
Our obligations under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of Coty Inc. organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of Coty Inc. and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of Coty Inc. and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of Coty Inc. under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.
Scheduled Amortization
We make quarterly payments of 1.25% and 0.25% , which began on September 30, 2018, of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, respectively. The remaining balance of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility will be payable on the maturity date for each facility, respectively.
Interest
The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at our option, either:
LIBOR of the applicable qualified currency, of which we can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or
Alternate base rate (“ABR”) plus the applicable margin.

56

Table of Contents

In the case of the 2018 Coty Revolving Credit Facility and the 2018 Coty Term A Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:
Pricing Tier
 
Total Net Leverage Ratio:
 
LIBOR plus:
 
Alternative Base Rate Margin:
1.0
 
Greater than or equal to 4.75:1
 
2.000%
 
1.000%
2.0
 
Less than 4.75:1 but greater than or equal to 4.00:1
 
1.750%
 
0.750%
3.0
 
Less than 4.00:1 but greater than or equal to 2.75:1
 
1.500%
 
0.500%
4.0
 
Less than 2.75:1 but greater than or equal to 2.00:1
 
1.250%
 
0.250%
5.0
 
Less than 2.00:1 but greater than or equal to 1.50:1
 
1.125%
 
0.125%
6.0
 
Less than 1.50:1
 
1.000%
 
—%
Pricing Tier
 
Debt Ratings S&P/Moody’s:
 
LIBOR plus:
 
Alternative Base Rate Margin:
5.0
 
Less than BB+/Ba1
 
2.000%
 
1.000%
4.0
 
BB+/Ba1
 
1.750%
 
0.750%
3.0
 
BBB-/Baa3
 
1.500%
 
0.500%
2.0
 
BBB/Baa2
 
1.250%
 
0.250%
1.0
 
BBB+/Baa1 or higher
 
1.125%
 
0.125%
In the case of the USD portion of the 2018 Coty Term B Facility, the applicable margin means  2.25%  per annum, in the case of LIBOR loans, and  1.25%  per annum, in the case of ABR loans. In the case of the Euro portion of the 2018 Coty Term B Facility, the applicable margin means  2.50%  per annum, in the case of EURIBOR loans.
In no event will LIBOR be deemed to be less than 0.00% per annum.
Debt Maturities Schedule
Aggregate maturities of our long-term debt, including the current portion of long-term debt and excluding capital lease obligations as of March 31, 2019 , are presented below:
Fiscal Year Ending June 30,
 
2019, remaining
$
47.0

2020
187.8

2021
187.8

2022
187.8

2023
4,084.2

Thereafter
3,067.9

Total
$
7,762.5

Covenants
The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.

57

Table of Contents

Quarterly Test Period Ending
Total Net Leverage Ratio  (a)  
March 31, 2019 through June 30, 2019
5.25 to 1.00
September 30, 2019 through December 31, 2019
5.00 to 1.00
March 31, 2020 through June 30, 2020
4.75 to 1.00
September 30, 2020 through December 31, 2020
4.50 to 1.00
March 31, 2021 through June 30, 2021
4.25 to 1.00
September 30, 2021 through June 30, 2023
4.00 to 1.00
 
 
(a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted cash and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement). Adjusted EBITDA as defined in the 2018 Coty Credit Agreement includes certain add backs related to cost savings, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement.
In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which our Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.
As of March 31, 2019 , we were in compliance with all covenants contained within the Debt Agreements.
Receivables Purchase Agreement
On March 19, 2019, we entered into an Uncommitted Receivables Purchase Agreement (the “Receivables Purchase Agreement”) with a financial institution, with an aggregate facility limit of $150.0. Eligible trade receivables are purchased by the financial institution for cash at net invoice value less a factoring fee. Pursuant to Receivables Purchase Agreement, we act as collections agent for the financial institution and are responsible for the collection, and remittance to the financial institution, of all customer payments related to trade receivables factored under this arrangement. For certain customer receivables factored, we will retain a recourse obligation of up to 10 percent of the respective invoice’s net invoice value, payable to the financial institution if the customer’s payment is not received by the contractual due date.
We account for trade receivable transfers under the Receivables Purchase Agreement as sales and derecognize the sold receivables from the Condensed Consolidated Balance Sheets. The fair value of sold receivables approximated their book value due to their short-term nature. We estimated that the fair value of our servicing responsibilities was not material. Cash received from the selling of receivables under the Receivables Purchase Agreement are presented as a change in trade receivables within the operating activities section of the Condensed Consolidated Statements of Cash Flows.
During the three and nine months ended March 31, 2019 , total trade receivables factored under the Receivables Purchase Agreement, net of collections, was $109.1 which reflects the timing of certain trade receivables factored late in the third quarter. Gross trade receivables factored under the Receivables Purchase Agreement during the three and nine months ended March 31, 2019 totaled $134.6 .
Cash Flows
 
Nine Months Ended
March 31,


2019
 
2018
Condensed Consolidated Statements of Cash Flows Data:
(in millions)
 
 
 
Net cash provided by operating activities
$
451.4

 
$
188.9

Net cash used in investing activities
(371.0
)
 
(580.7
)
Net cash (used in) provided by financing activities
(16.7
)
 
290.9


58

Table of Contents

Net cash provided by operating activities
Net cash provided by operating activities was $451.4 and $188.9 for the nine months ended March 31, 2019 and 2018 , respectively. The increase in net cash provided by operating activities of $262.5 was primarily due to an increase in cash flows from working capital of $192.4, other noncurrent assets and liabilities of $58.0 and a slight increase in net income after adjusting for non-cash items of $12.1. Working capital accounts were positively impacted primarily by higher cash from trade receivables and payables as a result of company-wide initiatives to improve collections from customers and phasing of payments, coupled with cost-cutting initiatives. Increases in prepaid expenses and other current assets and inventory also contributed to the overall working capital increase. Working capital increases were partially offset by decreases from accrued expenses and other current liabilities, which includes the impact from the winding down of the Global Integration Activities and sales related accrued liabilities.
Net cash used in investing activities
Net cash used in investing activities was $371.0 and $580.7 for the nine months ended March 31, 2019 and 2018 , respectively. The decrease in net cash used in investing activities of $209.7 primarily related to higher cash outflows of $224.7 from cash paid in prior year for business combinations including the Burberry Beauty Business for $245.1 compared to cash outflows in the current year of $40.8 for the purchase of a trademark. Current year decreases in cash used for investing activities were offset by a slight impact of higher cash payments for capital projects in the current year of $12.2.
Net cash (used in) provided by financing activities
During the nine months ended March 31, 2019 , net cash used in financing activities was $16.7 compared to net cash provided by financing activities during the nine months ended March 31, 2018 of $290.9 . The decrease of $307.6 in cash from financing related activities was primarily attributable to $295.8 lower net borrowings in the nine months ended March 31, 2019 compared to prior year, which was driven by lower borrowings and higher repayments on the Company's credit facilities as part of our deleveraging strategy. In addition, a decline of $18.0 of proceeds from employee share purchases of Class A Common Stock and Series A Preferred Stock and higher cash payments of $6.7 related to accrued debt issuance costs associated with the 2018 Coty Credit Agreement paid in the first half of fiscal 2019 contributed to the decreased cash flows from financing activities. Lower distributions of $19.7 related to distributions to noncontrolling interests, redeemable noncontrolling interests and mandatorily redeemable financial instruments, partially offset the overall decrease in cash from financing activities during the nine months ended March 31, 2019 compared to prior year due to lower profitability at Younique.
Dividends
The following dividends were declared during the nine months ended March 31, 2019 :
Declaration Date
 
Dividend Type
 
Dividend Per Share
 
Holders of Record Date
 
Dividend Value
 
Dividend Payment Date
 
Dividends Paid
 
Dividends Payable (a)
Fiscal 2019
  August 21, 2018
 
Quarterly
 
$
0.125

 
August 31, 2018
 
$
94.6

 
September 14, 2018
 
$
93.8

 
$
0.8

  November 7, 2018
 
Quarterly
 
$
0.125

 
November 30, 2018
 
$
95.1

 
December 14, 2018
 
$
93.9

 
$
1.2

  February 8, 2019
 
Quarterly
 
$
0.125

 
February 28, 2019
 
$
95.1

 
March 15, 2019
 
$
93.9

 
$
1.2

Fiscal 2019
 
 
 
$
0.375

 
 
 
$
284.8

 
 
 
$
281.6

 
$
3.2

 
 
(a)  
The dividend payable is the value of the remaining dividends payable upon settlement of the RSUs and phantom units outstanding as of the Holders of Record Date.
As may be declared by the Board of Directors (the “Board”), we anticipate issuing future dividends on a quarterly basis.
Stock Dividend Reinvestment Program
On May 8, 2019, the Board approved a stock dividend reinvestment program giving shareholders the option to receive their full dividend in cash or to receive their dividend in 50% cash / 50% common stock. Shareholders will be able to make this election on a quarterly basis, beginning with the third quarter 2019 dividend payment.

59

Table of Contents

Treasury Stock - Share Repurchase Program
On February 3, 2016, the Board authorized us to repurchase up to  $500.0 of our Class A Common Stock (the “Incremental Repurchase Program”). Until October 1, 2018, repurchases were subject to certain restrictions imposed by the tax matters agreement, dated October 1, 2016, as amended, between us and P&G entered into in connection with the P&G Beauty Business acquisition. Following October 1, 2018, repurchases may be made from time to time at our discretion, based on ongoing assessments of the capital needs of the business, the market price of our Class A Common Stock, available cash, our deleveraging strategy and general market conditions. For the three and nine months ended March 31, 2019 , we did not repurchase any shares of our Class A Common Stock. As of March 31, 2019 , we had authority for $396.8 remaining under the Incremental Repurchase Program.
Commitments and Contingencies
Mandatorily Redeemable Financial Interest
United Arab Emirates subsidiary
We are required under a shareholders agreement (the “U.A.E. Shareholders Agreement”) to purchase all of the shares held by the noncontrolling interest holder equal to 25% of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. We have determined such shares to be an MRFI that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the U.A.E Shareholders Agreement. As of March 31, 2019 and June 30, 2018 , the liability amounted to $7.7 and $8.2 , of which $6.3 and $6.7 , respectively, was recorded in Other noncurrent liabilities and $1.4 and $1.5 , respectively, was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.
Southeast Asian subsidiary
On May 23, 2017, we entered into the Sale of Shares and Termination Deed (the “Termination Agreement”) to purchase the remaining 49% noncontrolling interest from the noncontrolling interest holder of a certain Southeast Asian subsidiary for a purchase price of $45.0 . Additionally, all remaining retained earnings will be paid out as dividends prior to the purchase. As a result of the Termination Agreement, the noncontrolling interest balance is recorded as an MRFI. The MRFI balance will be accreted to the redemption value until the effective date of the purchase with changes in the balance being reflected in Other expense, net in the Condensed Consolidated Statements of Operations.
As of March 31, 2019 and June 30, 2018 , the MRFI liability amounted to $52.6 and $45.1 , respectively, which was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.
Redeemable Noncontrolling Interests
Noncontrolling interests, where we may be required to repurchase the noncontrolling interest under a put option or other contractual redemption requirement, are reported in the Condensed Consolidated Balance Sheet between liabilities and equity, as redeemable noncontrolling interests (“RNCI”). We adjust the RNCI to the higher of the redemption value or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends) on each balance sheet date with changes recognized as an adjustment to additional paid-in capital (“APIC”).
Younique
As of June 30, 2018, the Younique membership holders had a 40.6% membership interest in Foundation, which holds 100% of the units of Younique. During the nine months ended March 31, 2019 , additional shares of Foundation were issued to employees of Younique under a stock ownership program, incentive stock grants were granted and shares were forfeited under the program, resulting in a net impact of a 0.1% increase to the noncontrolling interest ownership percentage. The cumulative impact of the additional shares for the nine months ended March 31, 2019 was recorded as an increase to redeemable noncontrolling interests of $1.7 and a decrease in additional paid-in capital of $1.7 .
We account for the 40.7% noncontrolling interest portion of Foundation as RNCI due to the noncontrolling interest holder’s right to put their shares to us in certain circumstances. While Foundation is a majority-owned consolidated subsidiary, we record income tax expense based on our  59.3%  membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the  40.7%  noncontrolling interest of Foundation’s net income excluding a provision for income taxes. We recognized $369.7 and $597.7 as the RNCI balances as of March 31, 2019 and June 30, 2018 , respectively.
Subsidiary in the Middle East
As of March 31, 2019 , the noncontrolling interest holder in our subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. We recognized $80.4 and $63.6 as the RNCI balances as of March 31, 2019 and June 30, 2018 , respectively.

60

Table of Contents

Legal Contingencies
Brazilian Tax Assessments
In connection with a local tax audit of one of our subsidiaries in Brazil, we were notified of tax assessments issued in March of 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for the 2016-2017 tax periods. We are currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties, through March 31, 2019 amount to a total of R$249.0 million (approximately $63.8 ). We believe we have meritorious defenses and we have not recognized a loss for these assessments as we do not believe a loss is probable.
Contractual Obligations
Our principal contractual obligations and commitments as of March 31, 2019 are summarized in Item 7 - "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Contractual Obligations and Commitments," of our Fiscal 2018 Form 10-K, except as noted above. For the nine months ended March 31, 2019 , there have been no material changes in our contractual obligations outside the ordinary course of business.
Critical Accounting Policies
We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our Condensed Consolidated Financial Statements:
Revenue Recognition
Goodwill, Other Intangible Assets and Long-Lived Assets
Business Combinations
Inventory
Pension Benefit Costs
Income Taxes
Redeemable noncontrolling interests
As of March 31, 2019 , there have been no other material changes to the items disclosed as critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2018 Form 10-K, other than the adoption of ASC 606, Revenue from Contracts with Customers , as discussed in Note  3 Revenue Recognition  of the Condensed Consolidated Financial Statements. Below are updated disclosures regarding our goodwill and intangible assets.
Goodwill
Approach
Testing goodwill for impairment requires us to estimate fair values of reporting units using significant estimates and assumptions. The assumptions made will impact the outcome and ultimate results of the testing. We use industry accepted valuation models and set criteria that are reviewed and approved by various levels of management and, in certain instances, we engage independent third-party valuation specialists for advice. To determine fair value of the reporting unit, we use a combination of the income and market approaches. We believe the blended use of both models compensates for the inherent risk associated with either model if used on a stand-alone basis, and this combination is indicative of the factors a market participant would consider when performing a similar valuation.
Under the income approach, we determine fair value using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. Under the market approach, we utilize information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units, which creates valuation multiples that are applied to the operating performance of the reporting units being tested, to value the reporting unit.
The key estimates and factors used in these approaches include revenue growth rates and profit margins based on our internal forecasts, our specific weighted-average cost of capital used to discount future cash flows, and comparable market multiples for the industry segment as well as our historical operating trends. Certain future events and circumstances, including deterioration of market conditions, higher cost of capital, a decline in actual and expected consumer consumption and demands, could result in changes to these assumptions and judgments. A revision of these assumptions could cause the fair values of the reporting units to fall below their respective carrying values. We would calculate an impairment charge as the difference

61

Table of Contents

between a reporting unit’s carrying value and fair value in an amount not to exceed the carrying value of the reporting unit’s goodwill. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.
Results
During the three months ended March 31, 2019, we assessed whether there were any newly arisen impairment indicators and determined that no such indicators were present. Accordingly, no additional fair value assessments were required.
In the course of evaluating the results for the second quarter of fiscal 2019, we noted that since the previous impairment test, the cash flows associated with our Consumer Beauty reporting unit were adversely impacted by negative category trends and market share losses in the color cosmetics, hair color and mass fragrance categories; additional shelf-space losses for CoverGirl, Clairol, and Max Factor; expected increased costs in the short-term to offset the lower service levels caused by supply chain disruptions; and lower than expected net revenues and profitability for Younique. Additionally, we considered the impact of a 75 basis point increase in the discount rate, due to changes in the market assumptions, which adversely affected the fair value of the reporting unit. We concluded that these factors represented indicators of impairment that warranted an interim impairment test for goodwill and certain other intangible assets in the Consumer Beauty reporting unit.
To determine the fair value of our Consumer Beauty reporting unit, we used an average annual revenue growth rate of (3.3)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.0% . The result of the interim impairment test showed that the fair value of the reporting unit was lower than its carrying value, resulting in an $832.5 goodwill impairment charge and a remaining goodwill balance of $3,807.0 as of the second quarter of fiscal 2019. As the Consumer Beauty reporting unit was impaired, it has a 0% excess as of December 31, 2018 and as such, further material negative trends in its actual and expected business performance or an increase in the discount rate may result in further impairments. If the average annual revenue growth rate for fiscal 2019 to fiscal 2023 declined by 1% it may cause an additional impairment of $464.3 . If the discount rate increased by 0.5% , it may cause an additional impairment of $156.1 .
There were no impairments of goodwill at other reporting units during the interim impairment test. We determined that the fair values of the Luxury and Professional Beauty reporting units exceeded their carrying values by 74.5% and 10.8% , respectively, and had goodwill balances of $2,922.2 and $935.8 , respectively, at the end of the second quarter of fiscal 2019. To determine the fair value of these reporting units, we used an average annual revenue growth rate for fiscal 2019 to fiscal 2023 of 3.1% for Luxury and 0.5% for Professional Beauty and a discount rate of 8.0% . The fair value of the Professional Beauty reporting unit would fall below its carrying value if the assumed average annual growth rate for fiscal 2019 to fiscal 2023 fell 105 basis points or the discount rate increased by 90 basis points.
Other Intangible Assets
The carrying value of our indefinite-lived other intangible assets was $3,043.7 as of March 31, 2019 , and is comprised of trademarks for the following brands: OPI of $660.4 , CoverGirl of $533.0 , the professional product line of Wella of $440.0 , Max Factor of $340.0 , philosophy of $241.8 , Sally Hansen of $182.4 , ghd related trademarks of $157.6 , Clairol of $33.6 and other brands totaling $454.9 .
Approach
The trademarks’ fair values are based upon the income approach, primarily utilizing the relief from royalty methodology. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. An impairment loss is recognized when the estimated fair value of the intangible asset is less than the carrying value. Fair value calculation requires significant judgments in determining both the assets’ estimated cash flows as well as the appropriate discount and royalty rates applied to those cash flows to determine fair value. Variations in the economic conditions or a change in general consumer demands, operating results estimates or the application of alternative assumptions could produce significantly different results.
Results
During the three months ended March 31, 2019, we assessed whether there were any newly arisen impairment indicators and determined that no such indicators were present. Accordingly, no additional fair value assessments were required.
As noted above, in the course of evaluating the results for the second quarter of fiscal 2019, the cash flows associated with the Consumer Beauty reporting unit were adversely impacted during the quarter which warranted an interim impairment test for goodwill and certain other intangible assets in the Consumer Beauty reporting unit. Accordingly, we also re-evaluated future cash flows of intangible assets and the impact of a 75 basis point increase to the discount rate. This resulted in asset impairment charges of $90.8 related to indefinite-lived other intangible assets for our CoverGirl, Clairol and a regional Brazilian skin care trademark, and $7.0 related to a finite lived other intangible asset for a regional hair license agreement.
The fair value of the CoverGirl trademark fell below its carrying value using projections that assumed an average annual growth rate of (3.3)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . The fair value of the Clairol trademark fell

62

Table of Contents

below its carrying value using projections that assumed an average annual growth rate of (6.1)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . The fair value of the regional Brazilian skin care trademark fell below its carrying value using projections that assumed an annual growth rate of 7.7% for fiscal 2019 to fiscal 2023 and a discount rate of 13.0% . The regional hair license agreement was concluded to be fully impaired due to on-going shelf space losses.
In addition to the Consumer Beauty reporting unit, we also identified indicators of impairment related to the philosophy trademark that is part of the Luxury reporting unit. In addition to the impact of a 75 basis point increase in the discount rate, we considered the impact of lower than expected net revenue growth in the U.S. during the quarter, shelf space losses at key retailers and a decrease in the level of expected profitability of the trademark. We concluded that the fair value of the philosophy trademark fell below its carrying value using projections that assumed an average annual growth rate of 1.2% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . This resulted in an asset impairment charge of $22.8 .
As the trademarks for which impairment charges were recorded in the second quarter of fiscal 2019 no longer have any excess of their fair values over their carrying values as of December 31, 2018, any material decline in assumed average annual revenue growth rates or increase in the discount rate could result in additional impairment charges.
As a result of the interim impairment test performed during the second quarter of fiscal 2019, the fair value of our Max Factor trademark exceeded its carrying value by approximately 2.4% using projections that assumed an average annual revenue growth rate of (1.5)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . The fair value of the Max Factor trademark would fall below its carrying value if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 decreased by approximately 60 basis points or the discount rate increased by 20 basis points. The fair value of our Sally Hansen trademark exceeded its carrying value by approximately 2.0% using projections that assumed an average annual revenue growth rate of (2.9)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . The fair value of the Sally Hansen trademark would fall below its carrying value if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 decreased by approximately 50 basis points or the discount rate increased by 15 basis points. The fair value of our Bourjois trademark exceeded its carrying value by approximately 13.8% using projections that assumed an average annual revenue growth rate of (5.6)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5% . The fair value of the Bourjois trademark would fall below its carrying value if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 decreased by approximately 295 basis points or the discount rate increased by 90 basis points. Additionally, we are monitoring two regional trademarks with a combined carrying value of $52.1 and excess percentage of 0.7% and 9.8% , respectively.
In the interim impairment test we considered the impact of an increase to the discount rate of 75 basis points on the professional product line of Wella trademark that is part of the Professional Beauty reporting unit. We concluded that its fair value would exceed its carrying value by approximately 4.5% , using projections that assumed annual revenue growth rates ranging from (5.6)% (in fiscal 2019 due to the adverse impacts of the Supply Chain Disruptions and a negative foreign currency impact) to 2.0% for fiscal 2019 to 2023 and a discount rate of 8.5% . The fair value of the Wella trademark would fall below its carrying value if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 decreased by approximately 110 basis points or the discount rate increased by 40 basis points.
Item 3.  Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2018 Form 10-K.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Our management, with the participation of our Chief Executive Officer (the “CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2019 . Based on the evaluation of our disclosure controls and procedures as of March 31, 2019 , our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting

63

Table of Contents

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the third fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Part II. OTHER INFORMATION
Item 1. Legal Proceedings .
We are involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to our business, including consumer class or collective action, personal injury (including asbestos-related claims), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While we cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. However, management’s assessment of our current Legal Proceedings, is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings pending against us not presently known to us, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, we are in discussions with regulators, including discussions initiated by us, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, we can give no assurance that the results of any such Legal Proceedings will not materially affect our reputation, our business, prospects, financial condition, results of operations, or cash flows, nor the trading price of our securities.
Certain Litigation . Two purported stockholder class action lawsuits concerning the Offer and the Schedule 14D-9 have been filed by putative stockholders against the Company and the directors of the Company in the U.S. District Court for the District of Delaware. The first case, which was filed on April 3, 2019, is captioned Lawrence Phillips, on behalf of himself and all others similarly situated, vs. the Company, Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer and Paul S. Michaels, Case No. 1:19-cv-00628. The second case, which was filed on April 9, 2019, is captioned Robert Rumsey, individually and on behalf of all others similarly situated, v. the Company, Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer and Paul S. Michaels, Case No. 1:19-cv-00650. The plaintiffs allege that the Company’s Schedule 14D-9 omits certain information, including, among other things, certain financial data and certain analyses underlying the opinion of Centerview Partners LLC. Plaintiffs assert claims under the federal securities laws and seek, among other things, injunctive and/or monetary relief. The Company believes that plaintiffs’ allegations lack merit and intends to contest them vigorously. 

A third purported stockholder class action lawsuit concerning the Offer and the Schedule 14D-9 was filed against the directors of the Company, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company is not named as a defendant. The case, which was filed on May 6, 2019, is captioned Massachusetts Laborers’ Pension Fund, on behalf of itself and all similarly situated holders of Coty Inc., v. Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer, Paul S. Michaels, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V., Case No. 2019-0336-

64

Table of Contents

CB. The plaintiff alleges that the directors and the JAB Defendants breached their fiduciary duties to the Company’s stockholders and seeks, among other things, monetary relief.

Other Matters . In connection with the Offer, several putative stockholders served on the Company demands to inspect certain books and records of the Company pursuant to Section 220 of the Delaware General Corporation Law. Each demand seeks to inspect documents as part of a purported investigation of possible breaches of fiduciary duty by the Board in connection with the Offer.

Item 1A.  Risk Factors.
You should consider the following risks and uncertainties and all of the other information in this Quarterly Report on Form 10-Q and our other filings in connection with evaluating our business and the forward-looking information contained in this Quarterly Report on Form 10-Q. Our business and financial results may also be adversely affected by risks and uncertainties not presently known to us or that we currently believe to be immaterial. If any of the events contemplated by the following discussion of risks should occur or other risks arise or develop, our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities, may be materially and adversely affected. When used in this discussion, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation and the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries.

We have disclosed information about the risk factors that could adversely affect our business in Part I, Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for fiscal 2018 and subsequent Quarterly Reports on Form 10-Q. The information presented below supplements and updates and should be read in conjunction with the risk factors and information disclosed in those periodic reports.

JABC and its affiliates beneficially own approximately 60% of the fully diluted shares of our Class A Common Stock and, as such, have the ability to effect certain decisions requiring stockholder approval, which may be inconsistent with the interests of our other stockholders.
As a result of the completion of the Offer in May 2019, JABC, through an affiliate, Cottage Holdco B.V., owns approximately 60% of the outstanding shares of our Class A Common Stock. As a result, JABC has the ability to exercise control over certain decisions requiring stockholder approval, including the election of directors, amendments to our certificate of incorporation and approval of significant corporate transactions, such as a merger or other sale of the Company or our assets. In addition, several of the members of our Board of Directors are affiliated with JABC.
JABC’s interests may be different from or conflict with our interests or the interests of our other stockholders. In addition, this concentration of ownership may have the effect of delaying, preventing or deterring a change in control of us and may negatively affect the market price of our stock. Also, JABC and its affiliates are in the business of making investments in companies and may from time to time acquire and hold interests in businesses that compete indirectly with us. JABC or its affiliates may also pursue acquisition opportunities that are complementary to our business, and, as a result, those acquisition opportunities may not be available to us.
An affiliate of JABC has pledged all of its beneficially owned Class A Common Stock as a security interest for a credit facility which, in certain circumstances, may result in sales of our shares into the open market, depressing the trading price of our shares of Class A Common Stock.

All shares of Class A Common Stock beneficially owned by JABC are held by its affiliate, Cottage Holdco B.V., whose obligations under its credit facility are secured by a pledge of all such shares for the benefit of its lenders. Cottage Holdco B.V. was newly-created to consummate the Offer and does not have any material assets other than its holdings of our shares of Class A Common Stock and any dividends paid on such shares. It is only Cottage Holdco B.V., and not any of its affiliates, that is an obligor under the credit facility, which is secured by substantially all of the assets of Cottage Holdco B.V. (including the shares of our Class A Common Stock that it owns), subject to customary exceptions. The credit facility contains a maximum loan-to-value ratio which is designed to assure the lenders under the facility that the value of the collateral significantly exceeds the outstanding amount of the loan. If the trading price of our shares of Class A Common Stock drops significantly, Cottage Holdco B.V. may elect to sell its shares of our Class A Common Stock into the open market until such time as it has received proceeds sufficient prepay the loan and comply with the required loan-to-value ratio. Alternatively, JABC may, but is not required to, contribute additional equity to Cottage Holdco B.V., which would be used to prepay the loan and satisfy the ratio. Any sales by Cottage Holdco B.V. of our shares may themselves have a depressive effect on the trading price of our shares, which may, in

65

Table of Contents

turn, require additional selling to maintain the required loan-to-value ratio. There can be no assurance that our shares will trade at a price sufficient to prevent such sales. Any such sales by Cottage Holdco B.V. may have a material adverse effect on the trading price of our shares and the existence of this financing arrangement may itself have an adverse effect on the trading price of our shares.

We are a “controlled company” within the meaning of the New York Stock Exchange rules and, as a result, are entitled to rely on exemptions from certain corporate governance requirements that are designed to provide protection to stockholders of companies that are not “controlled companies”.

Because JABC and its affiliates own more than 50% of the total voting power of our common shares, we are a “controlled company” within the meaning of the New York Stock Exchange (“NYSE”) corporate governance standards. As a controlled company, we are exempt under the NYSE standards from the obligation to comply with certain NYSE corporate governance requirements, including the requirements:
that a majority of our board of directors consists of independent directors;
that we have a nominating committee that is composed entirely of independent directors with a written charter; addressing the committee’s purpose and responsibilities; and
that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
No shares of our Class A Common Stock were repurchased during the fiscal quarter ended March 31, 2019 .

66

Table of Contents

Item 5.   Other Information.
On May 8, 2019, the Board of Directors of the Company adopted resolutions (the “Resolutions”) approving the ratification of the issuance of certain shares of Class A Common Stock, pursuant to Section 204 of the Delaware General Corporation Law (the “Ratification”). A copy of the Resolutions adopted by the Board setting forth the information with respect to the Ratification required under Section 204 of the Delaware General Corporation Law is attached hereto as Exhibit 99.1.  Any claim that any defective corporate act or putative stock ratified pursuant to the Ratification is void or voidable due to the failure of authorization specified in the Resolutions, or that the Delaware Court of Chancery should declare in its discretion that the Ratification in accordance with Section 204 of the Delaware General Corporation Law not be effective or be effective only on certain conditions, must be brought within the later of (i) 120 days from the validation effective time (which is May 8, 2019) and (ii) the giving of this notice (which is deemed given on the date that this Form 10-Q is filed with the Securities and Exchange Commission).


Item 6. Exhibits, Financial Statement Schedules.
The exhibits listed below are filed as part of this Quarterly Report on Form 10-Q:
Exhibit Number
 
Description
 
 
 
 
 
 
 
 
 
 
 
101.INS
 
XBRL Instance Document.
101.SCH
 
XBRL Taxonomy Extension Schema Document.
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
 
XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.
Exhibit is a management contract or compensatory plan or arrangement.

67

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
COTY INC.
 
 
 
 
Date: May 8, 2019
 
By:
/s/Pierre Laubies
 
 
 
Name: Pierre Laubies
 
 
 
Title: Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/Pierre-André Terisse
 
 
 
Name: Pierre-André Terisse
 
 
 
Title: Chief Financial Officer
 
 
 
(Principal Financial Officer)


68


Exhibit 10.1
English Translation


EMPLOYMENT CONTRACT


BETWEEN:      The Company COTY SAS
     14 rue du Quatre Septembre
75002 PARIS
Represented by Robert Garcia, Director of Human Resources, Lead France. Hereinafter referred to as the "Company",

AND:          Mr. Pierre-André Terisse
Hereinafter referred to as the "Employee",
Hereinafter jointly referred to as the Parties.


The Parties have agreed to employee the Employee on an indefinite basis as of 1 February 2019 , who declares that (s)he is free of any obligation and is not bound to any other company by an employment contract or a non-competition clause.

If the Employment Contract is not signed by the Employee within 48 hours of its delivery or receipt by the Employee, the Letter of Offer and the Employment Contract offer shall be considered null and void.

The following has therefore been agreed:

1) START DATE, TERM

The Employee is employed as of 1 February 2019 and for an indefinite period.


2) DUTIES

The Employee will perform the duties of a/an Chief Financial Officer , with executive status (senior manager ).

The tasks entrusted to the Employee in this respect are, by nature, changing in nature and may be adapted according to the Company's operating requirements. Where applicable, the Employee undertakes to follow any training requested by the Company.

As an indication, it is specified that these duties correspond to coefficient 880 of the national collective agreement for the chemical and related industries (hereinafter referred to as the "Collective Agreement") currently applicable to the Company. The reference to the Collective Agreement in the Employment Contract is purely indicative and does not imply any contractualisation of the benefits provided for therein.


3) PLACE OF WORK, TRAVEL

On the start date of his/her employment, the Employee shall perform his duties in Paris, within the Company's establishment located at 14 rue du Quatre Septembre, 75002 Paris. However, his place of work may be moved to any place in Paris or within the Ile-de-France region in the interest of the proper functioning and development of the Company, without this change constituting a modification of the Employment Contract. The Employee expressly accepts the possibility of such a change.






Given the nature of his duties, the Employee may make frequent business trips both in France and abroad. The expenses related to travel necessary for the proper performance of his tasks will be reimbursed in accordance with the business expenses policy then in force within the Company.

4) HOURS OF WORK

In accordance with the provisions of Article L. 3111-2 of the Code du travail (French Employment Code), and taking into account the importance of the responsibilities entrusted to him/her, which will involve a great deal of independence in the organization of his/her working time, the wide autonomy of judgment, initiative and decision-making which (s)he will have and the level of his/her remuneration which is among the highest of the remuneration systems applied within the Company, the Parties agree that the Employee will have the status of:

Senior Manager . The Employee therefore expressly acknowledges that (s)he is not subject to any legal or contractual provisions relating to working hours.

In accordance with the collective company agreement on working hours and the organization of working time of 24 June 2015, the Employee will more specifically be part of "contractual category A, senior managers".

Consequently, the Employee's basic fixed remuneration as stipulated below in Article 5 shall be fixed and independent of the time the Employee devotes to the performance of his duties.


5 ) REMUNERATION

5.1) Basic annual fixed salary
In remuneration for his/her duties, the Employee will receive a basic annual fixed salary of a gross amount of €680,000 payable in 12 monthly installments.

5.2) Annual variable remuneration
In addition to the fixed salary provided for above, the Employee will be eligible to participate in the Coty Group's Annual Performance Plan (hereinafter referred to as the " APP "), currently in force within the Company.
In this context, the gross target bonus amount would be equivalent to 70% of the Employee's gross basic annual fixed salary.
The Company may, at any time and at its sole discretion, amend the APP Plan. The Employee will not have acquired any right to benefits under the APP and will therefore not be entitled to maintain them, in principle, as well as in the calculation methods defined by the APP or in the amounts actually paid under the APP, unless expressly stipulated in the APP.
The objectives, qualitative and/or quantitative, as well as the methods of calculating variable remuneration, will be defined unilaterally by the Company. This bonus will be prorated according to the actual employment start date by the Company. The right to variable remuneration under the APP is subject to the presence of the Employee on the date of payment.

6) COMPANY CAR/VEHICLE ALLOCATION

For the purposes of performing his/her duties, the Employee will benefit, at his/her choice, from a vehicle allowance, the amount of which will be determined in accordance with the car policy ("Car Policy France") in force within the Company, or a company vehicle, that the Company will make available to him/her under the conditions provided for by this same car policy.

In this respect, the Employee confirms that (s)he holds a valid driving license and undertakes to inform the Company without delay of any change in this respect.






The Employee will be allowed to use the company car made available to him/her for personal purposes.

No contravention or fine that the Employee has to pay for violations of the Highway Traffic Act, in the context of his/her personal or business use of the vehicle, shall be covered or reimbursed by the Company.

The use of a company car for personal needs constitutes a benefit in kind which will be taken into account both from a tax point of view and for the calculation of social security contributions.

In the event of an accident, the Employee must inform the Company and the insurance company within 48 hours, specifying the circumstances of the accident.

The car made available to the Employee must be returned to the Company in the event of termination of the Employment Contract for any reason whatsoever, as soon as the Employment Contract is effectively terminated or, with the agreement of the Employee, before that date.

The Company reserves the right to modify its car policy at any time, and in particular the terms and conditions of use of the company car.

7) ELIGIBILITY FOR THE LTIP AND OWNERSHIP PROGRAMME

The Employee will be eligible to participate in the “Long Term Incentive Plan” (LTIP) in the form of Restricted Shares Units (RSU). These RSUs are generally granted annually and are not considered fully vested until 5 years after the date they are granted. The granting cycle usually takes place in October. Any granting of shares is subject to review and approval by Coty's Executive Committee and is subject to the signature of the confidentiality and non-competition clauses provided for in the Employment Contract.

The Employee will also be eligible for the "Elite" Program of the Company's “Coty Ownership Plan”.

The Company may, at any time and at its sole discretion, amend the LTIP and/or the Ownership Plan. The Employee will not have acquired any right to benefits under these plans and will therefore not be entitled to maintain them, in principle, as well as in the calculation methods defined by them or in the amounts actually paid under these plans, unless expressly stipulated in these plans.

8) RELOCATION ASSISTANCE SERVICES

The mobility assistance services provided for in the Offer Letter of 8 January 2019 are no longer applicable and are therefore null and void , in particular (but not limited to) the "Relocation Allowance" and "Temporary Housing Assistance".

9) PAID LEAVE

The Employee will be granted paid leave in accordance with the legal and contractual provisions in force within the Company, the period for taking such leave being determined by agreement between the Employee and his supervisor, taking into account the needs related to the organization of the activity.

Unless otherwise agreed in writing by the Company, no carry-over of leave will be allowed from one year to the next.





10) PROFESSIONAL OBLIGATIONS






The Employee undertakes to comply with the instructions of the Management concerning the conditions under which the work is carried out and the rules governing its internal functioning, in particular the Company's Internal Regulations, the Charter of Professional Ethics, the instructions and specific work instructions that will be given to him as well as the utmost discretion on all matters concerning the activities of the Company and the group to which the Company belongs (hereinafter referred to as the "Group").

The Employee also undertakes to inform the Company without delay of any change in his personal situation with regard to the information provided by him at the employment start-date (address, telephone, marital status, civil status, etc.).

In the event of illness, accident or physical incapacity, and unless this is impossible due to major circumstances, the Employee must inform the Company of his absence on the same day and by any means and justify it by sending a certificate of absence from work within 48 working hours of his/her absence.

In the event that his work stoppage is extended, the Employee must send a certificate justifying this extension within the same time limit.


11) EXCLUSIVITY

During the performance of the Employment Contract, the Employee must devote all his/her activity and care to the Company and therefore refrains, without the prior written consent of the Parties, from carrying on another professional activity, either for his/her own account or for that of third parties.


12) PERSONAL DATA

The Employee agrees that the Company may collect, store and process any personal data that he/she may disclose to it in connection with the duties performed under the Employment Contract, in particular (and without this list being restrictive) for the purposes of administering personnel registers, processing pay and changes in remuneration and other benefits, conducting performance interviews and reviews, and keeping absence registers.

The Employee acknowledges and accepts that the Company may, as part of its responsibilities and obligations as an employer, be required to disclose personal information concerning the Employee after the termination of the Employment Contract. The Employee acknowledges that this situation does not affect his/her rights under law no. 78-17 of 6 January 1978.

13) CONFIDENTIALITY

The Employee is bound, regardless of his/her general obligation of confidentiality and professional secrecy, to an absolute obligation of discretion with regard to all Confidential Information (as defined below) of which (s)he may become aware as a result of
his/her duties or his/her membership of the Company.

As such, as from the effective date of the Employment Contract and subsequent to its termination, the Employee undertakes not to use or disclose to third parties any Confidential

Information except (i) for the performance of his/her duties under the Employment Contract, (ii) if otherwise required by law, regulation or judicial procedure, or (iii) at the request of a governmental authority, agency or institution.
 
For the purposes of the Employment Contract, the term "Confidential Information" refers to any exclusive or confidential information relating to the Company and the Group, to the Company's and the Group's customers, or to any other party with whom the Company or the Group maintains business relationships or which could provide the Company and/or the Group with a competitive advantage, and includes, but is not limited to, trade secrets, inventions (patentable or not), technological and commercial processes, business, product, strategy and marketing plans,





negotiation strategies, sales or other forecasts, financial information, customer lists or other documents protected by intellectual property, information relating to salaries and benefits, compilations of public data that become confidential and proprietary because of their compilation by the Company or one of the Group’s companies for use in the course of its business, and documents (including electronic files, video or audio cassettes) and oral communications incorporating Confidential Information.

The Employee must also comply with any obligation of confidentiality to which the Company may be bound with regard to third parties and of which the Employee has or should have knowledge, regardless of the source. The information cannot be considered Confidential Information if it is or becomes generally accessible to the public through any means other than unauthorized disclosure, an action by the Employee or decision of the Employee or disclosure by any other person who directly or indirectly receives such information from the Employee. Given the value attached to the Confidential Information, the Company takes measures to preserve its confidentiality and keep it secret. Confidential Information may be copied, disclosed or used by the Employee in the performance of his/her duties within the limits of what is necessary for the Company's business and, where applicable, in compliance with any commitments that may bind the Company to third parties. If the disclosure of information covered by this confidentiality obligation is required of the Employee, whether in legal proceedings or not, the Employee must inform the Company and obtain its written consent prior to any disclosure.


14) TERMINATION OF THE EMPLOYMENT CONTRACT

Subject to the applicable legal and contractual provisions, each of the Parties may terminate the Employment Contract, which shall terminate at the end of six (6) months ' notice following notification of the termination at the Company's or Employee's initiative.


15) NON-SOLLICITATION OF EMPLOYEES

In the event of termination of the Employment Contract, for any reason whatsoever, the Employee shall refrain, for a period of 12 months from the date of his/her actual departure from the Company, whether on his/her own account or on the account of a third party, whether an individual or a legal entity, from, directly or indirectly, offer employment to any person who was, on the last day worked by the Employee under the Employment Contract, an employee, consultant or corporate officer of the Company or the Group or to attempt, by any means whatsoever, directly or indirectly, to persuade or induce such person to accept another employment or to leave the Company or the Group.

 
16) NON-COMPETITION

Given the nature and importance of the duties performed by the Employee within the Company, the information and knowledge that (s)he has been able to or may acquire within the Company,
his/her training and experience but also the particularly competitive situation of the market on which the Company operates, the Employee shall refrain, except with the prior written consent of the Company, in the event of the termination of the Employment Contract by either Party or with the agreement of the Parties, for any reason whatsoever, from:

owning, acquiring directly or indirectly an interest in a company carrying out a competing activity of the Company or one of the Group's companies;

entering the service, in particular as an employee, corporate officer or consultant of a company competing, directly or indirectly, with the activities, services and products of the Company or one of the Group's companies;

creating or taking over, directly or indirectly, through an intermediary, an activity of the same or similar nature or a similar activity or to collaborate directly or indirectly, in particular as an employee, corporate officer or consultant in such an activity and, more generally, in any activity relating to the Company's business sector;






from soliciting or approaching, directly or indirectly, any customer, business partner of the Company or one of the Group’s companies or any natural person or legal entity having a business relationship with the Company (supplier or other) or with the Group, with whom the Employee has been in contact during the 12 months preceding the last day worked by the Employee under the Employment Contract for purposes other than the development of the Company, and in particular from encouraging them to cease their business relationship with the Company or one of the Group’s companies.

For the purposes of this clause, a "competing activity” is defined as any commercial, professional or other activity in the field of perfumes, make-up, cosmetics, hygiene and body and hair care products that competes in any way with any product, service or activity of the Group for which the Employee has worked or for which (s)he has assumed responsibility during the last two (2) years of his/her employment within the Company or the Group .

This prohibition of competition is applicable for a period of 12 months from the termination of the Employment Contract and applies to the following geographical area: all countries for which the Employee has carried out an activity on behalf of the Company in the 24 months preceding the end date of the Employment Contract.

In return for this prohibition of competition, the Employee will receive monthly compensation equal to 2/3 of his gross monthly salary, calculated on the basis of his/her remuneration, as defined in article 5.1 of the Employment Contract, received during the last 12 months preceding the notification of the termination .

In the event of a breach of this clause, the Employee shall pay the Company a sum fixed by mutual agreement at 2/3 of his gross monthly salary, calculated on the basis of his remuneration, as defined in article 5.1 of the Employment Contract, received during the last 12 months preceding the notification of the termination . The Company will then be released from its commitment to pay the financial contribution.

The payment of this compensation by the Employee shall not deprive the Company of its right to sue the Employee for the damage actually suffered and to have the cessation of competitive activity and the reimbursement of the sums paid by the Company to the Employee pursuant to this non-competition clause ordered under penalty payment.

In accordance with the provisions of the Collective Agreement, the Company may unilaterally remove the non-competition clause during the performance of the Employment Contract, it being specified that, in accordance with the terms of the Collective Agreement, this deletion will only take effect if the Employee is not dismissed within one year of the notification of the said deletion.

In accordance with the provisions of the Collective Agreement, if the Company terminates the Employment Contract for any reason whatsoever, it may, with the agreement of the Employee, release him in writing from his prohibition of competition at the time of the termination . In this case, the monthly compensation previously provided for will be paid to the Employee for a period of 3 months from the effective termination of his duties within the Company by the Employee.

In accordance with the provisions of the Collective Agreement, if the Employee terminates the Employment Agreement, (s)he must explicitly remind the Company in writing of the existence of this non-competition clause . The Company will then have a period of three weeks to release itself from the non-competition compensation previously provided for by releasing the Employee in writing from his/her prohibition of competition. In this case, the monthly compensation previously provided for will be paid to the Employee for a period of 3 months from the effective termination of his duties within the Company by the Employee.

In the event of a contractual termination of the Employment Contract, the Employee and the employer may agree to waive the non-competition obligation by expressly mentioning it in the termination form.


17) RETURN OF EQUIPMENT






During the performance or at the end of the Employment Contract, whatever the cause, the Employee must return, at the Company's request, all documents, drawings, notes, memoranda, diskettes, manuals, reports, specifications, tools, forms or any other property that may have been given to him/her in the performance of his/her duties, as well as any medium on which the Employee has stored or recorded data or information concerning the Company or one of the Group companies.

The Employee acknowledges that the aforementioned documents, information and property are the exclusive property of the Company and that (s)he has no right of retention over them.


18) SUPPLEMENTARY PENSION, PROVIDENT SCHEME, HEALTH CARE COSTS

The Employee will be affiliated to the following funds:

for the supplementary pension:
KLESIA, 1/13 rue Denise Buisson, 93554 MONTREUIL CEDEX

for the provident scheme and coverage of health expenses (unless otherwise provided for in the case of health expenses coverage):
VIVINTER, 82, rue Villeneuve, 92584 Clichy Cedex.


19) APPLICABLE LAW

The Employment Contract is subject to French law.

Any dispute relating to its conclusion, execution or termination shall fall within the sole jurisdiction of the French courts.
                                
The Company's representative and the Employee shall sign below, preceded by the handwritten words in French " lu et approuvé ” (read and approved), as well as their initials on each of the pages other than this one.



Paris, 1 February 2019

The Employee                                  For the Company
/s/ Pierre-Andre Terisse                         /s/ Robert Garcia





Exhibit 10.3
January 10, 2019
Luc VOLATIER
 
This entire offer letter is subject to the Coty Board validation


Dear Luc,

I am pleased to welcome you to Coty Services UK. (“Coty”).

This letter serves to confirm the terms of your offer. Your place of employment will be the Coty Geneva  office , Chemin Louis-Hubert, 1-3 - 1213 Petit-Lancy  provided, however, that within the normal course of your duties, you may be required to travel or relocate in accordance with business needs.
TITLE AND REPORTING
You will be appointed to the role of Chief Global Supply Chain Officer,  reporting to the Chief Executive Officer . You will be member of the Executive Committee of Coty.
EFFECTIVE DATE
You will commence employment in this role at the latest on January 14 th , 2018  (the “Effective Date”).
ANNUAL BASE SALARY
You will receive an annual base salary of CHF  650,000 ,  payable in accordance with Coty’s payroll practices and applicable law.
EMPLOYEE BENEFITS
You will be eligible for enrollment in Coty’s benefits plans and programs in effect from time to time for employees generally, subject to the terms and conditions of such plans and programs. Further information regarding these plans and programs will be provided to you on the Effective Date. Coty reserves the right to amend, modify or terminate any of its employee benefit plans or programs at any time and for any reason.
ANNUAL BONUS
You will be eligible to participate in Coty’s Annual Performance Plan (the “APP”) with a target award of 70%  of your annual base salary. The APP is designed to forge a powerful connection between your and the business’s performance and results, and your rewards. Through the APP, you can earn up to 360% of your target award based on business performance. On or around the Effective Date, you will receive further information regarding the APP. Your participation will be subject to the terms of the APP and contingent upon your entry into the attached restrictive covenant agreement. Your awards will be subject to discretionary review and approval of Coty’s Board of Directors. An APP brochure is attached for preview.
EQUITY & LONG-TERM INCENTIVE PLAN
You will be eligible to participate in the Coty Equity & Long-Term Incentive Plan (the “ELTIP”) in accordance with its terms. All equity grants are subject to discretionary review and approval of Coty’s Board of Directors. An ELTIP brochure is attached for preview. The annual ELTIP plan is 1 M USD with an initial grant of 1.5 M USD in the first 2 months of your appointment.





COTY OWNERSHIP PROGRAM
You will be invited to participate in the Coty ownership plan, the Elite program with target investment up to 5 M USD. Further details will be made available on or after the Effective Date.
COMPANY CAR

You will be provided with use of a company car or a car allowance in accordance with Coty’s policies in the United Kingdom.
VACATION
You will accrue vacation days pursuant to Coty’s standard vacation policies for its employees as in effect from time to time.
RELOCATION
SERVICES
Consistent with the International Transfer Policy "ITP",  the Company will provide the following relocation services:
Relocation Allowance: The Company shall pay you a relocation allowance, equal to one twelfth of your annual gross base salary, i.e CHF 54,167  subject to all applicable taxes and withholdings. The purpose of this allowance is to fully compensate all issues or concerns not otherwise dealt with in this Offer Letter. It will be paid to you on the next payroll cycle following your physical relocation, according to the local payroll practices in Geneva .
If you voluntarily cancel your move or resign within twelve (12) months  of your Effective Date, you will be required to reimburse the Company for the total amount of the relocation allowance perceived, in net of social charges and taxes.
Shipment of Household Goods: The Company will pay all reasonable costs of relocating your household goods from Amsterdam to Geneva using the most cost efficient mode available. The shipment will be organized through the preferred relocation agent, as determined globally by the Company. Note that any shipment of bulky or heavy items, alcoholic beverages or items prohibited by customs, as well as pets, plants, pianos, vehicles … will not be covered by the Company.
Temporary living: The Company shall reimburse you upon your arrival for the reasonable costs associated with your temporary housing expenses for a maximum of thirty (30) days. Temporary living may be used prior to your move to  Geneva , provided the maximum of days is not exceeded. Living expenses (meals and sundry expenses…) will not be covered by the Company. The temporary housing will be directly organized through the preferred relocation agent, as determined globally by the Company. 
Housing assistance: The Company will provide reasonable assistance with securing accommodation for you and your family in the area of Geneva,  upon your arrival, with the local relocation agency. The Company will also reimburse you for the agency fees associated with securing an accommodation in the area of London . Reimbursement will be made via an expense report with appropriate receipts.
Work papers and visa: The Company will pay the expense associated with securing the appropriate visa documents and work papers for you.
Tax Assistance :   You are personally responsible for the taxes associated with your income, and expressly exempt the Company and any related companies from any tax or related claims that may arise. The Company will make available to you, and pay the expense of a tax consultant (currently PricewaterhouseCoopers - PwC) for any reasonable tax preparation assistance required for your tax declarations in the Switzerland  for the 2018/2019  and 2019/2020  tax year. Should your employment be terminated during this period, the tax assistance would cease on the termination date.






CONFIDENTIALITY
You will not, during your employment with Coty or at any time thereafter, directly or indirectly disclose or use, for your own benefit or the benefit of any third party, any information disclosed to or acquired, developed, learned or known by you as a result of or in connection with your employment with Coty, that is not generally known in the industry in which Coty and its affiliates are engaged or ascertained from public or published information, about Coty and its affiliates (including without limitation its business, products, processes, systems and services, in existence or under development), its customers, vendors and suppliers (“Confidential Information”). You acknowledge that, because Confidential Information is extremely valuable, Coty and its affiliates take appropriate measures to maintain its confidentiality, and that you have an obligation to safeguard and protect Confidential Information from disclosure and use. You agree not to take with you any documents, materials or things that embody or contain Confidential Information when you leave Coty, and to return all such documents, material and things to Coty prior to your departure. If you are ever asked to disclose any Confidential Information, pursuant to legal process or otherwise, you agree to contact Coty and to seek (to the extent permitted by law) Coty’s consent prior to such disclosure. These confidentiality obligations are permanent and do not lapse upon the termination of your employment with Coty.
RESTRICTIVE COVENANTS
You will be required, as a condition of employment or continued employment, to execute the attached restrictive covenant agreement, which sets forth a reciprocal notice period and obligations you may have with respect to confidentiality, non-competition and non-solicitation.
GOVERNING LAW

This letter will be governed by the laws of Switzerland.   Any and all rights of any applicable works council or union will be observed, and Coty will comply with applicable law and works council and collective bargaining agreements associated with your Coty employment.
ASSIGNMENT
You may not assign any of your rights or obligations under this letter. This letter will be binding upon and inure to the benefit of Coty’s successors and assigns. Without limiting the foregoing, to the extent permissible under applicable law, Coty may assign its rights and delegate its duties hereunder in whole or in part to any transferee of all or a portion of the assets or business to which your employment relates.
ENTIRE AGREEMENT
This letter contains the entire understanding of you and Coty with respect to its subject matter, and supersedes and replaces all prior agreements and understandings, both written and oral, between you and Coty. You acknowledge and agree that no representations or promises concerning your employment with Coty have been made to you except as specifically set forth in this offer letter. Any amendment to this letter must be made in writing and signed by a duly authorized officer of Coty. You agree that your obligations and restrictions under this letter will continue in accordance with its terms, regardless of any change in your title, position or duties (unless otherwise agreed).





 

We look forward to receiving your acceptance of Coty’s offer by signature below by January 11th, 2019

We hope you share our excitement during this transformational time. We look forward to working together in building a true global leader in beauty.

Should you have any questions, please let us know.

With regards,


/s/ Sebastien Froidefond

Sebastien FROIDEFOND
Chief Human Resources Officer



Attachments:
APP Brochure
ELTIP Brochure and Plan Terms
Restrictive Covenant Agreement

Accepted and agreed: Luc Volatier

Sign: /s/ Luc Volatier

Print Name: Luc Volatier

Date: 10th January 2019












 





Exhibit 10.4


COTY

January 8, 2019


Laurent Kleitman


Dear Laurent:

This letter (the "Agreement and Release") confirms our agreement with regard to your separation from employment with Coty Inc. (the "Company"), effective July 7th, 2019 (the "Separation Date"). Our understanding and agreement with respect to your separation is as follows:

1. The last day of your active employment with the Company shall be January 8, 2019 (the "Active Employment Separation Date"). You will be on paid leave during the period from the Active Employment Separation Date through the Separation Date (the "Paid Leave Period").

2. Your total unconditional compensation, payments and benefits from the Company shall be as follows:

a. You will continue to be paid at your current annual base compensation rate of USD 812,000, less applicable statutory deductions and authorized withholdings, through the Separation Date, payable semi-monthly in accordance with the Company's regular and customary payroll schedule and practices.

b. Within 30 days after the Separation Date, you will be paid the sum of USD for all unused vacation benefits which shall accrue as of the Separation Date, which total TBC days, less applicable statutory deductions and authorized withholdings.

c. You will be reimbursed for reasonable documented business expenses incurred by you through the Separation Date, in accordance with Company policy.

d. If you currently have Company medical or dental coverage, you will continue to be eligible to participate in the Company's medical and dental insurance plans for active employees, until the 28th day after the Separation Date (i.e., August 4, 2019). You will receive, under separate cover, general information about your rights to elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act ("COBRA").

e. During the Paid Leave Period, you will remain an employee of the Company, and will perform, from either your home or the Company's offices (as the Company may direct), such duties and responsibilities as the Company reasonably requests, including, without limitation, with respect to transitioning your duties and responsibilities.

Nothing in this Agreement and Release is intended to impair any of these rights.

3. Provided that you execute and return this Agreement and Release to the Company no





later than February 4, 2019, and do not timely revoke your acceptance of this Agreement and Release, you will receive, in addition to the payments and benefits described in paragraph 2, the following:

a. Severance in the gross amount of USD 812,000, less applicable statutory deductions and authorized withholdings, representing twelve months' salary at your current base rate of compensation, payable in a lump sum within 60 days after the Separation Date.

b. Direct payment of your COBRA coverage premiums for the period of twelve months following the Separation Date.

c. An APP Award for the 2019 fiscal year, payable when APP awards are paid by the Company according to APP Targets as communicated to you by letter from Camillo Pane dated from September 17, 2018.

d. Reimbursement of repatriation costs, in accordance with Section 4.12 of your employment agreement with the Company, dated January 16, 2017 (the "Employment Agreement").

The payments and benefits described in this paragraph 3 shall be referred to collectively herein as the "Separation Benefits."

4. Provided that, in addition to timely executing and returning this Agreement and Release to the Company, and not revoking your acceptance of this Agreement and Release, you also execute and return to the Company the separation certificate attached as Exhibit A (the "Separation Certificate") not less than one day and not more than ten days following the Separation Date, and do not timely revoke your acceptance of the Separation Certificate, you will receive, in addition to the payments and benefits described in paragraphs 2 and 3:

a. Forgiveness of the amount of the Sign-On Payment that remains reimbursable by you to the Company pursuant to Section 3.3 of the Employment Agreement.

b. Up to 12 consecutive months of Executive until Landing Outplacement Services Program through Right Management, or other outplacement service provider selected by the Company, such services to commence no later than 30 days following the Separation Date.

The payments and benefits described in this paragraph 3 shall be referred to collectively herein as the "Supplemental Separation Benefits."

5. Except as expressly set forth in this Agreement and Release, you will cease to actively participate in all Company benefit plans and programs as of the Active Employment Separation Date.

6. a. Other than as set forth in this Agreement and Release, you acknowledge and agree that you are not entitled to any additional compensation, bonuses, incentive compensation, payments or benefits of any kind from the Releasees (as that term is defined in paragraph 8(d)), including, without limitation, any notice or separation payments otherwise due under any offer letter or employment agreement you have with the Company (including, without limitation, the Employment Agreement), or under the Coty Severance Pay Plan as amended and restated effective October 1, 2016 (the "Coty Severance Pay Plan") or any other severance plan, policy or arrangement of the Company, and that no representations or promises to the contrary have been made to you or to anyone on your behalf.

a. You further acknowledge and agree that, effective as of the Active Employment Separation Date, you will immediately forfeit in their entirety any and all unvested restricted stock units granted to you under the Long-Term Incentive Plan of the Company in which you currently participate (the “LTIP” and “ELITE”), in accordance with the terms of the LTIP and





ELITE and the forfeiture provisions of the award agreements or terms and conditions with respect thereto.

7. The Company will not object to any lawful application by you to receive unemployment benefits.

8. a.      As a condition of the Company’s willingness to enter into this Agreement and Release, and in consideration for the agreements of the Company contained herein (including, without limitation, the Separation Benefits), you hereby release, waive and forever discharge the Releasees from, and hereby acknowledge full accord and satisfaction of, all claims, demands, causes of action, and liabilities of any kind whatsoever (upon any legal or equitable theory, whether contractual, common law or statutory, under federal, state or local law or otherwise), whether known or unknown, asserted or unasserted, by reason of any act, omission, transaction, agreement or occurrence that you ever had, now have or hereafter may have against any of the Releasees up to and including the date of the execution of this Agreement and Release, except for the Company's obligations pursuant to this Agreement.

Without limiting the generality of the foregoing, you hereby release and forever discharge the Releasees from:

(i)
all claims relating to or arising from your employment with the Company, the terms and conditions of that employment, and the termination of that employment;

(ii)
all claims of employment discrimination or retaliation under any federal, state or local statute or ordinance, public policy or the common law, including, without limitation, claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Acts of 1866, 1870 and 1991, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Family and Medical Leave Act, the New York State and New York City Human Rights Laws, the New York Labor Law, the New York Civil Rights Law, the New York Equal Pay Law, the New York Whistleblower Law and the New York Constitution, as such laws have been amended from time to time;

(iii)
all contract and quasi-contract claims (including, without limitation, claims under the Employment Agreement), claims for promissory estoppel or detrimental reliance, claims for wages, bonuses, incentive compensation, and severance allowances or entitlements (including, without limitation, under the Coty Severance Pay Plan or any other plans, programs, or arrangements of the Company or its affiliates);

(iv)
all claims for employee benefits, including, without limitation, claims under the Employee Retirement Income Security Act of 1974; provided, however, that nothing in this paragraph 8 is intended to release, diminish, or otherwise affect any vested monies or other vested benefits to which you may be entitled from, under, or pursuant to any savings or retirement plan of the Company;

(v)
all claims for fraud, fraudulent inducement, slander, libel, defamation, disparagement, negligent or intentional infliction of emotional distress, personal injury, prima facie tort, negligence, compensatory or punitive damages, or any other claim for damages or injury of any





kind whatsoever; and,

(vi)
all claims for monetary recovery, including, without limitation, attorneys' fees, experts' fees, medical fees or expenses, costs and disbursements and the like.

a. You further agree to waive your rights under any other statute or regulation, state or federal, that provides that a general release does not extend to claims that you do not know or suspect to exist in your favor at the time of executing this Agreement and Release, which if known to you must have materially affected your settlement with the Company.

b. This general release is not intended to and does not affect any rights or claims you may have arising after the date this Agreement and Release is executed by you.

c. For purposes of this Agreement and Release, the term "Releasees" means the Company, its current and former direct and indirect affiliates, divisions, predecessors, successors and assigns (the "Coty Group"), each of their current and former officers, directors, employees, representatives, attorneys and agents, whether acting as agents or in individual capacities, and the Company's pension and welfare benefit plans (and their respective administrators, fiduciaries, trustees and insurers), whether acting as agents or in individual capacities, and this general release shall inure to the benefit of and shall be binding upon and enforceable by all such entities and individuals.

9. You agree to return to the Company, on or before the earlier of (i) the Separation Date or (ii) such earlier date as may be requested by the Company, computer equipment, office keys, credit and telephone cards, ID and access cards, etc., and all original and duplicate copies of your work product and files, calendars, books, employee handbooks, records, notes, notebooks, manuals, mobile phones, iPhones, iPads and similar electronic devices, external drives, thumb drives, memory cards and sticks, computer disks, diskettes, and any other magnetic, digital and other media materials you have in your possession or under your control belonging to the Coty Group, or containing Confidential Information (as defined in paragraph IO(b)). By signing this Agreement and Release, you confirm that you will not retain in your possession or under your control any of the documents or materials described in this paragraph 9, and that your entitlement to any portion of the Separation Benefits or Supplemental Separation Benefit is expressly conditioned upon all such documents and materials having been returned to the Company in accordance with the provisions of this paragraph 9.

10. a.      You agree that, except as provided in the next sentence, the terms and conditions of this Agreement and Release shall be kept in confidence. Unless and until you first obtain written permission from the Company's General Counsel, and only to the extent you obtain such permission, you will not knowingly disclose this information to anyone, except: (i) as reasonably necessary to enforce this Agreement and Release; (ii) to your attorneys or bona fide tax advisors; (iii) to your spouse or spousal equivalent; (iv) as permitted by paragraph 10(g) or paragraph 12(b); (v) to governmental taxing authorities; or, (vi) pursuant to compulsory legal process or a court order.

b. You acknowledge that, while employed by the Company, you had access to and possessed confidential and proprietary information and materials concerning the Coty Group and its agents, customers, employees, vendors, licensors, consultants and suppliers that are not publicly available, including, by way of example: information concerning research and development, trade secrets, sales, products, marketing, merchandising, distribution, manufacturing, finance, technology and intellectual property (patents, design patents, trademarks, trade dress, copyrights); technical and administrative manuals, associated forms, processes, computer hardware and software; strategic and business planning; human resources information concerning employees and former employees, including, without limitation, as to recruitment, retention and compensation, performance evaluations and succession planning; and, actual and threatened claims (collectively, "Confidential Information"). You agree that the Coty Group will be irreparably damaged if you use or disclose Confidential





Information, and you therefore agree never to use or disclose Confidential Information before it has become publicly known through no fault of your own except pursuant to compulsory legal process or a court order. If you are ever asked to disclose any Confidential Information, pursuant to legal process or otherwise, we request that you promptly contact the Company's General Counsel.

c. If permitted by law, you further agree to give reasonable notice to the Company's General Counsel of all attempts by third parties: (i) to compel disclosure of any Confidential Information; or, (ii) to require you to testify in any matter concerning any of the Releasees.

d. You agree that, prior to making any permitted disclosure pursuant to paragraph 10(a)(ii) or (iii), you shall obtain the agreement of the person to whom the disclosure is being made that he or she shall keep confidential the disclosed information.

e. You agree not to initiate any publicity or to solicit or initiate any demand or request by others not party to this Agreement and Release for any disclosure of the Confidential Information.

f. You agree to cooperate with the Company with respect to any inquiries or other matters, including any legal or administrative proceedings brought against the Company, that relate to or arise out of your employment with the Company.

g. Notwithstanding anything in this Agreement and Release to the contrary, you may, without informing or obtaining prior authorization from the Company: (i) disclose trade secrets in confidence to a federal, state or local government official, directly or indirectly, or to your attorney, solely for the purpose of reporting or investigating a suspected violation of law that directly pertains to the trade secrets; (ii) disclose trade secrets in a complaint or other document filed in a judicial or administrative proceeding that directly pertains to the trade secrets, if such filing is made under seal; and, (iii) disclose trade secrets to your attorney and use the trade secrets in a judicial or administrative proceeding brought by you against the Company alleging retaliation for your having reported a violation of law, provided that you file any document containing the trade secrets under seal and do not otherwise disclose the trade secrets, except as required by court order.

11. You agree that you will take no action that is intended, or would reasonably be expected, to harm, disparage or impair the reputation of any of the Releasees.

12. a. You represent that you have not commenced or caused to be commenced, or participated, aided or cooperated in, any action, charge, complaint or proceeding of any kind (on your behalf and/or on behalf of any other person or entity and/or on behalf of or as a member of any alleged class of persons) that is presently pending before any government agency charged with the enforcement of any law, or any self-regulatory authority (each, a "Government Agency"), or in any arbitral or judicial tribunal, against or involving any of the Releasees.

b. Nothing in this Agreement and Release (including, without limitation, your general release in paragraph 8, your return of materials covenant in paragraph 9, your non-disclosure, confidentiality and cooperation covenants in paragraph 10, your non-disparagement covenant in paragraph 11, and your representation in paragraph 12(a)) is intended to or shall (i) prevent, impede or interfere with your ability to file a charge or complaint with any Government Agency, or (ii) limit your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding conducted by any Government Agency, including providing documents or other information, without notice to or prior authorization from the Company.

13. The making of this Agreement and Release is not intended, and shall not be construed, as an admission that any of the Releasees has violated any federal, state or local law, ordinance or regulation, breached any contract, or committed any wrong whatsoever against you.






14. You acknowledge and agree that neither the Company nor anyone acting on its behalf has made any promises, commitments or representations to you concerning the subject matter of this Agreement and Release other than those contained in this Agreement and Release, and that you have not relied upon any statement or representation made by the Company or anyone acting on its behalf with respect to the basis or effect of this Agreement and Release or otherwise.

15. a.      You acknowledge that, before signing this Agreement and Release, you were given a period of at least 21 days in which to review and consider it; you have, in fact, carefully reviewed this Agreement and Release; and you are entering into it voluntarily and of your own free will. You further acknowledge that the Company encouraged you in writing to consult with your attorney before signing it and that, to the extent you wished to do so, you have done so. You further acknowledge that, if you executed this Agreement and Release before the end of the 21-day period, such early execution was completely voluntary, and that you had reasonable and ample time in which to review this Agreement and Release.

a. You acknowledge that, for a period of seven days after you sign this Agreement and Release, you have the right to revoke it by providing notice in writing to the Company's General Counsel, via Fed Ex or other overnight delivery service. This Agreement and Release will not become effective and enforceable until after the expiration of the seven-day revocation period.

b. You understand that your acceptance of any portion of the Separation Benefits at any time more than seven days after you sign this Agreement and Release confirms that you did not revoke your assent to this Agreement and Release and, therefore, that it is effective and enforceable.

c. The Company will only accept a copy of this Agreement and Release signed after the Active Employment Separation Date.

16. If, at any time after the date of the execution of this Agreement and Release, any provision of this Agreement and Release shall be held by any court of competent jurisdiction to be illegal, void or unenforceable, such provision shall be of no force and effect. However, the illegality or unenforceability of such provision shall have no effect upon, and shall not impair the enforceability of, any other provision of this Agreement and Release; provided, however, that if paragraph 8 is held to be illegal, void or unenforceable, you agree to promptly execute a valid general release and waiver in favor of the Releasees.

17. This Agreement and Release contains the entire understanding of the parties with respect to the subject matter hereof, and supersedes all prior agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof, except that any existing post-employment obligations you have with respect to confidentiality, noncompetition, nonsolicitation of clients and nonsolicitation of employees under any agreement entered into between you and the Company (including, without limitation, the Employment Agreement and the Confidentiality, Non-Competition, and Non-Solicitation Agreement between you and the Company) or common law, shall remain in full force and effect. This Agreement and Release may not be changed orally, and no modification, amendment or waiver of any of the provisions contained

in this Agreement and Release, nor any future representation, promise or condition in connection with the subject matter hereof, shall be binding upon any party unless made in writing and signed by such party.

18. This Agreement and Release shall bind you, your heirs, beneficiaries, trustees, administrators, executors, and legal representatives, and shall inure to the benefit of the Releasees, and their respective beneficiaries, trustees, administrators, executors, assigns and legal





representatives. You may not assign any of your rights or obligations under this Agreement and Release. Without limiting the foregoing, the Company may assign its rights and delegate its duties hereunder in whole or in part to any affiliate of the Company or to any transferee of all or a portion of the assets or business to which this Agreement and Release relates.

19. Should any provision of this Agreement and Release require interpretation or construction, it is agreed by the parties that the entity interpreting or construing the Agreement and Release shall not apply a presumption against one party by reason of the rule of construction that a document is to be construed more strictly against the party who prepared the document.

20. This Agreement and Release is governed by the laws of the State of New York, without regard to its conflict of laws provisions. Any disputes under this Agreement and Release shall be brought in a court of competent jurisdiction sitting in the Borough of Manhattan, City of New York, State of New York, USA. The parties hereby consent to the exclusive jurisdiction of such courts and to service of process in any manner provided under New York law . Each party irrevocably waives any objection it may now have or hereafter has with respect to the venue of any suit, action or proceeding brought in any such court, and waives any claim that such court is an inconvenient forum, and further agrees that service of process in accordance with the foregoing shall be deemed in every respect effective and valid personal service of process upon such party.

21. This Agreement and Release may be executed in more than one counterpart, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. Electronic copies and photocopies shall be treated as originals.




If this Agreement and Release is acceptable to you, please indicate your agreement by signing and dating the enclosed copy and returning it to me in the enclosed envelope.

Very truly yours,
/s/ Sebastien Froidefond
Sebastien Froidefond (CHRO)


READ THIS AGREEMENT AND RELEASE AND CAREFULLY CONSIDER ALL OF ITS PROVISIONS BEFORE SIGNING IT; IT HAS IMPORTANT LEGAL CONSEQUENCES AND INCLUDES A GENERAL RELEASE AND WAIVER OF KNOWN AND UNKNOWN CLAIMS. CONSULT YOUR ATTORNEY BEFORE SIGNING IT.

I acknowledge that I have read this Agreement and Release and that I understand and voluntarily accept its terms.

THIS IS A LEGALLY ENFORCEABLE DOCUMENT.

/s/ Laurent Kleitman
Laurent Kleitman
8 January 2019







Exhibit 21.1
Coty Inc.
Subsidiary List
as of March 31, 2019
Entity Name
Domestic Jurisdiction
Coty Argentina S.A.
Argentina
Coty Australia Holdings PTY Ltd.
Australia
Coty Australia Legacy Pty. Limited
Australia
Coty Australia PTY. Limited
Australia
Gresham Cosmetics Pty Ltd
Australia
HFC Prestige International Australia PTY Ltd
Australia
Jemella Australia Pty Limited
Australia
Revolver Distribution PTY Ltd.
Australia
Younique Australia Pty Ltd.
Australia
Coty Beauty Austria GmbH
Austria
HFC Prestige Products N.V.
Belgium
Younique Corporation
Belize
Coty Brasil Comércio Ltda
Brazil
Lancaster do Brasil Cosmeticos Ltda.
Brazil
Savoy Indústria de Cosméticos S.A.
Brazil
Younique do Brasil Participacoes Ltda.
Brazil
StarAsia Distributions (Cambodia) Ltd.
Cambodia
HFC Prestige International Canada, Inc.
Canada
TJoy Holdings Co. Ltd.
Cayman Islands
Coty Cosméticos Chile Limitada
Chile
Coty China Holding Limited
China
Coty Hong Kong Distribution Ltd.
China
Coty International Trade (Shanghai) Co., Ltd.
China
Coty Prestige Shanghai Ltd.
China
HFC (Shanghai) Cosmetics Co., Ltd
China
Nanjing Yanting Trade Co. Ltd.
China
Suzhou Ganon Trading Co., Ltd.
China
Suzhou Jiahua Biochemistry Co. Ltd
China
HFC Prestige Service Costa Rica S.R.L.
Costa Rica
Coty Ceska republika, s.r.o.
Czechia
GHD Scandinavia ApS
Denmark
HFC Prestige International Denmark ApS
Denmark
Coty Holdings UK Limited
England and Wales
Quest Beauty Limited
England and Wales
HFC Prestige International Finland Oy
Finland
Coty S.A.S.
France
Coty France S.A.S.
France
Else France S.A.S.
France
Fragrance Production S.A.S.
France
GHD France S.á r.l.
France
HFC Prestige Holding France
France
Coty Beauty Germany GmbH
Germany
Coty Brands Management GmbH
Germany
Coty Germany Holding GmbH
Germany
Coty Services and Logistics GmbH
Germany

1



Ghd Deutschland GmbH
Germany
HFC Prestige Manufacturing Cologne Germany GmbH
Germany
HFC Prestige Manufacturing Germany GmbH
Germany
HFC Prestige Products GmbH
Germany
HFC Prestige Service Germany GmbH
Germany
Sebastian Europe GmbH
Germany
Wella Grundstuecks- und Vermoegensverwalturngs GmbH & Co. KG
Germany
Zadafo Verwaltungsgesellschaft mbH
Germany
Coty Hellas S.A.
Greece
Wella Hellas MEPE
Greece
Chi Chun Industrial Co. Ltd.
Hong Kong
Coty Hong Kong Limited
Hong Kong
Coty INT Hong Kong Limited
Hong Kong
Coty Prestige Shanghai (HK) Ltd.
Hong Kong
Coty Prestige Southeast Asia (HK) Limited
Hong Kong
GHD Hong Kong Limited
Hong Kong
Ming-De Investment Co. Ltd.
Hong Kong
Super Globe Holdings Ltd.
Hong Kong
Younique Hong Kong, Limited
Hong Kong
Coty Hungary Kft.
Hungary
Coty India Beauty and Fragrance Products Private Limited
India
Wella India Private Limited
India
PT StarAsia Distributions Indonesia
Indonesia
PT. Coty Prestige Southeast Asia Indonesia
Indonesia
Coty Ireland Ltd.
Ireland
Coty UK&I Limited
Ireland
HFC Prestige Manufacturing Ireland Ltd.
Ireland
Coty Italia S.R.L.
Italy
GHD Italia S.r.l.
Italy
Younique Products Italy S.r.l
Italy
HFC Prestige Japan Godo Kaisha
Japan
OPI-Japan K.K.
Japan
Coty Korea Ltd.
Korea, Republic Of
HFC Prestige International Holding Luxembourg SARL
Luxembourg
HFC Prestige International Luxembourg SARL
Luxembourg
Coty INT Malaysia Sdn. Bhd.
Malaysia
Coty Prestige Southeast Asia (M) Sdn. Bhd.
Malaysia
Coty Beauty Mexico, S.A. de C.V.
Mexico
Coty México, S.A. de C.V.
Mexico
Galería Productora de Cosméticos, S. de R.L. de C.V.
Mexico
HFC Cosmetics S. de R.L. de C.V.
Mexico
HFC Prestige International S. de R.L. de C.V.
Mexico
YQ Products MEX S.de R.L. de C.V.
Mexico
Coty Lancaster S.A.M.
Monaco
Coty B.V.
Netherlands
Coty Global 1 B.V.
Netherlands
Coty Global 2 B.V.
Netherlands
Coty Global 3 B.V.
Netherlands
Coty Global 4 B.V.
Netherlands
Coty Global 5 B.V.
Netherlands

2



Coty Global Holdings B.V.
Netherlands
Coty Investments B.V.
Netherlands
HFC Prestige International Netherlands B.V.
Netherlands
HFC Prestige International Netherlands Holding B.V.
Netherlands
Lancaster B.V.
Netherlands
Younique Products B.V
Netherlands
Younique Products Cooperatief U.A.
Netherlands
HFC Prestige International New Zealand Limited
New Zealand
Jemella New Zealand Limited
New Zealand
GHD Scandinavia NUF (Norwegian Branch)
Norway
HFC Prestige International Norway AS
Norway
Coty Prestige Southeast Asia Philippines, Inc.
Philippines
Coty Eastern Europe sp. z.o.o.
Poland
HFC Prestige Service Poland Sp. z.o.o.
Poland
Wella Prestige Products Portugal S.A.
Portugal
HFC Prestige International Puerto Rico LLC
Puerto Rico
Coty Cosmetics Romania SRL
Romania
Bourjois Paris LLC
Russian Federation
LLC Capella
Russian Federation
Russwell Ltd
Russian Federation
Coty Arabia Trading Company LLC
Saudi Arabia
Coty Scot 1 LP
Scotland
Coty Scot 2 LP
Scotland
Coty Asia Pte. Ltd.
Singapore
Coty Prestige Southeast Asia Pte. Ltd.
Singapore
Coty Singapore Pte. Ltd.
Singapore
Coty Southeast Asia Pte. Limited
Singapore
HFC Prestige International Operations Switzerland SARL Singapore Branch
Singapore
HFC Prestige International Singapore Pte. Ltd.
Singapore
Coty Slovenská Republika s.r.o.
Slovakia
Coty Beauty South Africa (PTY) Ltd.
South Africa
Coty South Africa (Proprietary) Limited
South Africa
Good Hair Day South Africa (Proprietary) Limited
South Africa
Coty Beauty Spain, S.L.U.
Spain
Coty Spain S.L., Sociedad Unipersonal
Spain
GHD Spain, S A U
Spain
Younique Spain SL
Spain
HFC Prestige International Sweden AB
Sweden
Coty International S.a.r.l.
Switzerland
HFC Prestige International Holding Switzerland Sàrl
Switzerland
HFC Prestige International Operations Switzerland Sàrl
Switzerland
HFC Prestige International Switzerland Sàrl
Switzerland
So Be Cosmetics S.A.
Switzerland
Coty Prestige (Taiwan) Ltd.
Taiwan, Province Of China
StarAsia Taiwan Co., Ltd.
Taiwan, Province Of China
Coty Prestige Southeast Asia (Thailand) Company Limited
Thailand
HFC Prestige Manufacturing (Thailand) Ltd.
Thailand
HFC Prestij Satış ve Dağıtım Ltd. Şti.
Turkey
Coty Distribution Emirates L.L.C.
United Arab Emirates
Coty Middle East Fzco
United Arab Emirates

3



Coty Regional Trading FZE
United Arab Emirates
HFC Prestige International Operations SARL
United Arab Emirates
Beamly Ltd.
United Kingdom
Beauty International Ltd.
United Kingdom
Bourjois Limited
United Kingdom
Coty Brands Group Limited
United Kingdom
Coty Export U.K. Ltd.
United Kingdom
Coty Manufacturing UK Ltd.
United Kingdom
Coty Services U.K. Ltd.
United Kingdom
Coty U.K. Limited
United Kingdom
Coty UK&I Ltd
United Kingdom
Del Laboratories (U.K.) Limited
United Kingdom
ghd BondCo plc
United Kingdom
GHD Group Holdings Limited
United Kingdom
GHD Group Limited
United Kingdom
GHD Holdings Limited
United Kingdom
HFC Prestige Manufacturing UK Ltd
United Kingdom
HFC Prestige Products Ltd.
United Kingdom
HFC Prestige Service UK Ltd
United Kingdom
Jemella Group (Holdings) Limited
United Kingdom
Jemella Group Limited
United Kingdom
Jemella Limited
United Kingdom
Lancaster Group, Ltd.
United Kingdom
Lion/Gloria Bidco Limited
United Kingdom
Lion/Gloria Holdco Limited
United Kingdom
Lion/Gloria Midco 2 Limited
United Kingdom
Lion/Gloria Midco 3 Limited
United Kingdom
Lion/Gloria Midco Limited
United Kingdom
Lion/Gloria Topco Limited
United Kingdom
Rimmel International Ltd.
United Kingdom
GHD Professional, North America, Inc.
United States - CA
HFC Prestige Products, Inc.
United States - CT
Beamly Inc.
United States - DE
Calvin Klein Cosmetic Corporation
United States - DE
Coty Brands Management Inc.
United States - DE
Coty Holdings, Inc.
United States - DE
Coty Inc.
United States - DE
Coty International LLC
United States - DE
Coty US Holdings Inc.
United States - DE
Coty US LLC
United States - DE
DLI International Holding I LLC
United States - DE
DLI International Holding II Corp
United States - DE
Foundation Serviceco, LLC
United States - DE
Foundation, LLC
United States - DE
Galleria Co.
United States - DE
Graham Webb International, Inc.
United States - DE
HFC Prestige International U.S. LLC
United States - DE
Launch Beauty LLC
United States - DE
O P I Products, Inc.
United States - DE
Rimmel Inc.
United States - DE

4



The Wella Corporation
United States - DE
Noxell Corporation
United States - MD
Younique DISC Corporation
United States - UT
Younique International Holdings LLC
United States - UT
Younique, LLC
United States - UT
Coty Beauty Vietnam Company Limited
Viet Nam


5


Exhibit 31.1
Certification

I, Pierre Laubies, certify that:

1.                                        I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.                                        The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)                                       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)                                       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)                                        Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)                                       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.                                        The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a)                                       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)                                       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    May 8, 2019                    
 
/s/Pierre Laubies
 
 
Pierre Laubies
 
 
Chief Executive Officer
 




Exhibit 31.2
Certification

I, Pierre-André Terisse, certify that:

1.                                        I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.                                        The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)                                       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)                                       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)                                        Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)                                       Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.                                        The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a)                                       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)                                       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    May 8, 2019
 
/s/Pierre-André Terisse
 
 
Pierre-André Terisse
 
 
Chief Financial Officer




Exhibit 32.1
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2018 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2019
 /s/Pierre Laubies
 
 
Pierre Laubies
 
Chief Executive Officer


The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.





Exhibit 32.2
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2018 (the “Report”) of the Company fully complies with the requirements of section 13(a)  or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

                
Date: May 8, 2019
/s/Pierre-André Terisse
 
 
Pierre-André Terisse
 
Chief Financial Officer


The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.





Exhibit 99.1
Ratification of Equity Issuances
WHEREAS , the Company issued Common Stock before 2017 in connection with the vesting or exercise of non-qualified stock options, restricted stock and restricted stock units (collectively, the “Equity Awards”) approved and issued by the Board or the Remuneration & Compensation Committee of the Board (the “RNC”), or pursuant to authority delegated by the RNC to the Company’s Chief Executive Officer (the “CEO”), which such Equity Awards were issued on the dates and in the amounts specified in the stock ledger presented to the Board, which such stock ledger is attached hereto as Exhibit A and incorporated herein by reference;
WHEREAS , in consultation with its advisors, the Board has reviewed the Company’s current books and records (the “Books and Records”) and has identified that the Books and Records may not adequately reflect the intended approval and issuance of the Equity Awards by the Board, the RNC or the CEO, as applicable, and that there may therefore exist certain defective corporate acts and putative stock (as defined in Section 204(h) of the DGCL) that may require ratification under Section 204 of the DGCL;
WHEREAS , there is contemporaneous evidence in the Books and Records (including without limitation, subsequent minutes of the Board and the RNC, the stock ledger of the Company and the financial statements of the Company) of the intent to approve and issue the Equity Awards;
WHEREAS , at the respective times of issuance of the Equity Awards, the Company had sufficient authorized and unissued shares of Common Stock to accommodate the full exercise or vesting, as applicable, of the Equity Awards; and
WHEREAS , the Board has determined that it is advisable and in the best interests of the Company and its stockholders to acknowledge, confirm, approve and ratify the Equity Awards pursuant to and in accordance with Section 204 of the DGCL.
NOW, THEREFORE, BE IT
RESOLVED, that the issuances of the Equity Awards are the defective corporate acts and shares of putative stock, as applicable, to be ratified hereby; and be it
FURTHER RESOLVED , that the Equity Awards were issued on the date(s) and in the amounts set forth in the stock ledger attached hereto as Exhibit A ; and be it
FURTHER RESOLVED , that the nature of the failure of authorization in respect of each of the Equity Awards is that such Equity Awards may not have been duly authorized and approved by the Board, the RNC or the CEO, as applicable, in accordance with applicable law; and be it
FURTHER RESOLVED , that, pursuant to and in accordance with Section 204 of the DGCL, the Equity Awards be, and they hereby are, acknowledged, confirmed, approved and ratified in all respects; and be it
FURTHER RESOLVED , that the officers of the Company be, and each hereby is, authorized, empowered and directed, for and on behalf of the Company, to give notice of the ratification of the Equity Awards in accordance with Section 204(g) of the DGCL; and be it
FURTHER RESOLVED , that the Equity Awards (and the shares of Common Stock issued upon exercise or vesting thereof as applicable) shall, from and after the validation effective time of these resolutions, as provided in Section 204 of the DGCL, be validly issued as of the date(s) such Equity Awards were initially issued (and such shares of Common Stock shall be validly issued, fully paid and non-assessable shares of Common Stock effective as of the time such shares were originally issued).










Exhibit A
Equity Award Issuance Date
Aggregate Number of Equity Awards Granted
Aggregate Number of Shares of Common Stock Issued Upon Vesting or Exercise
February 24, 1998
1 award of Non-Qualified Stock Options
16,670
March 12, 1998
1 award of Non-Qualified Stock Options
16,670
June 1, 1998
4 awards of Non-Qualified Stock Options
54,995
June 22, 1998
3 awards of Non-Qualified Stock Options
103,335
June 30, 1998
31 awards of Non-Qualified Stock Options
745,695
June 14, 2000
1 award of Restricted Stock
9,265
July 31, 2001
1 award of Restricted Stock
7,125
October 9, 2001
1 award of Restricted Stock
4,275
October 10, 2001
3 awards of Restricted Stock
114,250
December 31, 2001
42 awards of Restricted Stock
1,457,190
March 29, 2002
1 award of Restricted Stock
10,690
May 13, 2002
1 award of Restricted Stock
43,750
September 27, 2002
1 award of Restricted Stock
18,750
December 6, 2002
1 award of Restricted Stock
50,000
December 11, 2002
1 award of Restricted Stock
7,125
January 1, 2003
1 award of Restricted Stock
457,000
March 11, 2004
2 awards of Restricted Stock
100,000
March 15, 2004
1 award of Non-Qualified Stock Options
1,670
March 26, 2004
7 awards of Non-Qualified Stock Options
183,005
April 8, 2004
4 awards of Non-Qualified Stock Options
116,835
April 30, 2004
6 awards of Non-Qualified Stock Options
65,685
May 31, 2004
5 awards of Non-Qualified Stock Options
21,100
June 30, 2004
18 awards of Non-Qualified Stock Options
170,480
September 30, 2004
17 awards of Non-Qualified Stock Options,
2 awards of Restricted Stock
579,170
October 31, 2004
5 awards of Non-Qualified Stock Options
53,165
November 30, 2004
31 awards of Non-Qualified Stock Options
1,318,270
December 31, 2004
23 awards of Non-Qualified Stock Options
248,705
January 1, 2005
5 awards of Non-Qualified Stock Options
208,205
January 31, 2005
45 awards of Non-Qualified Stock Options
1,255,015
March 31, 2005
25 awards of Non-Qualified Stock Options
553,230
April 30, 2005
16 awards of Non-Qualified Stock Options
330,065
May 31, 2005
4 awards of Non-Qualified Stock Options
13,840





June 30, 2005
6 awards of Non-Qualified Stock Options
63,800
September 30, 2005
20 awards of Non-Qualified Stock Options
197,235
October 17, 2005
11 awards of Restricted Stock
2,647,915
October 31, 2005
19 awards of Non-Qualified Stock Options,
1 award of Restricted Stock
136,645
November 30, 2005
1 award of Non-Qualified Stock Options
6,665
December 31, 2005
11 awards of Non-Qualified Stock Options
153,390
January 31, 2006
3 awards of Non-Qualified Stock Options
25,000
March 31, 2006
13 awards of Non-Qualified Stock Options
197,670
April 30, 2006
20 awards of Non-Qualified Stock Options
214,840
May 31 2006
10 awards of Non-Qualified Stock Options
80,835
June 30, 2006
10 awards of Non-Qualified Stock Options
92,690
July 31, 2006
1 award of Non-Qualified Stock Options
10,000
September 30, 2006
17 awards of Non-Qualified Stock Options
606,630
October 31, 2006
7 awards of Non-Qualified Stock Options
191,285
November 30, 2006
9 awards of Non-Qualified Stock Options
90,830
December 31, 2006
6 awards of Non-Qualified Stock Options
64,165
January 31, 2007
6 awards of Non-Qualified Stock Options
22,130
February 5, 2007
2 awards of Non-Qualified Stock Options
34,300
February 6, 2007
2 awards of Non-Qualified Stock Options
22,500
March 31, 2007
120 awards of Non-Qualified Stock Options
837,660
April 30, 2007
42 awards of Non-Qualified Stock Options
1,343,435
May 31, 2007
4 awards of Non-Qualified Stock Options
42,500
June 1, 2007
3 awards of Restricted Stock
100,000
June 30, 2007
6 awards of Non-Qualified Stock Options
44,900
July 31, 2007
12 awards of Non-Qualified Stock Options
132,050
September 30, 2007
22 awards of Non-Qualified Stock Options
440,425
October 31, 2007
16 awards of Non-Qualified Stock Options
422,695
November 30, 2007
12 awards of Non-Qualified Stock Options
100,090
December 31, 2007
4 awards of Non-Qualified Stock Options
61,250
January 31, 2008
74 awards of Non-Qualified Stock Options
2,322,095
February 29, 2008
3 awards of Non-Qualified Stock Options
105,000
April 30, 2008
12 awards of Non-Qualified Stock Options
102,535
May 30, 2008
5 awards of Non-Qualified Stock Options
59,330





June 30, 2008
4 awards of Non-Qualified Stock Options
46,250
July 31, 2008
9 awards of Non-Qualified Stock Options
1,706,900
September 30, 2008
29 awards of Non-Qualified Stock Options
1,112,050
October 31, 2008
42 awards of Non-Qualified Stock Options
1,849,650
November 28, 2008
54 awards of Non-Qualified Stock Options
2,078,785
December 31, 2008
4 awards of Non-Qualified Stock Options
1,000,000
February 3, 2009
48 awards of Non-Qualified Stock Options
583,660
July 7, 2009
45 awards of Non-Qualified Stock Options
1,193,950
October 2, 2009
48 awards of Non-Qualified Stock Options
980,400
January 4, 2010
30 awards of Non-Qualified Stock Options
1,472,550
April 12, 2010
56 awards of Non-Qualified Stock Options
1,588,560
July 7, 2010
16 awards of Non-Qualified Stock Options
465,750
October 14, 2010
8 awards of Non-Qualified Stock Options
77,080
January 3, 2011
26 awards of Non-Qualified Stock Options
322,025
April 8, 2011
12 awards of Non-Qualified Stock Options
1,172,000
July 11, 2011
9 awards of Non-Qualified Stock Options
117,400
September 23, 2011
1 award of Restricted Stock Units,
3 awards of Restricted Stock
40,000 (including 30,000 shares of Common Stock issued as Restricted Stock)
October 18, 2011
10 awards of Non-Qualified Stock Options
155,000
January 10, 2012
17 awards of Non-Qualified Stock Options
250,250
April 13, 2012
12 awards of Non-Qualified Stock Options
225,209
July 12, 2012
36 awards of Non-Qualified Stock Options
563,708
July 31, 2012
1 award of Restricted Stock Units
460,375
November 12, 2012
58 awards of Non-Qualified Stock Options
2,137,444
December 31, 2012
1 award of Restricted Stock Units
10,000
January 1, 2013
2 awards of Restricted Stock Units
30,000
January 17, 2013
27 awards of Non-Qualified Stock Options, 25 awards of Restricted Stock Units
761,774 (including 278,509 shares of Common Stock issued as Restricted Stock)
February 28, 2013
1 award of Restricted Stock Units
150
April 23, 2013
59 awards of Non-Qualified Stock Options,
7 awards of Restricted Stock Units
11,405,184 (including 15,530 shares of Common Stock issued as Restricted Stock)
June 12, 2013
37 awards of Restricted Stock
869,770





June 13, 2013
2 awards of Non-Qualified Stock Options,
18 awards of Restricted Stock Units
781,284
June 14, 2013
3 awards of Non-Qualified Stock Options
80,000
June 17, 2013
2 awards of Non-Qualified Stock Options
20,000
June 18, 2013
1 award of Non-Qualified Stock Options
7,500
June 19, 2013
1 award of Non-Qualified Stock Options
12,500
June 21, 2013
3 awards of Non-Qualified Stock Options
25,000
July 2, 2013
2 awards of Non-Qualified Stock Options
15,800
July 10, 2013
3 awards of Non-Qualified Stock Options
39,200
July 31, 2013
1 award of Restricted Stock Units
1,015
August 5, 2013
1 award of Non-Qualified Stock Options
10,000
August 28, 2013
2 awards of Non-Qualified Stock Options
57,260
August 29, 2013
3 awards of Non-Qualified Stock Options
66,500
September 13, 2013
2 awards of Non-Qualified Stock Options
80,000
September 20, 2013
1 award of Non-Qualified Stock Options
7,000
September 24, 2013
1 award of Non-Qualified Stock Options
15,000
September 26, 2013
1 award of Non-Qualified Stock Options
10,000
September 27, 2013
2 awards of Non-Qualified Stock Options
14,000
October 10, 2013
1 award of Non-Qualified Stock Options
10,000
October 16, 2013
2 awards of Non-Qualified Stock Options
30,000
November 7, 2013
1 award of Non-Qualified Stock Options
8,000
November 8, 2013
1 award of Non-Qualified Stock Options
10,000
November 11, 2013
5 awards of Non-Qualified Stock Options
31,363
November 14, 2013
1 award of Non-Qualified Stock Options,
4 awards of Restricted Stock Units
50,500
November 18, 2013
1 award of Non-Qualified Stock Options
20,000
November 21, 2013
1 award of Non-Qualified Stock Options
3,000
November 22, 2013
3 awards of Non-Qualified Stock Options
25,000
November 25, 2013
1 award of Non-Qualified Stock Options
3,000
November 27, 2013
1 award of Non-Qualified Stock Options
2,000
December 10, 2013
2 awards of Non-Qualified Stock Options
30,000
December 11, 2013
1 award of Non-Qualified Stock Options
27,500
December 12, 2013
1 award of Non-Qualified Stock Options
20,000
December 16, 2013
1 award of Non-Qualified Stock Options
4,600
December 23, 2013
1 award of Non-Qualified Stock Options
100
December 23, 2013
1 award of Restricted Stock Units
710
January 7, 2014
7 awards of Non-Qualified Stock Options
46,250
January 8, 2014
1 award of Non-Qualified Stock Options
25,000
January 10, 2014
4 awards of Non-Qualified Stock Options
15,500
January 14, 2014
1 award of Non-Qualified Stock Options
5,000
January 16, 2014
2 awards of Non-Qualified Stock Options
15,000
February 5, 2014
1 award of Non-Qualified Stock Options
10,000
February 6, 2014
1 award of Non-Qualified Stock Options
2,500
February 7, 2014
1 award of Non-Qualified Stock Options
300





February 10, 2014
1 award of Non-Qualified Stock Options
5,000
February 12, 2014
1 award of Non-Qualified Stock Options
5,000
February 14, 2014
7 awards of Non-Qualified Stock Options
55,381
February 18, 2014
4 awards of Non-Qualified Stock Options
85,000
February 18, 2014
7 awards of Non-Qualified Stock Options
70,300
February 20, 2014
5 awards of Non-Qualified Stock Options
120,450
February 21, 2014
3 awards of Non-Qualified Stock Options
50,000
February 24, 2014
1 award of Non-Qualified Stock Options
1,500
February 26, 2014
1 award of Non-Qualified Stock Options
5,000
February 27, 2014
1 award of Non-Qualified Stock Options
28,250
March 2, 2014
5 awards of Restricted Stock Units
68,500
March 3, 2014
1 award of Non-Qualified Stock Options
5,000
March 4, 2014
1 award of Non-Qualified Stock Options
7,500
March 6, 2014
1 award of Non-Qualified Stock Options
60,000
March 7, 2014
2 awards of Non-Qualified Stock Options
96,812
March 10, 2014
7 awards of Non-Qualified Stock Options
111,988
March 11, 2014
3 awards of Non-Qualified Stock Options
109,575
March 12, 2014
2 awards of Non-Qualified Stock Options
147,200
March 13, 2014
1 award of Non-Qualified Stock Options
9,275
March 17, 2014
1 award of Non-Qualified Stock Options
7,500
March 20, 2014
1 award of Non-Qualified Stock Options
3,750
March 25, 2014
2 awards of Non-Qualified Stock Options
77,500
March 28, 2014
1 award of Non-Qualified Stock Options
5,000
March 31, 2014
1 award of Non-Qualified Stock Options
40
April 1, 2014
2 awards of Non-Qualified Stock Options
17,500
April 3, 2014
2 awards of Non-Qualified Stock Options
7,460
April 7, 2014
1 award of Non-Qualified Stock Options
5,000
April 8, 2014
1 award of Non-Qualified Stock Options
37,500
April 9, 2014
1 award of Non-Qualified Stock Options
400
April 10, 2014
2 awards of Non-Qualified Stock Options
12,500
April 21, 2014
2 awards of Non-Qualified Stock Options
8,750
April 22, 2014
1 award of Non-Qualified Stock Options
4,000
April 28, 2014
2 awards of Non-Qualified Stock Options
33,600
April 29, 2014
3 awards of Non-Qualified Stock Options
14,900
May 1, 2014
1 award of Non-Qualified Stock Options
31,250
May 2, 2014
2 awards of Non-Qualified Stock Options
11,000
May 5, 2014
1 award of Restricted Stock Units
657
May 6, 2014
1 award of Non-Qualified Stock Options
4,066
May 7, 2014
1 award of Non-Qualified Stock Options
5,000
May 8, 2014
3 awards of Non-Qualified Stock Options
11,752
May 16, 2014
1 award of Non-Qualified Stock Options
50,000
May 19, 2014
1 award of Non-Qualified Stock Options
7,500
May 20, 2014
1 award of Non-Qualified Stock Options
3,750
May 21, 2014
3 awards of Non-Qualified Stock Options
48,000
May 23, 2014
2 awards of Non-Qualified Stock Options
15,000
May 27, 2014
2 awards of Non-Qualified Stock Options
30,000





May 28, 2014
1 award of Non-Qualified Stock Options
5,000
May 30, 2014
1 award of Non-Qualified Stock Options
7,500
June 2, 2014
1 award of Non-Qualified Stock Options
31,250
June 3, 2014
2 awards of Non-Qualified Stock Options
35,000
June 4, 2014
4 awards of Non-Qualified Stock Options
110,150
June 5, 2014
1 award of Non-Qualified Stock Options
57,900
June 6, 2014
6 awards of Non-Qualified Stock Options
99,600
June 9, 2014
7 awards of Non-Qualified Stock Options
161,213
June 10, 2014
4 awards of Non-Qualified Stock Options
75,787
June 11, 2014
2 awards of Non-Qualified Stock Options
30,000
June 12, 2014
4 awards of Non-Qualified Stock Options,
7 awards of Restricted Stock Units
224,483
June 13, 2014
5 awards of Non-Qualified Stock Options,
18 awards of Restricted Stock Units
1,133,451
June 16, 2014
1 award of Non-Qualified Stock Options
14,600
June 17, 2014
1 award of Non-Qualified Stock Options
15,000
June 18, 2014
1 award of Non-Qualified Stock Options
5,000
June 19, 2014
1 award of Non-Qualified Stock Options
12,500
June 20, 2014
1 award of Non-Qualified Stock Options
3,750
June 24, 2014
1 award of Non-Qualified Stock Options
5,000
June 26, 2014
2 awards of Non-Qualified Stock Options
12,500
June 30, 2014
2 awards of Restricted Stock Units
2,183
July 1, 2014
1 award of Non-Qualified Stock Options
31,250
July 3, 2014
1 award of Non-Qualified Stock Options
5,000
July 9, 2014
1 award of Non-Qualified Stock Options
5,000
July 11, 2014
2 awards of Non-Qualified Stock Options
12,500
July 15, 2014
2 awards of Restricted Stock Units
428
July 21, 2014
1 award of Non-Qualified Stock Options
3,750
July 29, 2014
1 award of Non-Qualified Stock Options
15,000
July 31, 2014
1 award of Non-Qualified Stock Options
1,000
August 1, 2014
1 award of Non-Qualified Stock Options
31,250
August 7, 2014
1 award of Non-Qualified Stock Options
5,000
August 11, 2014
3 awards of Non-Qualified Stock Options
6,106
August 18, 2014
1 award of Non-Qualified Stock Options
15,000
August 19, 2014
1 award of Non-Qualified Stock Options
2,500
August 21, 2014
1 award of Non-Qualified Stock Options
20,000
August 22, 2014
1 award of Non-Qualified Stock Options
2,500
August 29, 2014
4 awards of Non-Qualified Stock Options
80,000
September 2, 2014
1 award of Non-Qualified Stock Options
31,250
September 3, 2014
2 awards of Non-Qualified Stock Options
21,741
September 4, 2014
1 award of Non-Qualified Stock Options
14,059
September 5, 2014
3 awards of Non-Qualified Stock Options
98,500
September 8, 2014
12 awards of Non-Qualified Stock Options
190,000





September 9, 2014
6 awards of Non-Qualified Stock Options
118,450
September 10, 2014
4 awards of Non-Qualified Stock Options
60,000
September 11, 2014
5 awards of Non-Qualified Stock Options
60,000
September 12, 2014
5 awards of Non-Qualified Stock Options
47,500
September 15, 2014
7 awards of Non-Qualified Stock Options
101,000
September 16, 2014
2 awards of Non-Qualified Stock Options
17,500
September 17, 2014
1 award of Non-Qualified Stock Options
10,000
September 18, 2014
2 awards of Non-Qualified Stock Options
10,000
September 30, 2014
1 award of Non-Qualified Stock Options
40,000
October 1, 2014
2 awards of Non-Qualified Stock Options
31,250
October 7, 2014
2 awards of Non-Qualified Stock Options
10,000
October 9, 2014
4 awards of Non-Qualified Stock Options
1,424,700
October 15, 2014
1 award of Restricted Stock Units
739
October 21, 2014
1 award of Non-Qualified Stock Options
5,000
October 22, 2014
1 award of Non-Qualified Stock Options
15,000
October 28, 2014
1 award of Non-Qualified Stock Options
7,500
October 30, 2014
1 award of Non-Qualified Stock Options
9,097
November 3, 2014
2 awards of Non-Qualified Stock Options
38,750
November 6, 2014
4 awards of Non-Qualified Stock Options
43,000
November 7, 2014
7 awards of Non-Qualified Stock Options
100,000
November 10, 2014
8 awards of Non-Qualified Stock Options
112,250
November 11, 2014
10 awards of Non-Qualified Stock Options
109,303
November 12, 2014
9 awards of Non-Qualified Stock Options,
1 award of Restricted Stock Units
108,500
November 13, 2014
4 awards of Non-Qualified Stock Options,
3 awards of Restricted Stock Units
61,997
November 14, 2014
2 awards of Non-Qualified Stock Options
57,500
November 18, 2014
4 awards of Non-Qualified Stock Options
115,100
November 19, 2014
3 awards of Non-Qualified Stock Options
134,100
November 20, 2014
7 awards of Non-Qualified Stock Options
93,636
November 21, 2014
1 award of Non-Qualified Stock Options
2,290
November 25, 2014
7 awards of Non-Qualified Stock Options
67,007
November 26, 2014
2 awards of Non-Qualified Stock Options
17,500
November 28, 2014
4 awards of Non-Qualified Stock Options
43,750
December 1, 2014
2 awards of Non-Qualified Stock Options
46,250
December 2, 2014
2 awards of Non-Qualified Stock Options
12,000
December 4, 2014
1 award of Non-Qualified Stock Options
150,000
December 5, 2014
3 awards of Non-Qualified Stock Options
55,000
December 10, 2014
1 award of Non-Qualified Stock Options
50,000
December 11, 2014
1 award of Non-Qualified Stock Options
1,000
December 12, 2014
2 awards of Non-Qualified Stock Options
13,000
December 16, 2014
1 award of Non-Qualified Stock Options
5,000
December 17, 2014
1 award of Non-Qualified Stock Options
7,500





December 19, 2014
4 awards of Non-Qualified Stock Options
65,000
December 24, 2014
1 award of Non-Qualified Stock Options
3,000
December 26, 2014
1 award of Non-Qualified Stock Options
1,500
December 29, 2014
1 award of Non-Qualified Stock Options
15,000
December 30, 2014
1 award of Non-Qualified Stock Options
1,500
December 31, 2014
2 awards of Restricted Stock Units
42,190
January 2, 2015
2 awards of Non-Qualified Stock Options
17,500
January 7, 2015
2 awards of Non-Qualified Stock Options
20,400
January 31, 2015
3 awards of Restricted Stock Units
2,213
February 4, 2015
2 awards of Non-Qualified Stock Options
5,900
February 5, 2015
6 awards of Non-Qualified Stock Options
71,333
February 6, 2015
16 awards of Non-Qualified Stock Options
223,346
February 9, 2015
4 awards of Non-Qualified Stock Options
87,400
February 10, 2015
1 award of Non-Qualified Stock Options
897
February 12, 2015
1 award of Non-Qualified Stock Options
18,103
February 13, 2015
1 award of Non-Qualified Stock Options
1,700
February 17, 2015
2 awards of Non-Qualified Stock Options
3,200
February 19, 2015
1 award of Non-Qualified Stock Options
5,000
February 23, 2015
2 awards of Non-Qualified Stock Options
6,800
February 24, 2015
1 award of Non-Qualified Stock Options
8,200
February 27, 2015
2 awards of Non-Qualified Stock Options
23,350
March 2, 2015
4 awards of Non-Qualified Stock Options
96,500
March 3, 2015
1 award of Non-Qualified Stock Options
25,000
March 5, 2015
4 awards of Non-Qualified Stock Options
18,364
March 9, 2015
1 award of Non-Qualified Stock Options
1,600
March 16, 2015
1 award of Non-Qualified Stock Options
5,000
March 17, 2015
3 awards of Non-Qualified Stock Options
72,500
March 18, 2015
2 awards of Non-Qualified Stock Options
38,500
March 19, 2015
2 awards of Non-Qualified Stock Options
44,100
March 20, 2015
4 awards of Non-Qualified Stock Options
36,900
March 23, 2015
1 award of Non-Qualified Stock Options
2,000
April 6, 2015
1 award of Non-Qualified Stock Options
7,100
May 8, 2015
3 awards of Non-Qualified Stock Options
28,500
May 11, 2015
1 award of Non-Qualified Stock Options
2,000
May 12, 2015
1 award of Non-Qualified Stock Options
25,000
May 20, 2015
1 award of Non-Qualified Stock Options
6,250
May 26, 2015
2 awards of Non-Qualified Stock Options
14,000
May 27, 2015
1 award of Non-Qualified Stock Options
9,000
May 28, 2015
1 award of Non-Qualified Stock Options
2,500
June 1, 2015
2 awards of Non-Qualified Stock Options
5,678
June 2, 2015
2 awards of Non-Qualified Stock Options
38,322
June 5, 2015
3 awards of Non-Qualified Stock Options
45,000
June 10, 2015
1 award of Non-Qualified Stock Options
2,000
June 15, 2015
1 award of Non-Qualified Stock Options
7,500
June 16, 2015
11 awards of Non-Qualified Stock Options
245,217





June 30, 2015
3 awards of Restricted Stock Units
1,426
July 10, 2015
1 award of Non-Qualified Stock Options
5,000
July 27, 2015
1 award of Restricted Stock Units
8,335
August 13, 2015
1 award of Non-Qualified Stock Options
20,000
August 14, 2015
2 awards of Non-Qualified Stock Options
8,300
August 17, 2015
1 award of Non-Qualified Stock Options
10,000
August 19, 2015
1 award of Non-Qualified Stock Options
5,000
August 21, 2015
2 awards of Non-Qualified Stock Options
75,000
August 24, 2015
2 awards of Non-Qualified Stock Options
10,000
August 25, 2015
1 award of Non-Qualified Stock Options
7,500
August 27, 2015
2 awards of Non-Qualified Stock Options
9,500
August 28, 2015
2 awards of Non-Qualified Stock Options
14,000
August 31, 2015
2 awards of Non-Qualified Stock Options,
2 awards of Restricted Stock Units
47,286
September 1, 2015
1 award of Non-Qualified Stock Options
30,000
September 2, 2015
1 award of Non-Qualified Stock Options
5,000
September 3, 2015
2 awards of Non-Qualified Stock Options
10,000
September 4, 2015
2 awards of Non-Qualified Stock Options
101,323
September 9, 2015
2 awards of Non-Qualified Stock Options
2,500
September 11, 2015
3 awards of Non-Qualified Stock Options
35,300
September 14, 2015
12 awards of Non-Qualified Stock Options
197,500
September 15, 2015
13 awards of Non-Qualified Stock Options
282,000
September 16, 2015
5 awards of Non-Qualified Stock Options
151,500
September 17, 2015
2 awards of Non-Qualified Stock Options
51,255
September 18, 2015
1 award of Non-Qualified Stock Options
23,986
September 21, 2015
1 award of Non-Qualified Stock Options
500
October 13, 2015
1 award of Non-Qualified Stock Options
129,781
October 26, 2015
1 award of Non-Qualified Stock Options
40,000
October 27, 2015
2 awards of Non-Qualified Stock Options
17,185
October 30, 2015
1 award of Non-Qualified Stock Options
98,562
November 6, 2015
2 awards of Non-Qualified Stock Options
31,500
November 9, 2015
1 award of Non-Qualified Stock Options
2,500
November 10, 2015
10 awards of Non-Qualified Stock Options
125,500
November 11, 2015
16 awards of Non-Qualified Stock Options
157,800
November 12, 2015
4 awards of Non-Qualified Stock Options
25,000
November 15, 2015
4 awards of Restricted Stock Units
50,000
November 20, 2015
1 award of Non-Qualified Stock Options
3,000
November 25, 2015
1 award of Non-Qualified Stock Options
12,500
November 30, 2015
1 award of Non-Qualified Stock Options
5,000
December 3, 2015
1 award of Non-Qualified Stock Options
4,400
December 7, 2015
1 award of Non-Qualified Stock Options
16,370
December 9, 2015
6 awards of Non-Qualified Stock Options
77,900





December 10, 2015
2 awards of Non-Qualified Stock Options
50,010
December 11, 2015
4 awards of Non-Qualified Stock Options
40,500
December 16, 2015
4 awards of Non-Qualified Stock Options
22,500
December 17, 2015
5 awards of Non-Qualified Stock Options
25,000
December 31, 2015
4 awards of Restricted Stock Units
6,381
January 11, 2016
1 award of Non-Qualified Stock Options
90,000
January 25, 2016
1 award of Restricted Stock Units
4,167
February 5, 2016
10 awards of Non-Qualified Stock Options
251,597
February 9, 2016
2 awards of Non-Qualified Stock Options
144,980
February 11, 2016
1 award of Non-Qualified Stock Options
3,174
February 12, 2016
3 awards of Non-Qualified Stock Options
4,200
February 16, 2016
3 awards of Non-Qualified Stock Options
111,196
February 17, 2016
15 awards of Non-Qualified Stock Options
407,153
February 18, 2016
4 awards of Non-Qualified Stock Options
207,224
February 19, 2016
5 awards of Non-Qualified Stock Options
28,300
February 22, 2016
1 award of Non-Qualified Stock Options
10,000
February 23, 2016
1 award of Non-Qualified Stock Options
10,000
February 24, 2016
2 awards of Non-Qualified Stock Options
14,000
February 25, 2016
7 awards of Non-Qualified Stock Options
56,316
February 29, 2016
1 award of Non-Qualified Stock Options
2,000
March 2, 2016
3 awards of Non-Qualified Stock Options
57,300
March 3, 2016
1 award of Non-Qualified Stock Options
200
March 4, 2016
1 award of Non-Qualified Stock Options
2,000
March 8, 2016
3 awards of Non-Qualified Stock Options
60,053
March 9, 2016
4 awards of Non-Qualified Stock Options
141,500
March 10, 2016
2 awards of Non-Qualified Stock Options
28,976
March 11, 2016
4 awards of Non-Qualified Stock Options
68,136
March 14, 2016
2 awards of Non-Qualified Stock Options
31,393
March 15, 2016
1 award of Non-Qualified Stock Options
800
March 16, 2016
5 awards of Non-Qualified Stock Options
33,737
March 17, 2016
1 award of Non-Qualified Stock Options
35,555
April 4, 2016
2 awards of Non-Qualified Stock Options
31,477
April 6, 2016
2 awards of Non-Qualified Stock Options
12,000
April 8, 2016
1 award of Non-Qualified Stock Options
15,000
April 18, 2016
2 awards of Non-Qualified Stock Options
37,500
April 19, 2016
1 award of Non-Qualified Stock Options
62,876
April 20, 2016
1 award of Non-Qualified Stock Options
23,360
April 21, 2016
1 award of Non-Qualified Stock Options
12,618
April 25, 2016
1 award of Non-Qualified Stock Options
800
April 27, 2016
1 award of Non-Qualified Stock Options
47,130
April 28, 2016
2 awards of Non-Qualified Stock Options
93,721
April 29, 2016
1 award of Non-Qualified Stock Options
32,325
May 4, 2016
1 award of Non-Qualified Stock Options
10,000
May 5, 2016
2 awards of Non-Qualified Stock Options
46,500
May 10, 2016
1 award of Non-Qualified Stock Options
45,000





May 13, 2016
4 awards of Restricted Stock Units
38,685
May 16, 2016
1 award of Non-Qualified Stock Options
2,500
May 25, 2016
1 award of Non-Qualified Stock Options
350
May 31, 2016
2 awards of Non-Qualified Stock Options
11,000
June 2, 2016
1 award of Non-Qualified Stock Options
97
June 3, 2016
4 awards of Non-Qualified Stock Options
25,000
June 6, 2016
3 awards of Non-Qualified Stock Options
39,200
June 7, 2016
1 award of Non-Qualified Stock Options
17,500
June 9, 2016
1 award of Non-Qualified Stock Options
20,000
June 13, 2016
1 award of Non-Qualified Stock Options
25,000
June 14, 2016
1 award of Non-Qualified Stock Options
5,000
June 15, 2016
4 awards of Non-Qualified Stock Options
13,571
June 16, 2016
2 awards of Non-Qualified Stock Options
132,750
July 11, 2016
1 award of Restricted Stock Units
20,862
August 9, 2016
3 awards of Non-Qualified Stock Options
238,953
August 10, 2016
1 award of Non-Qualified Stock Options
29,167
August 11, 2016
1 award of Non-Qualified Stock Options
15,750
August 12, 2016
1 award of Non-Qualified Stock Options
2,000
August 15, 2016
1 award of Non-Qualified Stock Options
3,732
August 16, 2016
1 award of Non-Qualified Stock Options
100
August 17, 2016
1 award of Non-Qualified Stock Options
3,000
August 18, 2016
6 awards of Non-Qualified Stock Options
32,850
August 19, 2016
1 award of Non-Qualified Stock Options
10,000
August 22, 2016
1 award of Non-Qualified Stock Options
15,000
August 23, 2016
1 award of Non-Qualified Stock Options
350
August 25, 2016
1 award of Non-Qualified Stock Options
32,000
August 29, 2016
2 awards of Non-Qualified Stock Options
40,000
August 30, 2016
1 award of Non-Qualified Stock Options
54,000
September 7, 2016
1 award of Non-Qualified Stock Options
20,000
September 9, 2016
2 awards of Non-Qualified Stock Options
12,400
September 14, 2016
4 awards of Non-Qualified Stock Options
33,900
September 15, 2016
3 awards of Non-Qualified Stock Options
65,500
September 16, 2016
3 awards of Non-Qualified Stock Options
17,500
October 5, 2016
2 awards of Non-Qualified Stock Options
68,000
October 31, 2016
4 awards of Restricted Stock Units
7,249
November 10, 2016
3 awards of Non-Qualified Stock Options
27,500
November 14, 2016
2 awards of Non-Qualified Stock Options
20,000
November 15, 2016
1 award of Non-Qualified Stock Options,
5 awards of Restricted Stock Units
75,000
November 16, 2016
2 awards of Non-Qualified Stock Options
20,000
November 17, 2016
2 awards of Non-Qualified Stock Options
16,000
November 18, 2016
3 awards of Non-Qualified Stock Options
22,500
November 21, 2016
3 awards of Non-Qualified Stock Options
180,168
November 22, 2016
1 award of Non-Qualified Stock Options
49,000
November 25, 2016
1 award of Non-Qualified Stock Options
3,500
November 28, 2016
2 awards of Non-Qualified Stock Options
79,500





December 1, 2016
1 award of Non-Qualified Stock Options
2,000
December 5, 2016
1 award of Non-Qualified Stock Options
10,000
December 6, 2016
1 award of Non-Qualified Stock Options
10,000
December 7, 2016
1 award of Non-Qualified Stock Options
8,000
December 8, 2016
2 awards of Non-Qualified Stock Options
28,500
December 12, 2016
1 award of Non-Qualified Stock Options
20,000
December 13, 2016
1 award of Non-Qualified Stock Options
25,000
December 14, 2016
2 awards of Non-Qualified Stock Options
17,500
December 15, 2016
1 award of Non-Qualified Stock Options
8,000
December 16, 2016
2 awards of Non-Qualified Stock Options
31,500
December 20, 2016
1 award of Non-Qualified Stock Options
20,000
December 22, 2016
1 award of Non-Qualified Stock Options
8,000
January 3, 2017
1 award of Non-Qualified Stock Options
10,000
January 4, 2017
1 award of Non-Qualified Stock Options
10,000
January 6, 2017
1 award of Non-Qualified Stock Options
20,000
January 12, 2017
1 award of Non-Qualified Stock Options
17,088
January 20, 2017
3 awards of Non-Qualified Stock Options
28,755
January 23, 2017
2 awards of Non-Qualified Stock Options,
1 award of Restricted Stock Units
15,122
January 25, 2017
1 award of Non-Qualified Stock Options
5,000
January 31, 2017
5 awards of Restricted Stock Units
4,962
February 7, 2017
3 awards of Non-Qualified Stock Options
48,500
February 9, 2017
1 award of Non-Qualified Stock Options
15,000
February 10, 2017
2 awards of Non-Qualified Stock Options
30,000
February 13, 2017
2 awards of Non-Qualified Stock Options
52,500
February 15, 2017
8 awards of Non-Qualified Stock Options
52,875
February 16, 2017
1 award of Non-Qualified Stock Options
1,900
February 17, 2017
1 award of Non-Qualified Stock Options
30,000
February 21, 2017
1 award of Non-Qualified Stock Options
10,000
February 28, 2017
1 award of Non-Qualified Stock Options
1,000
March 1, 2017
3 awards of Non-Qualified Stock Options
37,500
March 2, 2017
1 award of Non-Qualified Stock Options
8,000
March 7, 2017
3 awards of Non-Qualified Stock Options
36,000
March 8, 2017
1 award of Non-Qualified Stock Options
2,000
March 9, 2017
2 awards of Non-Qualified Stock Options
33,477
March 10, 2017
2 awards of Non-Qualified Stock Options
11,000
March 13, 2017
3 awards of Non-Qualified Stock Options
19,000
March 14, 2017
1 award of Non-Qualified Stock Options
11,250
March 15, 2017
1 award of Non-Qualified Stock Options
13,000
March 16, 2017
5 awards of Non-Qualified Stock Options
39,500
March 17, 2017
6 awards of Non-Qualified Stock Options
48,000
March 22, 2017
2 awards of Non-Qualified Stock Options
15,000
May 8, 2017
1 award of Non-Qualified Stock Options
15,000
May 10, 2017
2 awards of Non-Qualified Stock Options
15,000
May 12, 2017
3 awards of Non-Qualified Stock Options
40,000





May 15, 2017
1 award of Non-Qualified Stock Options
3,000
May 17, 2017
1 award of Non-Qualified Stock Options
15,100
May 19, 2017
1 award of Non-Qualified Stock Options
5,000
June 1, 2017
1 award of Non-Qualified Stock Options
3,000
June 6, 2017
2 awards of Non-Qualified Stock Options
17,000
June 12, 2017
6 awards of Non-Qualified Stock Options
71,075
June 13, 2017
1 award of Non-Qualified Stock Options
10,000
June 15, 2017
1 award of Non-Qualified Stock Options
1,500
June 16, 2017
1 award of Non-Qualified Stock Options
17,500
June 30, 2017
3 awards of Restricted Stock Units
38,738
July 26, 2017
2 awards of Non-Qualified Stock Options
420,600
August 10, 2017
2 awards of Non-Qualified Stock Options
382,630
August 11, 2017
2 awards of Non-Qualified Stock Options
150,000
August 24, 2017
1 award of Non-Qualified Stock Options
20,000
August 25, 2017
3 awards of Non-Qualified Stock Options
6,000
August 29, 2017
1 award of Non-Qualified Stock Options
10,000
August 30, 2017
2 awards of Non-Qualified Stock Options
6,000
August 31, 2017
4 awards of Restricted Stock Units
1,269
September 1, 2017
5 awards of Non-Qualified Stock Options
62,500
September 5, 2017
3 awards of Non-Qualified Stock Options
30,320
September 6, 2017
3 awards of Non-Qualified Stock Options
18,680
September 7, 2017
4 awards of Non-Qualified Stock Options
39,000
September 8, 2017
3 awards of Non-Qualified Stock Options
25,000
September 11, 2017
1 award of Non-Qualified Stock Options
2,500
September 15, 2017
3 awards of Non-Qualified Stock Options
21,000
September 25, 2017
125 awards of Restricted Stock Units
401,647
September 30, 2017
1 award of Restricted Stock Units
190
October 13, 2017
6 awards of Restricted Stock Units
2,890
October 17, 2017
1 award of Non-Qualified Stock Options
5,000
October 27, 2017
4 awards of Non-Qualified Stock Options
2,356
November 13, 2017
3 awards of Non-Qualified Stock Options
45,000
November 14, 2017
4 awards of Non-Qualified Stock Options
74,000
November 15, 2017
5 awards of Restricted Stock Units
70,000
November 25, 2017
2 awards of Restricted Stock Units
721
November 27, 2017
1 award of Non-Qualified Stock Options
2,500
December 4, 2017
1 award of Non-Qualified Stock Options
1,000
December 7, 2017
2 awards of Non-Qualified Stock Options
25,000
December 8, 2017
1 award of Non-Qualified Stock Options
6,500
December 11, 2017
3 awards of Non-Qualified Stock Options
5,208
December 12, 2017
3 awards of Non-Qualified Stock Options
19,173
December 13, 2017
4 awards of Non-Qualified Stock Options
32,865
December 20, 2017
2 awards of Non-Qualified Stock Options
25,000
December 29, 2017
1 award of Non-Qualified Stock Options
18,000
January 16, 2018
1 award of Non-Qualified Stock Options
11,000
January 17, 2018
12 awards of Restricted Stock Units
8,012
February 8, 2018
1 award of Non-Qualified Stock Options
5,000





February 9, 2018
1 award of Non-Qualified Stock Options
26,957
February 12, 2018
8 awards of Non-Qualified Stock Options
213,053
February 14, 2018
7 awards of Non-Qualified Stock Options
122,067
February 15, 2018
2 awards of Non-Qualified Stock Options
86,000
February 16, 2018
1 award of Non-Qualified Stock Options
5,000
February 20, 2018
1 award of Non-Qualified Stock Options
17
February 21, 2018
2 awards of Non-Qualified Stock Options
22,000
February 22, 2018
1 award of Non-Qualified Stock Options
18,000
March 5, 2018
3 awards of Non-Qualified Stock Options
20,000
March 6, 2018
2 awards of Non-Qualified Stock Options
13,000
March 8, 2018
1 award of Non-Qualified Stock Options
37,500
March 16, 2018
2 awards of Non-Qualified Stock Options
30,067
April 16, 2018
2 awards of Non-Qualified Stock Options
30,067
April 23, 2018
2 awards of Restricted Stock Units
1,514
April 27, 2018
1 award of Non-Qualified Stock Options
25,000
April 30, 2018
1 award of Non-Qualified Stock Options
10,000
May 4, 2018
2 awards of Non-Qualified Stock Options
17,000
May 7, 2018
1 award of Non-Qualified Stock Options
15,000
May 9, 2018
1 award of Non-Qualified Stock Options
10,000
May 11, 2018
4 awards of Non-Qualified Stock Options
74,976
May 15, 2018
1 award of Non-Qualified Stock Options
10,000
May 22, 2018
1 award of Non-Qualified Stock Options
48,101
May 27, 2018
1 award of Restricted Stock Units
472
May 30, 2018
1 award of Non-Qualified Stock Options
10,000
May 31, 2018
1 award of Non-Qualified Stock Options
5,000
July 5, 2018
1 award of Non-Qualified Stock Options,
3 awards of Restricted Stock
2,428 (including 997 shares of Common Stock issued as Restricted Stock)
July 10, 2018
1 award of Non-Qualified Stock Options
20,000
July 27, 2018
2 awards of Non-Qualified Stock Options
15,000
August 3, 2018
2 awards of Non-Qualified Stock Options
5,000
August 8, 2018
1 award of Non-Qualified Stock Options
12,500
August 13, 2018
1 award of Non-Qualified Stock Options
7,000
August 24, 2018
1 award of Non-Qualified Stock Options
5,000
September 19, 2018
1 award of Non-Qualified Stock Options
10,000
September 30, 2018
104 awards of Restricted Stock Units
262,947
October 13, 2018
4 awards of Restricted Stock Units
1,354
December 7, 2018
2 awards of Non-Qualified Stock Options
15,000
December 10, 2018
3 awards of Non-Qualified Stock Options
19,000
December 16, 2018
1 award of Restricted Stock Units
804
December 31, 2018
1 award of Restricted Stock Units,
2 awards of Restricted Stock
3,195 (including 1,653 shares of Common Stock issued as Restricted Stock)
January 4, 2019
1 award of Non-Qualified Stock Options
10,000
January 7, 2019
8 awards of Non-Qualified Stock Options
101,545
January 12, 2019
4 awards of Restricted Stock
99,312





February 19, 2019
2 awards of Non-Qualified Stock Options,
1 award of Restricted Stock
8,486 (including 986 shares of Common Stock issued as Restricted Stock)
February 20, 2019
1 award of Non-Qualified Stock Options
20,000
March 1, 2019
1 award of Restricted Stock
12,745
March 13, 2019
1 award of Restricted Stock
1,053
March 28, 2019
1 award of Non-Qualified Stock Options
5,000
March 31, 2019
4 awards of Restricted Stock
3,922